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ABSTRACT
To date, all attempts to isolate PCB dechlorinators using traditional isolation
techniques have failed. In addition, the study of PCB dechlorinating organisms has been
hampered because researchers were unable to grow the organisms in sediment-free, defined
media.

Three microbial species capable of reductive dechlorination of polychlorinated

biphenyls have been identified. These three species are from two phylogenetically distinct
branches, Dehalococcoides (Bedard et al., 2007) and the DF-1/o-17 group (Wu et al., 2002a;
Cutter et al., 2001). The three cultures from which polychlorinated biphenyl dechlorinators
have been identified used similar strategies to “wean” the microbes from the sediments. In
this

research,

a

sediment-free

culture

capable

of

dechlorinating

2,2’,3,3’,4,6’-

hexachlorobiphenyl (PCB 132) and 2,2’,3,4’,6-pentachlorobiphenyl (PCB 91) was developed
from the sediments of Lake Hartwell, South Carolina. The culture is designated the LH
culture. The microorganisms in the LH culture responsible for dechlorinating the PCBs
were identified as two Dehalococcoides strains.
Quantitative real time polymerase chain reaction showed that the number of
Dehalococcoides present in the PCB amended treatment increased as PCB 132 was
dechlorinated, while the numbers remained constant in the treatment without PCBs added.
This indicated that PCBs were required for growth of Dehalococcoides. Quantitative real time
polymerase chain reaction using reductive dehalogenase specific primers and probes for
reductive dehalogenase genes showed that the ardA gene was present, but the tceA, bvcA, and
vcrA genes were not. There were approximately half as many copies of the ardA gene as
there were Dehalococcoides 16S ribosomal ribonucleic acid copies, indicating the presence of

ii

two organisms, one of which contained the ardA gene, while the other did not.
Dehalococcoides specific primers were used to amplify and clone nearly complete 16S rRNA
sequences from the LH second enrichment culture. The sequences were nearly identical.
The LH 16S rRNA sequence most closely matched all known Dehalococcoides strains (>98%).
The LH culture was tested to determine if it would dechlorinate chlorinated
benzenes and/or chlorinated ethenes.

These two classes of compounds were chosen

because they are known to be dechlorinated by various Dehalococcoides strains. The LH
culture failed to dechlorinate any of the chlorinated compounds tested. This suggests that
the two Dehalococcoides strains in the LH culture are novel strains; all of the previously
identified Dehalococcoides strains dechlorinate one or more of the chlorinated compounds
tested.
Previous research has shown that different electron donors can affect the rate of
polychlorinated biphenyl dechlorination (Pulliam Holoman et al., 1998; Wu et al., 2000).
Lactate, acetate, propionate, and hydrogen were provided as electron donors to determine
their effects on the LH culture. Polychlorinated biphenyl dechlorination occurred with each
electron donor. However, dechlorination was the greatest with hydrogen as the electron
donor. This differs from two of the known polychlorinated biphenyl dechlorinators, o-17
and DF-1. It is possible that the LH dechlorinators utilized the hydrogen available in each
of the treatments, while other organisms in the mixed culture utilized the lactate, propionate,
and acetate.
Three microbial inhibitors, 2-bromoethanesulfonate, molybdate, and vancomycin,
were tested to determine their effects on the LH culture. By selecting compounds that
specifically inhibit certain types of microorganisms their role in the mixed culture can be
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inferred. 2-Bromoethanesulfonate inhibits methanogens. Molybdate inhibits sulfate reducing
bacteria. Vancomycin inhibits the gram positive bacteria. BES and molybdate completely
inhibited dechlorination in the LH culture but vancomycin did not, suggesting that
methanogens and sulfate reducing bacteria provide growth factors to the dechlorinators.
A series of experiments was conducted to determine if the addition of a culture
known to contain Dehalococcoides that chlororespire chlorinated ethenes could enhance
polychlorinated biphenyl dechlorination in Lake Hartwell.

Under the experimental

conditions the commercial culture did not enhance dechlorination of the polychlorinated
biphenyls and appears to be unable to dechlorinate PCB 132. The commercial culture used
in these experiments contains strains BAV1, FL2, and CBDB1 (Duhamel et al., 2004).
Considering that the commercial culture used contains three strains of Dehalococcoides, two of
which have been shown to be present in a PCB dechlorinating culture, it is surprising that
activity was not seen in these experiments.
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CHAPTER ONE

INTRODUCTION AND OBJECTIVES
1.1. Introduction
Polychlorinated biphenyls (PCBs) were first produced as complex mixtures in 1929
(Erickson, 1997). These mixtures were produced in several countries under a number of
trade names, including: Aroclor (United States); Clophen (Germany); Phenoclor and
Pyralene (France); Kanechlor (Japan); Fenchlor (Italy); Delor (Czechoslovokia); and Sovol
(USSR) (Erickson, 1992).

PCBs have been used in a wide variety of industrial and

commercial applications, including dielectric fluids in capacitors and transformers; additives
in pesticides, carbonless copy paper, paints, adhesives and sealants; heat transfer fluids;
lubricating and cutting oils; and hydraulic fluids (Erickson, 1997). Total global production of
PCBs was estimated to be about 1.1 x 109 kg through 1980 (Erickson, 1997).
It is estimated that 2.1 x 108 kg of PCBs, or approximately one-fifth of the total
world-wide production, have been released into the environment (Hutzinger and Verrkamp,
1981). Currently, 306 sites on the National Priorities List (NPL) are contaminated with
PCBs (US EPA, 2007). Given the longevity of PCBs in the environment (their production
and use in the United States was banned in 1979), their continued production in other
countries, and their toxic effects [PCBs can act as endocrine disruptors, teratogens, and
carginogens (Cogliano, 1998)], they pose a serious risk to human and environmental health.
Treatment options for PCB contaminated sites are limited and often prohibitively
expensive. The most commonly used remediation strategies, including pump and treat, soil
vapor extraction, in situ steam stripping, surfactants, and cosolvent flooding, are not feasible
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because of the physico-chemical characteristics of PCBs, namely their very low solubilities
and vapor pressures. Thus, the most prevalent remediation strategies for PCB-contaminated
sites are removal of contaminated sediments/soils which are then incinerated or confined in
hazardous waste landfills, or sequestration of the contaminated sediments via capping. Both
of these alternatives can be extremely expensive.

The U.S. Environmental Protection

Agency (EPA) Record of Decision for the Hudson River Superfund Site calls for dredging
approximately 2.65 x 106 yd3 of contaminated sediments at an estimated cost of
$460,000,000 (US EPA, 2000).
Bioremediation is an attractive alternative to dredging and capping.

In situ

bioremediation typically has lower operating and maintenance costs than other remedial
strategies. While it is known that reductive dechlorination of PCBs does occur in situ, very
little is known about the microorganisms responsible for such transformations.

Only

recently have the microorganisms responsible for dechlorination of PCBs in three different
cultures been identified. This lack of basic knowledge about the microorganisms responsible
for the reductive dechlorination of PCBs is an impediment to improving the remediation of
PCB contaminated sites. The more that can be learned about microorganisms capable of
dechlorinating PCBs the more likely it will be that effective remediation strategies will be
developed. The bioremediation of tetrachloroethene (PCE) and trichloroethene (TCE) is an
example of this. The discovery of Dehalococcoides ethenogenes strain 195, which dechlorinates
PCE completely, producing ethene, made bioremediation of PCE and TCE contaminated
sites feasible (Ritalahti et al., 2010). With the discovery of each new Dehalococcoides strain and
that particular strain’s metabolic capabilities, the options for designing bioremediation
strategies for chloroethene (CE) contaminated sites increases.

2

The identification and characterization of the PCB-dechlorinating microbe(s) from
Lake Hartwell, SC, will add to the body of knowledge about these microorganisms. The
characterization of the dechlorinators’ metabolic capabilities is essential to be able to design
effective treatment strategies. In addition, for any in situ bioremediation strategy to be
effective there must be some knowledge of how the organism interacts with other organisms
present. Any knowledge gained about the interactions of the species in mixed enrichment
culture and in bioaugmentation experiments will prove useful in this effort.
1.2. PCB Nomenclature
PCBs are a class of compounds characterized by a biphenyl ring with one to ten
chlorines attached.

The general structure of PCBs is shown in Figure 1.1a.

The

International Union of Pure and Applied Chemistry (IUPAC) naming system for PCBs is
illustrated in Figure 1.1b. The rings are numbered so that the first ring (the numbers not
followed by the ' symbol) has the lower numbers (i.e. 2,3) and the second ring (designated by
the ' symbol, i.e. 2',4') has the higher numbers of chlorines. IUPAC has also adopted a
system in which the congeners are numbered 1-209, based on the numbering proposed by
Ballschmiter and Zell (1980). The traditional positional descriptors, ortho, meta, and para, are
also used to describe the chlorination of the biphenyl rings (Figure 1.1c). In addition, the
adoption of a common naming scheme has come into use. In this naming scheme, the
chlorines on each ring are numbered, the chlorines of the first ring are listed sequentially,
and then the chlorines of the second ring are listed, separated by a hyphen. An example of
this naming scheme is demonstrated in Figure 1.1d. Throughout this text congeners will be
identified using the IUPAC congener numbers, i.e PCB 132.
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IUPAC: 2,2',3,3',4,6'-hexachlorobiphenyl
Common: 234-236 hexachlorobiphenyl
Figure 1.1 PCB nomenclature; (a) General structure, (b) Chlorine position numbers,
(c) Position relative to the biphenyl bridge, (d) IUPAC and common nomenclature
example.
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1.3. Research Objectives
The overall objective of this research was to identify and characterize the
microorganism(s) responsible for the dechlorination of PCBs in Lake Hartwell sediments.
The specific objectives were as follows:
1)

Develop and characterize an enrichment culture from Lake Hartwell sediments that
reductively dechlorinates PCBs.

2)

Identify the microorganism(s) responsible for reductive dechlorination of PCBs in
the enrichment culture.

Characterize the enrichment culture in terms of its

utilization of other chlorinated compounds as electron acceptors, and the effects of
electron donors and inhibitors on the culture.
3)

Determine if a commercially available culture capable of dechlorinating chlorinated
ethenes is also capable of dechlorinating 2,2’,3,3’,4,6’-hexachlorobiphenyl (PCB 132)
and the effect of bioaugmenting the PCB-dechlorinating enrichment culture with the
commercial culture.
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CHAPTER TWO
LITERATURE REVIEW

2.1. PCB Contamination in Lake Hartwell
Lake Hartwell is a large (56,000 acre) reservoir, portions of which were contaminated
with PCBs as the result of the operation of a capacitor manufacturing plant by Sangamo
Weston, Inc., located in the watershed of the Twelve Mile Creek arm of the lake (SCDHEC,
1976). The plant operated from 1955 to 1978 and utilized 315,000 to 907,000 kilograms of
PCBs per year (US EPA, 1994). It is estimated that about three percent of the PCBs used
were discharged into Twelve Mile Creek, and an additional 181,000 kilograms were
discharged into neighboring Town Creek (US EPA, 1994).

Extensive surveys of the

sediments in Lake Hartwell showed that PCB concentrations were highest in the Twelve
Mile Creek arm of the reservoir, with levels decreasing with distance downstream from
Madden Bridge (Route 15) (Dunnivant, 1985; Germann, 1988; Polansky, 1984). This trend
was mirrored in the PCB concentrations in non-migratory fish (RMT, 1999; US EPA, 1994).
In the 1970s, the U.S. EPA and the South Carolina Department of Health and
Environmental Control (SCDHEC) discovered that fish in the Seneca River arm of Lake
Hartwell had PCB burdens greater than the U.S. Food and Drug Administration’s (FDA)
safe tolerance limit of 5 ppm (prior to 1984). A fish advisory was issued by SCDHEC in
1976 advising that fish caught north of Highway 24 on the Seneca River be released and not
eaten. In 1984, when the U.S. FDA lowered their recommended tolerance limit to 2 ppm,
an additional recommendation was issued that all fish over 3 pounds taken from any portion
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of Lake Hartwell be released and not consumed (SCDHEC, 1987). Figure 2.1 shows the
location of Lake Hartwell and some of the relevant sampling sites used in previous studies.
In 1987, it was proposed that the Twelve Mile Creek watershed and the Seneca River
arm of Lake Hartwell be added to the NPL. The site was finalized on the NPL in 1990
(Elzerman et al., 1991). In 1994, the U.S. EPA issued a Record of Decision for the site, with
monitored natural attenuation and institutional controls selected as the final remedy (US
EPA, 1994).

Inherent in the decision by the U.S. EPA were the assumptions that

sedimentation and management of the Twelve Mile Creek impoundments would result in a
“natural” capping of the contaminated sediments, sequestering them from the biota.
2.2. Current Knowledge of Biodegradation
PCBs can undergo degradation by aerobic microorganisms, resulting in their
transformation to other chlorinated compounds (usually chlorinated benzoates), or by
anaerobic microorganisms, via reductive dechlorination. Reductive dechlorination and the
microorganisms responsible for this process in Lake Hartwell sediments are the focus of this
research.
2.2.1. Reductive Dechlorination
2.2.1.1. Discovery and Mechanisms
Reductive dechlorination is an anaerobic process in which chlorines are removed
from the biphenyl ring and replaced with hydrogen, with the addition of two electrons to the
PCB. Figure 2.2 shows the general reaction.
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Figure 2.1 Map of Lake Hartwell, SC.
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Figure 2.2 PCB dechlorination pathway; [H] = H+ + e-

Reductive dechlorination of PCBs was first proposed as a transformation mechanism
when early measurements of PCB congeners in Hudson River sediments were found to
differ significantly from the congener composition of the original Aroclors released into that
environment (Brown et al., 1984). More highly chlorinated congeners decreased while lower
chlorinated congeners and ortho substituted congeners increased (Brown et al., 1984).
Laboratory experiments later showed that microorganisms eluted from Hudson River
sediments were capable of reductively dechlorinating many of the congeners present in
commercial Aroclors (Quensen et al., 1988; Quensen et al., 1990). Subsequent investigations
have shown similar evidence, both in situ and in vitro, at a variety of PCB-contaminated sites
including the St. Lawrence River (Sokol et al., 1994b), Woods Pond (Bedard and May, 1996),
Silver Lake (Bedard and Quensen, 1995), New Bedford Harbor (Lake et al., 1991; Lake et al.,
1992), Lake Hartwell (Pakdeesusuk et al., 2005), and Charleston Harbor (Wu et al., 1998;
Berkaw et al., 1996).
Reductive dechlorination can occur via metabolic processes, in which the chlorinated
compound serves as the terminal electron acceptor in a respiratory process. The growth of
the Dehalococcoides population in a mixed culture was linked to the dechlorination of Aroclor
1260 (Bedard et al., 2007). The growth of two Chloroflexi bacteria was linked to their use of
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PCBs as terminal electron acceptor (Wu et al., 2002a; Cutter et al., 2001). Bacterium o-17
reductively dechlorinated 2,3,5,6-tetrachlorbiphenyl (PCB 65) with a combination of acetate,
butyrate, and propionate as the only electron donors (Cutter et al., 1998). Bacterium DF-1
dechlorinated 2,3,4,5-tetrachlorobiphenyl (PCB 61) using the same three fatty acids as the
electron donor (Wu et al., 2000).
2.2.1.2. Environmental Conditions
Every microbial species has optimal growth conditions. Thus, the environmental
conditions in which microorganisms reside may affect both the rate and extent of PCB
dechlorination. PCB concentration, the availability of electron donors, the presence of
alternate electron acceptors, micronutrients, temperature, and PCB bioavailability have all
been shown to impact PCB dechlorination.
In early studies of reductive dechlorination, a relationship between PCB
concentration and the rate and extent of dechlorination was observed (Abramowicz et al.,
1993; Fish, 1996; Quensen et al., 1988; Rhee et al., 1993c; Sokol et al., 1995; Sokol et al.,
1998). It has been proposed that there is a concentration threshold, below which reductive
dechlorination does not occur. The value of this threshold varies given the site being
studied. Reported values include 14 µg/g dry sediment for upper Hudson River sediments
(Quensen et al., 1988), and 40 µg/g dry sediment for St. Lawrence River sediments (Sokol et
al., 1998). Further study of St. Lawrence River sediments found that the congeners in
Aroclor 1248 fell into three different categories based on their threshold concentration:
those that were dechlorinated if the concentration was greater than 40 µg/g dry sediment;
those that were dechlorinated if the concentration was greater than 60 µg/g dry sediment;
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and lower chlorinated congeners that increased in concentration with time as more highly
chlorinated congeners were dechlorinated (Cho et al., 2003).
As discussed previously, an electron donor is required for reductive dechlorination to
occur. In the case of PCBs, it has been shown that the addition of an electron donor
shortened the lag time and/or increased the rate of dechlorination in PCB-contaminated
sediments, but did not increase the extent of dechlorination (Abramowicz et al., 1993; Alder
et al., 1993; Klasson et al., 1996; Sokol et al., 1994a). The greatest difficulty with determining
the effects of electron donors on dechlorination is the lack of sediment-free cultures. The
presence of sediment means that electron donors other than the one being studied are
present and can have a confounding effect, making it difficult to draw conclusions on the
effect of the addition.
If the reductive dechlorination is metabolic, with the PCB serving as the terminal
electron acceptor, then the presence of other possible electron acceptors, such as nitrate and
sulfate, may be inhibitory to the process. If, on the other hand, the process is cometabolic,
an additional electron acceptor is necessary.

The effect of nitrate on reductive

dechlorination of PCBs is unclear. Some experiments have shown complete inhibition of
dechlorination in upper Hudson River sediments at 16 mM nitrate (Rhee et al., 1993a).
However, other experiments demonstrated dechlorination in upper Hudson River sediments
at a nitrate concentration of 10 mM (Morris et al., 1992). It is possible that the inhibition is
concentration dependent, or that in the study by Morris et al. (1992) dechlorination occurred
after denitrification had consumed the nitrate. The effect of sulfate on dechlorination is also
unclear. It has been reported that PCB dechlorination in upper Hudson River sediments,
Silver Lake sediments, and New Bedford Harbor sediments was completely inhibited by

11

sulfate at a concentration of 30 mM (Alder et al., 1993). However, under other conditions
partial inhibition (Rhee et al., 1993a) or no inhibition (Morris et al., 1992) occurred in
microcosms amended with 10 mM sulfate. More thorough investigations that follow both
the PCB concentrations and the concentrations of alternative electron acceptors are needed
to clarify this subject, but are beyond the scope of this research study.
In addition to an electron donor and an electron acceptor, microorganisms require a
variety of trace nutrients for growth. The trace minerals contained in Revised Anaerobic
Minimal Media (RAMM; boron, cobalt, copper, manganese, molybdenum, nickel, selenium,
and zinc) increased the rate of dechlorination of Aroclor 1242 in microcosm studies
(Abramowicz et al., 1993). The rate of dechlorination of 2,3,3’,4,4’-pentachlorobiphenyl
(PCB 105) increased with the individual addition of each of the following metals: zinc,
copper, nickel, selenium, and boron (Abramowicz et al., 1993). Given the difficulties of
culturing PCB dechlorinators, it is likely there is more to discover about the nutritional
requirements of these microbes.
In addition, a variety of environmental factors can affect microbial growth. Each
microbial species has an optimum growth temperature, a minimum temperature below
which the organism will not grow, and a maximum temperature above which the organism
will not grow. pH can also affect microbial growth. Most microorganisms grow best in the
neutral pH range (pH 6-8). However, some species have extremely acidic (pH = 0.7) or
extremely alkaline (pH = 11) optimal pHs. Osmotic effects also play a role in microbial
growth. Most organisms grow best when the water activity is between 0.9 and 1.0.
Of these factors, temperature is the only one that has been studied in depth for
microorganisms capable of dechlorinating PCBs. Temperature has been shown to influence
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the rate, extent, and products of PCB dechlorination (Tiedje et al., 1993; Wu et al., 1996).
The optimum temperature for PCB dechlorination in Hudson River sediments was 25 ˚C,
with a range of 12-37 ˚C (Tiedje et al., 1993). A similar temperature range (12- 34 ˚C) for
dechlorination was reported for Sandy Creek Nature Center Pond and Woods Pond
sediments (Wu et al., 1996). In addition, dechlorination under thermophilic conditions (5060 ˚C) was observed in one of the sediment cultures (Wu et al., 1996). The dechlorination of
Aroclor 1260 in Woods Pond, MA, sediments was strongly affected by temperature (Wu et
al., 1997b). At lower temperatures (15 ˚C), process N1,2 dominated; at higher temperatures
(34 C), process P3 was dominant (Wu et al., 1997b). At moderate temperatures (25 ˚C), a
combination of processes N, LP4, and P was observed (Wu et al., 1997b).
2.2.2. Evidence of PCB Dechlorination in Lake Hartwell
A variety of field and laboratory evidence has been accumulated showing that
reductive dechlorination has occurred in situ in the contaminated sediments of Lake
Hartwell. Field surveys were conducted in 1987 (Germann, 1988), 1998 (Pakdeesusuk et al.,
2005), and 2005 (Sivey, 2005). A comparison of the three data sets and an analysis of the
trends observed over time are provided by Sivey and Lee (2007). For all three time points,
the average number of chlorines per biphenyl decreases with sediment depth while the
percent ortho chlorines increases with depth, thereby providing evidence that reductive
dechlorination has occurred in the deeper, anaerobic sediments. In addition, a comparison

1

Dechlorination processes describe different dechlorination patterns first observed in situ and later in vitro.
An overview of the various processes can be found in Bedard and Quensen (1995).
2
Process N is characterized by the removal of flanked meta chlorines.
3
Process P is characterized by the removal of flanked para chorines.
4
Process LP is characterized by the removal of unflanked para chlorines.
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of equivalent depths shows that the average number of chlorines per biphenyl has decreased
over time, while the percent ortho chlorines has increased over time.
Studies conducted by the U.S. EPA, to evaluate the recovery of sediments in the
Lake Hartwell Superfund site, showed similar results. Analysis of sediment cores taken in
2000 and 2001 showed that total PCB concentrations were less than 1 mg/kg for surface
sediments (0-10 cm) in Twelve Mile Creek and less than 10 mg/kg for surface sediments (010 cm) in the upper portion of Lake Hartwell (Brenner et al., 2004). This indicates that
natural sedimentation is occurring, and that the more heavily contaminated sediments are
being buried. Looking at the homologs, surface sediments contained approximately 30%
mono-, di-, and tricholorobiphenyls; 65-69% tetra-, penta-, and hexachlorobiphenyls; and
less than 5% hepta-, octa-, nona-, and decachlorobiphneyls (Magar et al., 2005a). Buried
sediments, on the other hand, contained approximately 80% mono-, di-, and
tricholorobiphenyls and approximately 20% tetra-, penta-, and hexachlorobiphenyls (Magar
et al., 2005a). Polytopic vector analysis was used to identify the end member patterns of the
PCB congeners. The predominant patterns found in the surface sediments were Aroclor
1242 and a 1:1 mixture of Aroclor 1248 and Aroclor 1254, representing the PCB source
pattern (Magar et al., 2005b). The predominant patterns found in the buried sediments were
consistent with the end products of Process C5 and Process H'6 dechlorination (Magar et al.,
2005b).
Microcosm studies, using sediment from Lake Hartwell as inoculum, demonstrated
the ability of the native microorganisms to dechlorinate Aroclor 1254 (Pakdeesusuk et al.,
5
Process C is a combination of processes M and Q. Thus flanked and unflanked meta chlorines (Process
M) and flanked and unflanked para chlorines (Process Q) are removed.
6
Process H' is characterized by the removal of flanked and doubly flanked para chlorines.
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2003b). Microcosms containing sediment from the G30 site (Figure 2.1), which is the same
site where cores were taken to use in this research, showed a decrease in the average number
of chlorines per biphenyl from 4.8 to 2.9, with a maximum rate of dechlorination of
0.87 µg-atoms Cl- per gram sediment dry weight per week. Microcosms inoculated with
sediment from the G33 site (Figure 2.1) showed a statistically similar decrease (Student’s t
test, α = 0.05) in the average number of chlorines per biphenyl, from 4.9 to 3.0. The rate of
dechlorination, however, was significantly lower: 0.29 µg-atoms Cl- per gram sediment dry
weight per week. Thus, there is evidence, both in situ and in vitro, that the reductive
dechlorination of PCBs has occurred in Lake Hartwell.
PCB 132 was selected to further study reductive dechlorination in Lake Hartwell
sediments and to enrich for dechlorinating microorganisms in this research for several
reasons. PCB 132 has been shown to be reductively dechlorinated in microcosms inoculated
with Lake Hartwell sediments (Pakdeesusuk et al., 2003a). In addition, PCB 132 is a major
component of PCB mixtures (Aroclor 1248 and 1254) released into Lake Hartwell.
2.2.3. Identification of PCB Dechlorinators
To date, two phylogenetically distinct groups of microorganisms have been
implicated in the reductive dechlorination of PCBs. The Dehalococcoides population of a
mixed culture (designated the JN culture) is responsible for the dechlorination of Aroclor
1260 (Bedard et al., 2007). The JN culture was developed from Aroclor 1260 contaminated
Housatonic River (Lenox, MA) sediments (Bedard et al., 2006). The second group of PCB
dechlorinators identified, known as the DF-1/o-17 group, was enriched from PCB
contaminated harbor sediments.

The first dechlorinator was enriched from Baltimore
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Harbor sediments, which are contaminated with PCBs, as well as a wide variety of other
contaminants including polycyclic aromatic hydrocarbons, metals, and pesticides.

This

organism, designated bacterium o-17 (Cutter et al., 2001), is unusual in that it specifically
removes chlorines from the ortho positions. The second dechlorinator was obtained from
Charleston Harbor sediments, another highly contaminated sediment.

This organism,

designated DF-1 (Wu et al., 2002a), removes chlorines from the meta or para position as long
as they are doubly flanked.
To date, all attempts to isolate PCB dechlorinators using traditional isolation
techniques have failed. In addition, the study of PCB dechlorinating organisms has been
hampered because researchers were unable to grow the organisms in sediment-free, defined
media. The three cultures from which PCB dechlorinators have been identified used similar
strategies to “wean” the microbes from the sediments.
The following procedure was utilized in developing the JN culture (Bedard et al.,
2006). Microcosms containing contaminated Housatonic River sediments and ultrapure
H2O (60% wet sediment, 40% water) were amended with disodium malate (10 mM) and
2,6-dibromobiphenyl (26-BB, 350 µM), which served as a “primer” for PCB dechlorination.
Next, three sequential transfers were made into a sterilized sediment slurry, having the same
composition as the microcosms and also amended with disodium malate and 26-BB. In
addition a vitamin solution was added. Supernatant from the third transfer containing
sediment was used to inoculate (10% final volume) a defined minimal medium amended
with selenite-tungstate, vitamins, and a trace element solution. Because sediment was no
longer present, providing a PCB source, a system for adding Aroclor 1260 to the bottles
prior to inoculation was developed. Aroclor 1260, dissolved in acetone, was added to sterile
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silica. The bottoms and walls of the bottles were coated with this mixture, and then the
acetone was evaporated under a stream of N2 gas.
The following procedure was utilized in the identification of bacterium o-17 (Cutter
et al., 1998). The initial culture contained approximately 5% dry weight sediment/volume, in
estuarine salts medium with sodium acetate, propionate, and butyrate added as electron
donors. These cultures were spiked with PCB 65. Sequential transfers were made by
transferring culture supernatant (10% v/v) to new bottles containing 0.1% (dry wt/v dried
sediment) autoclaved Baltimore Harbor sediment. After several transfers, a sediment-free
culture was established by following the same transfer protocol, only omitting the sediment.
A similar procedure was utilized to enrich for bacterium DF-1 (Wu et al., 2000).
Initial cultures were prepared as described above, except Charleston Harbor sediments were
used as the inoculum and they were spiked with PCB 61. Sequential transfers were made by
transferring culture supernatant (1% v/v) into new bottles containing 5% (dry wt/v)
autoclaved Charleston Harbor sediment. After four additional transfers, the amount of
sediment was reduced to 0.1% (dry wt/v). After six transfers into media containing 0.1%
(dry wt/v) sediment, transfers were made without the addition of sediment, to establish a
sediment-free culture.
Because traditional isolation techniques have proven ineffective with PCB
dechlorinators, researchers have utilized molecular techniques to identify them.

The

growing library of known 16S ribosomal ribonucleic acid (rRNA) sequences has allowed
researchers to test mixed cultures for known dechlorinating organisms, using targeted
polymerase chain reaction (PCR) primers. Advances in quantitative real-time PCR (qPCR)
enable researchers to link the growth of particular microbes to dechlorinating activities.
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Techniques such as denaturing gradient gel electrophoresis (DGGE) and terminal-restriction
fragment length polymorphism (RFLP) are used to monitor changes in the community
structure of mixed cultures.
The JN culture was probed for the 16S rRNA sequences of eight known
dehalorespiring organisms: Dehalococcoides, Anaeromyxobacter, Sulfitobacterium, Desulfuromonas,
Dehalobacter, Sulfurospirillum, Geobacter, and DF-1/o-17 type Chloroflexi, using a nested PCR
approach and primers specific for each group (Bedard et al., 2007). Dehalococcoides was the
only bacteria detected in the JN culture genomic deoxyribonucleic acid (DNA) (Bedard et al.,
2007). qPCR was used to link the increase in Dehalococcoides numbers in the JN culture to the
dechlorination of Aroclor 1260 (Bedard et al., 2007). Using these numbers a yield of 9.25 x
108 ± 0.13 x 108 cells per µmol chloride released was calculated (Bedard et al., 2007).
DGGE was used to monitor the community profile of the o-17 culture in response
to various culture conditions (Cutter et al., 2001). The band on the DGGE gel associated
with the dechlorinating activity was identified and sequenced. Two bands, designated A and
E, were seen in all the actively dechlorinating treatments.

To determine whether the

microorganism represented by band A or by band E was responsible for the dechlorinating
activity, cultures were grown with acetate and PCB, then transferred into media with acetate
but without PCB, then transferred from those cultures back into media containing PCB. A
comparison of the DGGE profiles of these three cultures showed that band A disappeared
when PCB was not supplied, indicating that this organism requires PCB to grow. Band A
was excised from the DGGE gel and its DNA sequenced. Phylogenetic analysis of the
sequence indicated that bacterium o-17 was most closely related to Dehalococcoides spp.,
members of a deep branch most closely related to the green non-sulfur bacteria.
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Reductive analysis of DGGE profiles was also used to identify bacterium DF-1 (Wu
et al., 2002a). The DGGE profiles of the DF-1 mixed culture grown with and without PCB
were compared. The DGGE pattern of the PCB-fed culture showed five distinct bands
designated A through E. The DGGE pattern of the culture grown without PCB contained
only bands B through E. This indicates that band A is associated with the dechlorinating
activity.

Microscopic observation of the dechlorinating culture revealed two distinct

morphotypes, a vibrio and a very small irregular cocci. Using a medium selective for sulfate
reducing bacteria (SRBs), the vibrio morphotype was isolated in pure culture. Experiments
with this isolate showed that it was unable to dechlorinate PCB 61. DGGE analysis of this
pure vibrio culture revealed bands B through E, providing confirmation that the species
represented by band A is the dechlorinator. The DGGE bands were excised from the gel,
reamplified, and sequenced. Based on the 16S ribosomal DNA (rDNA) sequence, the
dechlorinator is closely related to Dehalococcoides spp., but is most similar to bacterium o-17
(89%).
A variety of approaches were used to characterize the microorganisms in all three
mixed cultures. The effects of various carbon and energy sources were studied, to determine
the optimal growth conditions. The microcosms and sediment containing JN cultures were
amended with malate (10 mM) as a carbon and energy source (Bedard et al., 2006).
Subsequent sediment-free transfers were carried out in parallel with pyruvate, butyrate,
acetate + formate, or acetate + H2 (Bedard et al., 2006). Initially PCB dechlorination was
faster with pyruvate or butyrate as the carbon and energy source, but by the eighth transfer
without sediment, dechlorination was fastest with acetate + H2 (Bedard et al., 2006).
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Both DF-1 and o-17 were initially fed a mixture of acetate, propionate, and butyrate.
In subsequent transfers of both cultures it was found that PCB dechlorination was faster
when the cultures were fed acetate alone, versus the fatty acid mixture (Cutter et al., 2001;
Pulliam Holoman et al., 1998). Additional tests of the o-17 culture showed that neither
H2:CO2 nor H2:formate supported dechlorination (Cutter et al., 2001). Further studies of the
DF-1 culture tested a variety of carbon and energy sources, including: acetate, butyrate,
crotonate, formate, fumarate, lactate, malate, propionate, pyruvate, and succinate (Wu et al.,
2000). The rate of dechlorination increased 114% when fumarate was supplied as the
carbon and energy source, compared to when the culture was fed the three-fatty-acid
mixture (Wu et al., 2000).
The use of selective microbial inhibitors was also used to help characterize the three
PCB dechlorinating cultures. A parallel set of JN transfer cultures amended with 5 µg/mL
vancomycin, an antibiotic that targets gram-positive bacteria, showed accelerated
dechlorination rates compared to unamended cultures (Bedard et al., 2007). Analysis of the
community structure of JN cultures in the presence and absence of vancomycin indicated
that the proportions of Bacteroidales and Clostridiales decreased and the proportion of
Dehalococcoides increased when vancomycin was present (Bedard et al., 2007).
In the DF-1 culture, the addition of vancomycin resulted in a slight decrease in the
rate of dechlorination (Wu et al., 2000). Vancomycin completely inhibited methanogenesis
in the sediment-containing o-17 culture, but had no effect on dechlorination (Pulliam
Holoman et al., 1998). While Pulliam Holoman et al. (1998) offered no explanation for why
vancomycin, which is a known inhibitor of gram-positive bacteria, inhibited methanogenesis,
which is a metabolic function found in Archaea, it is possible that at high concentrations
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vancomycin also inhibits some Archaea.

Vancomycin inhibits the completion of the

peptidoglycan repeating units found in the cell walls of gram-positive bacteria. The cell walls
of Archaea contain pseudo-peptidoglycan, which has repeating units with a structure very
similar to those of peptidoglycan. Thus, vancomycin may also inhibit the formation of
pseudo-peptidoglycan, especially at high concentrations.
2-Bromoethanesulfonic acid (BES) specifically inhibits methanogens. The effect of
adding BES to the sediment-free o-17 culture was dependent on the concentration of acetate
provided.

When BES (1-3 mM) was added to cultures fed 5 mM sodium acetate,

dechlorinating activity decreased below detectable levels.

When the sodium acetate

concentration was higher (20 mM) dechlorination continued (Cutter et al., 2001). The
addition of BES to the sediment-free DF-1 culture, fed fumarate, resulted in a slight
decrease in the rate of dechlorination (Wu et al., 2000).
Molybdate specifically inhibits SRBs. The addition of molybdate to the o-17 culture
which contained sediment (Pulliam Holoman et al., 1998), and to the sediment-free DF-1
culture (Wu et al., 2000), completely inhibited dechlorination in both cultures. It appears
that SRBs may play an important role in the dechlorinating activities in marine sediments;
whether this is true in freshwater sediments remains to be seen.
In addition, the effects of ampicillin (active against gram negative and gram positive
bacteria); and chloramphenicol, neomycin, and streptomycin (all of which are broad
spectrum antibiotics that inhibit protein synthesis) on DF-1 were tested (Wu et al., 2000).
Addition of each of these, individually, with a final concentration of 10 mg/L, completely
inhibited dechlorination.
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2.2.4. Dehaolococcoides ethenogenes
Dehalococcoides ethenogenes is one of the best studied microbial species known to
accomplish the reductive dechlorination of chlorinated compounds. D. ethenogenes strain 195
was first isolated from an enrichment culture fed H2 and PCE (Maymó-Gatell et al., 1997),
which was developed from a laboratory reactor seeded with digested sludge from a waste
water treatment plant (Freedman and Gossett, 1989).

Strain 195 was the first PCE

dechlorinator isolated that was capable of reducing PCE all the way to ethene (MaymóGatell et al., 1997). Metabolic studies of strain 195 have shown it uses PCE, TCE, cisdichloroethene (DCE), 1,1-DCE, and 1,2 dichloroethane (DCA) as terminal electron
acceptors for growth (Maymó-Gatell et al., 1999). The final step of converting vinyl chloride
(VC) to ethene, however, is co-metabolic (Maymó-Gatell et al., 1999).
Since the discovery of D. ethenogenes strain 195, several additional strains have been
identified. Dehalococcoides strain BAV1, which uses cis-DCE, trans-DCE, 1,1-DCE, VC, vinyl
bromide, and 1,2-DCA as terminal electron acceptors for growth, was isolated (He et al.,
2003).

Dehalococcoides strain CBDB1 dechlorinates 1,2,3-trichlorobenzene (triCB); 1,2,4-

triCB; 1,2,3,4-tetrachlorobenzene (tetraCB); 1,2,3,5-tetraCB; and 1,2,4,5-tetraCB; in a
respiratory process (Adrian et al., 2000). Dehalococcoides strain VS dehalorespires cis-DCE and
VC (Cupples et al., 2003).
Dehalococcoides species have been found to dechlorinate a variety of more complicated
chlorinated compounds. A Dehalococcoides species, strain CBDB1, was identified in four
dioxin-dechlorinating enrichment cultures (Bunge et al., 2003). In addition, Dehalococcoides
strain CBDB1 dechlorinates certain dioxin congeners (Bunge et al., 2003). D. ethenogenes
strain

195

can

dechlorinate

1,2,3,4-tetrachlorodibenzo-p-dioxin;
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1,2,3,4-

tetrachloronaphthalene; hexachlorobenzene; and 2,3,4,5,6-pentachlorobiphenyl (Fennell et
al., 2004). Further study is needed to determine if strain 195 is capable of dechlorinating
other PCB congeners, as well as to test the capabilities of other Dehalococcoides species. Table
2.1 lists the currently known Dehalococcoides strains and their activities against a variety of
chlorinated compounds.
2.3. Chirality
2.3.1. Background
The term chiral is used to describe atropisomers that exist as non-superimposable
mirror images as a result of asymmetry in their structure. There are two major types of
asymmetry: 1) tetrahedral asymmetry around a sp3 bonded carbon or phosphorus atom, with
four different substituent groups attached to the chiral atom; and 2) axial asymmetry about a
carbon-carbon or carbon-nitrogen bond with sterically restricted rotation. Figure 2.3 shows
examples of both types of asymmetry. The pair of chiral molecules that are mirror images of
one another are referred to as enantiomers.
In symmetric environments, the enantiomers of a chiral compound have the same
chemical and physical properties except for the direction in which they rotate polarized light.
The enantiomer which rotates polarized light to the right is designated as (+) and the
enantiomer which rotates light to the left is designated as (-). Thus, when chiral compounds
are produced commercially in a symmetric environment, both enantiomers are produced in
equal amounts, known as a racemic mixture.
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Table 2.1 The dechlorinating activities of various Dehalococcoides strains and known PCB-dechlorinating cultures. ‘+’
indicates the compound has been tested and is used as a terminal electron acceptor. ‘-’ indicates the compound has
been tested and is not dechlorinated. ‘●’ indicates the compound is used co-metabolically. ‘nt’ indicates the compound
has not been tested.
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+ (11)
+ (10) + (11)
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(PCBs)

o-17
(PCBs)

JN
(PCBs)
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(Cornell)

(Pinellas)

KB-1/VC

CBDB1
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● (8)
+ (8)
+ (8)
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- (8)
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Compound
PCE
TCE
cDCE
tDCE
1,1-DCE
VC
Vinyl bromide
1,2-dibromoethane
1,1-difluoroethene
2-chloro-1,1-difluoroethene
chlorotrifluoroethene
trichlorofluoroethene
1,1-dichloro-2,2-difluoroethene
1,2-dichloro-1,2-difluoroethene
chlorinated propanes
1,2-diCP
1,1,1-trichloroethane
1,1,2-trichloroethane
1,1-dichloroethane
1,2-dichloroethane
chloroethane

strain 195

Culture

+ (14) + (15)
● (14) + (15)
- (14) - (15)
- (14) - (15)
- (14) - (15)
- (14) - (15)
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BAV1
(Pinellas)

GT
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(Victoria)

FL2
(Pinellas)

CBDB1
(Pinellas)

KB-1/VC
(Pinellas)

MB
(Cornell)

JN
(PCBs)

o-17
(PCBs)

DF-1
(PCBs)

25

Compound
chloroform
carbon tetrachloride
1,3-dichlorodibenzo-p-dioxin
2,3-dichlorodibenzo-p-dioxin
1,2,3-trichlorodibenzo-p-dioxin
1,2,4-trichlorodibenzo-p-dioxin
2,3,7-trichlorodibenzo-p-dioxin
1,2,3,4-tetrachlorodibenzo-p-dioxin
1,3,7,8-tetrachlorodibenzo-p-dioxin
2,3,7,8-tetrachlorodibenzo-p-dioxin
1,2,3,7,8-pentachlorodibenzo-p-dioxin
trichlorodibenzofuran
1,2,3,4-tetrachlorodibenzofuran
dichloronaphthalene
trichloronaphthalene
1,2,3,4-tetrachloronaphthalene
monochlorobenzene
dichlorobenzene
1,2-dichlorobenzene
1,3-dichlorobenzene
1-4-dichlorobenzene
1,2,3-trichlorobenzene
1,2,4-trichlorobenzene
1,3,5-trichlorobenzene
1,2,3,4-tetrachlorobenzene

strain 195
(Cornell)

Table 2.1 continued
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BAV1
(Pinellas)

GT
(Pinellas)

VS
(Victoria)

FL2
(Pinellas)

CBDB1
(Pinellas)

KB-1/VC
(Pinellas)

MB
(Cornell)

JN
(PCBs)

o-17
(PCBs)

DF-1
(PCBs)
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Compound
1,2,3,5-tetrachlorobenzene
1,2,4,5-tetrachlorobenzene
pentachlorobenzene
hexachlorobenzene
2-chlorobiphenyl
3-chlorobiphenyl
4-chlorobiphenyl
2,3-dichlorobiphenyl
2,4-dichlorobiphenyl
2,5-dichlorobiphenyl
2,6-dichlorobiphenyl
2,2’-dichlorobiphenyl
3,4-dichlorobiphenyl
3,5-dichlorobiphenyl
2,2’,6-trichlorobiphenyl
2,3,4-trichlorobiphenyl
2,3,5-trichlorobiphenyl
2,3,6-trichlorobiphenyl
2,4,5-trichlorobiphenyl
2,4,6-trichlorobiphenyl
3,4,5-trichlorobiphenyl
2,2’,6,6’-tetrachlorobiphenyl
2,3,4,5-tetrachlorobiphenyl
2,3’,4’,5-tetrachlorobiphenyl
2,3,4,6-tetrachlorobiphenyl
2,3’,4’,6-tetrachlorobiphenyl

strain 195
(Cornell)

Table 2.1 continued
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FL2
(Pinellas)

CBDB1
(Pinellas)

KB-1/VC
(Pinellas)

MB
(Cornell)
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nt
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nt
+ (14)
+ (12)
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+ (12)
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+ (12)
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+ (12)
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+ (12)
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(PCBs)
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(Victoria)
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(PCBs)
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JN
(PCBs)

BAV1
(Pinellas)
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Compound
2,3,5,6-tetrachlorobiphenyl
2,4,4’,5-tetrachlorobiphenyl
2,2’,3,3’,6-pentachlorobiphenyl
2,2’,3,4,4’-pentachlorobiphenyl
2,2’,3,4,5’-pentachlorobiphenyl
2,2’,3,4’,5-pentachlorobiphenyl
2,2’,3,4’,6-pentachlorobiphenyl
2,2’,3,5,5’-pentachlorobiphenyl
2,2’,3,5,6’-pentachlorobiphenyl
2,2’,3,5’,6-pentachlorobiphenyl
2,2’,4,4’,5-pentachlorobiphenyl
2,2’,4,5,5’-pentachlorobiphenyl
2,2’,4,5,6’-pentachlorobiphenyl
2,3,3’,4,4’-pentachlorobiphenyl
2,3,3’,4’,6-pentachlorobiphenyl
2,3’,4,4’,5-pentachlorobiphenyl
2,3,4,5,6-pentachlorobiphenyl
2,2’,3,3’,4,4’-hexachlorobiphenyl
2,2’,3,3’,4,5’-hexachlorobiphenyl
2,2’,3,3’,4,6-hexachlorobiphenyl
2,2’,3,3’,4,6’-hexachlorobiphenyl
2,2’,3,3’,5,5’-hexachlorobiphenyl
2,2’,3,3’,5,6-hexachlorobiphenyl
2,2’,3,3’,5,6’-hexachlorobiphenyl
2,2’,3,3’,6,6’-hexachlorobiphenyl
2,2’,3,4,4’,5-hexachlorobiphenyl

strain 195
(Cornell)
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nt
+ (12)
nt
+ (12)
nt
nt
+ (14)
+ (12)
nt
+ (12)
nt
+ (12)
nt
+ (12)
nt
+ (12)
nt
+ (12)
nt
+ (12)
nt
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DF-1
(PCBs)

GT
(Pinellas)

nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt

o-17
(PCBs)

BAV1
(Pinellas)

28

Compound
2,2’,3,4,4’,5’-hexachlorobiphenyl
2,2’,3,4,4’,6-hexachlorobiphenyl
2,2’,3,4,5,5’-hexachlorobiphenyl
2,2’,3,4’,5,5’-hexachlorobiphenyl
2,2’,3,4’,5,6-hexachlorobiphenyl
2,2’,3,4,5,6’-hexachlorobiphenyl
2,2’,3,4,5’,6-hexachlorobiphenyl
2,2’,3,4’,5’,6-hexachlorobiphenyl
2,2’,3,4’,6,6’-hexachlorobiphenyl
2,2’,3,5,5’,6-hexachlorobiphenyl
2,2’,4,4’,5,5’-hexachlorobiphenyl
2,2’,4,4’,5,6’-hexachlorobiphenyl
2,2’,4,4’,6,6’-hexachlorobiphenyl
2,3,3’,4,4’,6-hexachlorobiphenyl
2,3,3’,4’,5’,6-hexachlorobiphenyl
2,3,3’,4’,5,6-hexachlorobiphenyl
2,3’,4,4’,5,5’-hexachlorobiphenyl
2,3,3’,4,4’,5-hexachlorobiphenyl
2,3,3’,5,5’,6-hexachlorobiphenyl
2,2’,3,3’,4,4’,5-heptachlorobiphenyl
2,2’,3,3’,4,4’,6-heptachlorobiphenyl
2,2’,3,3’,4,5,5’-heptachlorobiphenyl
2,2’,3,3’,4,5,6’-heptachlorobiphenyl
2,2’,3,3’,4’,5,6-heptachlorobiphenyl
2,2’,3,3’,4,6,6’-heptachlorobiphenyl
2,2’,3,3’,5,5’,6-heptachlorobiphenyl

strain 195
(Cornell)

Table 2.1 cntd.

nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
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MB
(Cornell)

JN
(PCBs)

o-17
(PCBs)

DF-1
(PCBs)

KB-1/VC
(Pinellas)

nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt

CBDB1
(Pinellas)

nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt

FL2
(Pinellas)

GT
(Pinellas)

nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt

VS
(Victoria)

BAV1
(Pinellas)
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Compound
2,2’,3,3’,5,6,6’-heptachlorobiphenyl
2,2’,3,4,4’,5’,6-heptachlorobiphenyl
2,2’,3,4,5,5’,6-heptachlorobiphenyl
2,2’,3,4’,5,5’,6-heptachlorobiphenyl
2,3,3’,4,4’,5,6-heptachlorobiphenyl
2,3,3’,4’,5,5’,6-heptachlorobiphenyl
2,2’,3,3’,4,4’,5,5’-octachlorobiphenyl
2,2’,3,3’,4,4’,5,6-octachlorobiphenyl
2,2’,3,3’,4,4’,5,6’-octachlorobiphenyl
2,2’,3,3’,4,5,5’,6’-octachlorobiphenyl
2,2’,3,4,4’,5,5’,6-octachlorobiphenyl
2,2’,3,3’,4,4’,5,5’,6-nonachlorobiphenyl
Aroclor 1260
2,4,6-trichlorophenol
pentachlorophenol
(1) (Bunge et al., 2003)
(3) (Fennell et al., 2004)
(5) (Maymó-Gatell et al., 1999)
(7) (Müller et al., 2004)
(9) (Sung et al., 2006)
(11) (Cheng and He, 2009)
(13) (Wu et al., 2002b)
(15) (Miller et al., 2005)

strain 195
(Cornell)

Table 2.1 cntd.

nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
- (11)
nt
nt
nt
nt
- (11)
nt
nt
nt
nt
- (11)
(2) (Adrian et al., 2000)
(4) (He et al., 2003)
(6) (Maymó-Gatell et al., 1997)
(8) (He et al., 2005)
(10) (Duhamel et al., 2004)
(12) (Bedard et al., 2007)
(14) (May et al., 2006)

+ (12)
+ (12)
+ (12)
+ (12)
+ (12)
+ (12)
+ (12)
+ (12)
+ (12)
+ (12)
+ (12)
+ (12)
+ (12)
nt
nt

nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
- (14)
nt
nt

nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
nt
- (13)

HOOC

H

H

COOH

Cl

Cl

Figure 2.3 Examples of tetrahedral and axial chirality.

In asymmetric environments, such as biological systems, the enantiomers may
interact differently. One enantiomer may react more rapidly than the other, resulting in
enantioenrichment or enantioselectivity. A number of chiral compounds have been found
to undergo enantioselective biodegradation, including the herbicide mecoprop (Zipper et al.,
1996), hexachlorocyclohexane (Vetter and Schurig, 1997), and chlordane (Buser et al., 1992),
among others.
The enantiomeric fraction (EF) is currently used to quantify the degree of
enantioselectivity. EF is defined as the chromatographic peak area of the (+) enantiomer
over the sum of the peak areas of both enantiomers (equation 2.1). If the elution order of
the enantiomers is unknown, EF is defined as the peak area of the first eluting enantiomer
over the sum of the peak areas of both enantiomers (equation 2.2) (Harner et al., 2000).
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A+
( A+ + A− )
A1
EF =
( A1 + A2 )

EF =

(2.1)
(2.2)

The EF can range from 0 to 1.0, with an EF = 0.5 representing a racemic mixture.
In some of the early literature, the enantiomeric ratio (ER) is used to describe the
degree of enantioselectivity. ER is defined as the peak area of the (+) enantiomer divided by
the peak area of the (-) enantiomer (equation 2.3), or the peak area of the first eluting
enantiomer divided by the peak area of the second eluting enantiomer when the elution
order is unknown (equation 2.4) (Harner et al., 2000).
A+
A−
A
ER = 1
A2

ER =

(2.3)
(2.4)

Thus the ER can range from 0 to ∞, with an ER = 1.0 representing a racemic mixture.
2.3.2. Atropisomeric PCBs
PCB congeners are considered to be atropisomers if they display axial asymmetry
and have a sufficient energy barrier (≥83 kJ/mol) to prevent rotation about the carboncarbon bridge of the biphenyl moiety (Vetter et al., 1997). Chlorines in the ortho position
provide the steric interference needed for congeners to assume non-planar, asymmetric
conformations. Of the 78 congeners with three or four ortho chlorines, only 19 are predicted
to have rotational energy barriers of 83 kJ/mol or more under environmental conditions
(Kaiser, 1974). These congeners are listed in Table 2.2. Because of the high energy barrier
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of these congeners, the enantiomers are stable even under the high temperature necessary
for gas chromatographic separation (Wong and Garrison, 2000).
2.3.3. Enantiomers and their Environmental Implications
Because the different enantiomers of a chiral compound may undergo different
reaction rates in chiral environments, such as biological systems where many reactions are
enzyme-catalyzed, chiral analysis is a promising tool for studying the contribution of
biodegradation to the fate of chiral compounds in the environment. For example, (S)mecoprop is degraded preferentially over (R)-mecoprop by Sphingomonas herbicidovorans MH
(Zipper et al., 1996). In a study of groundwater contaminated with racemic mecoprop, chiral
analysis showed that at downstream sites there was an excess of (R)-mecoprop, indicating
biodegradation of the mecoprop was occurring in situ (Zipper et al., 1998).
Table 2.2 Chiral PCB congeners
IUPAC Number
Ring 1
Ring 2
PCB 45
2,3,6
2
PCB 84
2,3,6
2,3
PCB 88
2,3,4,6
2
PCB 91
2,3,6
2,4
PCB 95
2,3,6
2,5
PCB 131
2,3,4,6
2,3
PCB 132
2,3,4
2,3,6
PCB 135
2,3,5
2,3,6
PCB 136
2,3,6
2,3,6
PCB 139
2,3,4,6
2,4
PCB 144
2,3,4,6
2,5
PCB 149
2,3,6
2,4,5
PCB 171
2,3,4,6
2,3,4
PCB 174
2,3,4,5
2,3,6
PCB 175
2,3,4,6
2,3,5
PCB 176
2,3,4,6
2,3,6
PCB 183
2,3,4,6
2,4,5
PCB 196
2,3,4,5
2,3,4,6
PCB 197
2,3,4,6
2,3,4,6
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The utility of chiral analysis of PCBs for investigating reductive dechlorination of
PCBs has been demonstrated (Hall, 2004). Chiral analysis provided evidence of reductive
dechlorination in soils in which the PCB levels were so low that achiral analysis of the PCBs
was inconclusive (Hall, 2004). Wong et al. (2001) have proposed that, in addition to using
chiral analysis of PCBs to identify in situ reductive dechlorination, chiral analysis of PCBs
may be used to determine different dechlorination pathways and the various microbial
populations responsible for the different pathways.
The changes in EF of PCB 132, 2,2’,3,4’,5,6’-hexachlorobiphenyl (PCB 149), and
Aroclor 1254 in microcosms inoculated with sediment from Lake Hartwell, SC have been
studied (Pakdeesusuk et al., 2003a). In this Lake Hartwell sediment system, the behavior of
PCB 132 and PCB 149 was unusual. Both are dechlorinated to chiral daughter products,
PCB 132 to 2,2’,3,4’,6-pentachlorobiphenyl (PCB 91) and PCB 149 to 2,2’,3,5’,6pentachlorbiphenyl (PCB 95). In both cases, the parent enantiomers were dechlorinated in a
non-enantioselective manner, that is, both congeners were dechlorinated at the same rate.
Both daughter products were dechlorinated in an enantioselective manner, however, with the
EF of PCB 91 decreasing over time, while the EF of PCB 95 increased with time. The EF
of four congeners (PCB 149, 136, 95, and 91) were determined in the Aroclor 1254-spiked
microcosms. The PCB 149 was again dechlorinated in a non-enantioselective manner, as
was the 2,2’,3,3’,6,6’-hexachlorobiphenyl (PCB 136).

Both the PCB 95 and 91 were

degraded enantioselectively, showing the same direction of change in EF as was seen in the
microcosms spiked with the single congeners.
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CHAPTER THREE
MATERIALS AND METHODS

3.1. Chemicals
Neat PCB 132 was purchased from NeoSyn (New Milford, CT). PCB 91, 51, and 19
were purchased as 100 µg/mL solutions in isooctane from Accustandard (New Haven, CT).
Aldrin was purchased from Supelco (Bellefonte, PA).

Octachloronaphthalene was

purchased from Ultra Scientific (North Kingstown, RI). Isooctane (nanograde), potassium
phosphate dibasic, potassium phosphate monobasic, iron chloride monohydrate, zinc sulfate
monohydrate, cobalt chloride hexahydrate, nickel chloride hexahydrate, sodium sulfide
nonahydrate, and sodium hydroxide were purchased from Mallinckrodt (St. Louis, MO).
Unless otherwise specified, all chemicals obtained from Mallinckrodt were of analytical
reagent grade.

Acetone (pesticide grade), manganese sulfate monohydrate, boric acid,

sodium molybdate monohydrate, sodium carbonate, sodium bicarbonate, and formamide
(super pure) were purchased from Fisher Scientific (Fairlawn, NJ). All chemicals obtained
from Fisher were of American Chemical Society (ACS) certified grade, unless otherwise
specified. Sodium sulfate, sodium chloride, both ACS grade, and acrylamide (Omnipur)
were purchased from EMD (Durham, NC). Alumina and magnesium sulfate heptahydrate
(ACS grade) were purchased from EM Science (Gibbstown, NJ). Ammonium bicarbonate,
sodium selenite, calcium sulfate, and resazurin, all ACS reagent grade, were purchased from
Sigma-Aldrich (Milwaukee, WI). Copper sulfate pentahydrate was purchased from VWR
Scientific (West Chester, PA). Urea and ethidium bromide (10mg/mL), both molecular
biology certified, were purchased from Shelton Scientific, Inc. (Peosta, IA). Ammonium
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persulfate was purchased from Lancaster Synthesis, Inc. (Windham, NH).

N,N,N’,N’-

tetramethylethylenediamine (ultrapure bioreagent) was purchased from J.T. Baker
(Phillipsburg, NJ). All oligonucleotide primers and probes were purchased from Integrated
DNA Technologies, Inc. (Coralville, CA).
Anhydrous sodium sulfate was prepared prior to use by placing it in a 105 C oven
overnight. Deactivated alumina was prepared by placing it in a 500 C oven for four hours
prior to use.
RAMM (Shelton and Tiedje, 1984) was used for preparation of the microcosms and
cultures with the following substitutions: NH4HCO3 (873 mg/L) for NH4Cl; CaSO4 (69.5
mg/L) for CaCl2*2H2O; MgSO4*7H2O (121 mg/L) for MgCl2*6H2O; MnSO4*H2O (0.427
mg/L) for MnCl2*4H2O; ZnSO4*7H2O (0.105 mg/L) for ZnCl2; CuSO4*5H2O (0.557
mg/L) for CuCl2. Also, the amount of sodium bicarbonate was reduced to 365 mg/L. The
molar concentration of each ion of concern was maintained throughout these changes.
These modifications were made to reduce the background chloride concentration in the
microcosms so the amount of chloride released via dechlorination could be monitored using
ion chromatography.
3.2. Lake Hartwell Microcosms
Lake Hartwell sediment was used to inoculate the microcosms. Sediment cores were
taken from sampling location G30, located on the Twelve Mile Creek arm of Lake Hartwell
(34°42’30’’N 82°50’50’’W). A Wildco gravity corer, holding a Lexan™ tube (5 cm diameter
by 76 cm long) and an eggshell core catcher (5 cm) were used to collect the sediment cores.
The corer was washed with tap water prior to use. The Lexan™ tubes were washed with
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detergent, rinsed five times with hot water and then rinsed five times with Milli-Q water and
allowed to air dry before use.

The sediment cores were transported to L.G. Rich

Environmental Lab (Clemson University, Anderson, SC) and extruded and sectioned within
24 hours. The section of one of the cores corresponding to 25-55 cm deep was used to
inoculate the microcosms. An analysis of sediment taken from this site in 1998 showed
higher levels of total PCBs in this section (Pakdeesusuk et al., 2005). The reasoning was that
the dechlorinating microbial population in this segment should be more active due to the
higher concentration of PCBs.
The initial microcosms were prepared in triplicate with the six treatments shown in
Table 3.1. The sediment was homogenized in a blender (Waring Commercial Blender,
model 31BL92, high speed for 2 min) inside an anaerobic chamber (Coy Laboratory
Products, Grasslake, MI) with an atmosphere of approximately 98% N2 and 2% H2 (all
mention of the anaerobic chamber hereafter refers to this chamber and atmospheric
composition). The homogenized sediment was then mixed with the modified RAMM in a
ratio of 15:50 (wet weight, g: volume, mL) as previously described (Pakdeesusuk et al.,
2003b). Resazurin (1 mg/L) served as a redox indicator. While stirring constantly, 100 mL
of the sediment and RAMM slurry was transferred to sterile 160 mL serum bottles, which
were then crimp sealed with Teflon-faced red rubber septa. The bottles were removed from
the chamber and purged for 1 minute with a 70% N2 and 30% CO2 gas mixture to
equilibrate the bicarbonate in the medium with CO2 in the headspace and thereby adjust the
pH to approximately 7. The bottles were spiked with PCB 132 (dissolved in acetone) at a
final concentration of 500 µg/g sediment (dry weight) or 0.158 mM (total PCB 132 added
divided by the total volume, sediment plus media), as described previously (Pakdeesusuk et
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al., 2003b). A sodium lactate solution was added as an electron donor to provide a final
concentration of 150 mg/L. This concentration supplied enough electron equivalents to
completely dechlorinate the PCB 132 added and to satisfy the sulfate demand; the
concentration of sulfate in the modified RAMM was 1.0 mM. Killed controls were prepared
in a similar manner except they were autoclaved for 60 min on three consecutive days prior
to the addition of PCB 132 (lactate was not added to the killed controls). Microcosms were
incubated quiescently, in an upright position, at room temperature (22-24 C), inside the
anaerobic chamber and inside boxes to exclude light.
Table 3.1 Lake Hartwell (LH) microcosm treatment matrix
Treatment
1-1
1-2
1-3
LH +
Killed
PCB132
Control
Live Control
Live
√
√
Killed
√
Sediment
√
√
√
RAMM
√
√
√
PCB 132
√
√
Lactate
√
Acetone
√

1-4
Electron Donor
Control
√
√
√
√
√

3.3. Lake Hartwell Enrichment Culture
To begin enriching for the PCB 132 dechlorinating organisms from Lake Hartwell
sediments, the first enrichment culture was prepared by transferring supernatant from
treatment 1-1 (LH + PCB 132) of the microcosms to new bottles. Each bottle of treatment
1-1 (LH + PCB 132) was shaken vigorously, then the sediment was allowed to settle for five
minutes. The liquid above the sediment was removed and used to inoculate the first
enrichment cultures which contained PCB 132; dried, autoclaved sediment; and RAMM.
Killed controls were not prepared for the enrichment cultures. It is reasonable to assume
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that since reductive dechlorination did not occur in the sediment-rich, heterogeneous
environment of treatment 1-2 (Killed Control) of the microcosms it would not occur in a
killed control for enrichment cultures either. The treatment matrix is shown in Table 3.2.
Table 3.2 LH first enrichment culture treatment matrix.
Treatment
2-1
2-2
LH + PCB 132
Live Control
Live
√
√
Autoclaved Sediment
√
RAMM
√
√
PCB 132
√
√
Lactate
√
Treatment 1-1
√
√
The procedure was as follows. The serum bottles (160 mL) were plated with PCB
132. In this procedure, 1 mL of a 5.71 mg/mL solution of PCB 132 in acetone was added to
each bottle. Once the bottles were filled (100 mL), this resulted in a nominal concentration
of 0.158 mM (i.e., if all of the PCB 132 were dissolved) identical to that of the microcosms.
The acetone was then evaporated using a stream of high purity nitrogen gas while rolling the
bottle along an inclined surface to evenly distribute the PCB 132 along the bottom half of
the bottle. This was done to remove the acetone, which can serve as an electron donor.
The bottles were then capped with grey rubber stoppers and crimp sealed. The headspace of
the empty bottle was checked for acetone using a gas chromatograph (GC) with a flame
ionization detector (FID). The bottles were opened and 0.1 g of Lake Hartwell sediment
that had been dried at 105ºC overnight and then autoclaved at 121ºC for 60 min on three
consecutive days was added to the bottles.

The bottles were placed in the anaerobic

chamber. Treatment 1-1 (Table 3.1) was used to inoculate the enrichment bottles in the
following manner. The microcosm bottles were shaken vigorously by hand. The bottles
were opened and the contents allowed to settle. Then 10 mL of the supernatant from the
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microcosms was transferred to the new bottles, i.e. the enrichment culture bottle. The
enrichment culture bottles were filled to 100 mL with modified RAMM, then sealed with
grey rubber stoppers and crimp tops. Once all of the enrichment culture bottles were made,
the bottles were removed from the glove box and purged for one min with a 70% N2 and
30% CO2 gas mixture to equilibrate the pH. The enrichment culture bottles were placed on
a shaker table overnight to equilibrate and were sampled the next day.
The second enrichment culture was set-up by transferring supernatant from
treatment 2-1 (LH + PCB 132) to new bottles. Killed controls were not prepared for the
second enrichment culture. It is reasonable to assume that as reductive dechlorination did
not occur in the sediment-rich, heterogeneous environment of treatment 1-2 (Killed
Control) of the microcosms it would not occur in a killed control for the enrichment culture
either. The treatment matrix is shown in Table 3.3.
Table 3.3 LH second enrichment culture treatment matrix.
Treatment
3-1
3-2
3-3
Electron Donor
LH + PCB 132
Live Control
Control
Live
√
√
√
RAMM
√
√
√
PCB 132
√
Lactate
√
√
Treatment 2-1
√
√
√
The second enrichment culture was prepared in the same manner as the first
enrichment culture with the following modifications. First, the second enrichment culture
was prepared in 160-mL serum bottles that had been modified by connecting a 1 cm-insidediameter test tube at a right angle to the side of each bottle near the base, resulting in a final
bottle volume of 173 mL. These modified serum bottles resemble culture flasks with a side
arm (e.g., Bellco Biotecnology or Ace Glass), making it possible to monitor growth by
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determining optical density at 600 nm. When plating these bottles the PCB solution was
plated onto the sides of the main bottle, not the side arm. Second, these bottles did not have
dried, autoclaved sediment added to them. The only sediment present was due to carryover
in the supernatant from the first enrichment culture.
3.4. Alternative Electron Acceptor Experiment
The ability of the LH enrichment culture to use chlorinated benzenes and CEs as
electron acceptors was tested. Six treatments were prepared, in triplicate. Three of the
treatments tested the enrichment culture’s ability to utilize 1,2-dichlorobenzene (1,2-diCB);
1,3-dichlorobenzene (1,3-diCB); 1,4-dichlorobenzene (1,4-diCB); and 1,2,4-trichlorobenzene
(1,2,4-triCB). The treatments consisted of a treatment inoculated with the Lake Hartwell
enrichment culture, a positive control [inoculated with a mixed culture known to
dechlorinate 1,2,4-triCB, designated the VJ culture (Elango et al., 2010)], and a media
control. Three of the treatments tested the enrichment culture’s ability to utilize PCE, TCE,
cis-DCE, and VC.

The treatments consisted of a treatment inoculated with the Lake

Hartwell enrichment culture, a positive control [inoculated with a mixed culture known to
dechlorinate PCE to ethene, designated the SRS culture (Wood, 2006)], and a media control.
The treatment matrix is shown in Table 3.4.
The alternative electron acceptor culture bottles were prepared by transferring 1 mL
of supernatant from bottle #2 of treatment 3-1 (LH + PCB 132) to 160 mL serum bottles
for treatments 4-1 (CB LH Culture) and 4-4 (CE LH Culture). For treatment 4-2 (CB
Positive Control), 1 mL of supernatant from the VJ culture was used as the inoculum.
Treatment 4-5 (CE Positive Control) was inoculated with 1 mL of supernatant from the SRS
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culture. Immediately prior to inoculation the protein content of the three cultures was
quantified to ensure that the LH culture treatments contained at least as much protein, and
therefore microorganisms, as the positive controls. Results for the protein assay are shown
in Table 3.5.

√
√

Chloroethene
Media Control

√
√

√
√

4-6

Chloroethene
Positive Control

√
√
√

4-5

Chloroethene
LH Culture

√
√
√

Chlorobenzene
Media Control

Chlorobenzene
Positive Control

Live
RAMM
Chlorobenzenes
Chloroethenes
Lactate
LH culture
VJ culture
SRS culture

Chlorobenzene
LH Culture

Table 3.4 Alternative electron acceptor treatment matrix
Treatment
4-1
4-2
4-3
4-4

√
√

√
√

√

√
√
√

√
√

√

√

Table 3.5 Protein concentrations of the three cultures used to inoculate the
alternative electron acceptor treatments
Protein Conc
Culture
(µg/mL)
LH (treatment 3-3)
122.9
VJ
8.9
SRS
55.8
The chlorinated benzenes, PCE, TCE, and cis-DCE were added as saturated media.
VC was added as a gas using a gas-tight syringe (Supelco, Bellefonte, PA). The amount of
each compound added is shown in Table 3.6.
The bottles were filled to 100 mL and crimp sealed with Teflon-lined red rubber
septa. Lactate was added as a sodium lactate solution to provide an electron donor for
reductive dechlorination. The amount of lactate added provided 100 times the number of
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equivalents needed to reductively dechlorinate all of the chlorinated compounds in the bottle
and resulted in a final lactate concentration of 3.80 mM (4.56 meq/bottle).
Table 3.6 Amount of chlorinated compounds added
Amount
Aqueous Conc.
Compound
(µmol/bottle)
(mg/L)
1,2-diCB
2.74
3.85
1,3-diCB
2.55
3.52
1,4-diCB
2.66
3.69
1,2,4-triCB
1.60
2.80
PCE
1.45
1.73
TCE
1.67
1.82
cDCE
1.80
1.61
VC
2.00
0.78
3.5. Electron Donor Experiment
The effect of lactate, acetate, propionate, and hydrogen, as electron donors, on the
dechlorinating activity of the enrichment culture was tested. Nine treatments were prepared,

√
√

√

√

√

√

√

√

√

√

5-8

5-9
Live Control

√
√

5-7

Hydrogen
Control

Hydrogen +
PCB 132

√
√

5-6

Propionate
Control

Propionate +
PCB 132

√
√
√

5-5

Acetate
Control

Acetate +
PCB 132

Live
RAMM
Lactate
Acetate
Propionate
H2
PCB 132
Treatment 3-3
Bottle #2

Lactate +
PCB 132

Table 3.7 Electron donor experiment matrix
Treatment
5-1
5-2
5-3
5-4

Lactate
Control

in triplicate. Table 3.7 shows the treatment matrix.

√
√
√

√
√

√
√

√
√

√
√

√

√
√
√
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√

√

√

√
√

√

Bottles for the electron donor treatments were prepared in a similar manner to the
second enrichment culture, with the following exceptions. In each triplicate, two replicates
were prepared in modified serum bottles to allow for absorbance measurements, while the
third replicate was prepared in a regular 160-mL serum bottle. Each bottle was inoculated
with 1 mL of supernatant from bottle #2 of treatment 3-1 (LH + PCB 132). Finally, each
bottle was plated with 1.25 mg PCB 132, dissolved in isooctane rather than acetone. The
initial amount of each electron donor to be added was 2.1 meq/bottle, one hundred times
the amount required for dechlorination of the PCB 132. Thus the initial amounts for each
electron donor per bottle were: 0.175 mmol (19.6 mg) lactate, 0.2625 mmol (21.5 mg)
acetate, 0.175 mmol (16.8 mg) propionate, and 1.05 mmol (25 mL) hydroden gas. Due to
the large volume of gas required for the hydrogen-fed treatment, the initial electron donor
amount was divided into five equal portions, with each portion being added when the
previous one had been consumed. The three organic acids were added as aqueous solutions.
The H2 was added using a gas tight syringe at room temperature and standard pressure.
3.6. Microbial Inhibitor Experiment
The effect of three targeted microbial inhibitors on the dechlorinating activity of the
enrichment culture was tested. BES specifically inhibits methanogenesis. Molybdate is a
structural analog of sulfate, inhibiting the activity of SRBs. Vancomycin is a broad spectrum
antibiotic that inhibits gram positive bacteria. The treatment matrix for this experiment is
shown in Table 3.8.
Each treatment of the inhibitor experiment was prepared, in triplicate, in a manner
similar to the electron donor experiment, using the same inoculum and PCB solution to
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plate the bottles. However, all replicates of the inhibitor were prepared using 160 mL serum
bottles. Lactate served as the electron donor for all treatments, with the same initial amount
(2.1 meq/bottle) and portioning as the electron donor treatments. The three inhibitors were
added as aqueous solutions through the septa using a precision syringe.

The final

concentration for each treatment was 5 mM BES, 20 mM sodium molybdate, and 100
µg/mL vancomycin.
Table 3.8 Inhibitor experiment matrix
Treatment
6-1

Live
RAMM
Lactate
BES
Molybdate
Vancomycin
PCB 132
Treatment 3-3 Bottle #2

6-2

6-3

BES
√
√
√
√

Molybdate
√
√
√

Vancomycin
√
√
√

6-4
No
Inhibitor
Control
√
√
√

√
√

√
√

√
√
√

√
√

√

3.7. Bioaugmentation Experiments
Bioaugmented microcosms were prepared in an identical manner to the LH
microcosms (section 3.3) to evaluate the effect of a commercially available culture, which
was known to dechlorinate PCE completely to ethene, on the PCB dechlorinating activity of
the LH culture. This commercial chlorinated ethene bioaugmentation culture (CCEBC) was
used in accordance with the vendor’s recommended practice.

These bioaugmented

microcosms were prepared in triplicate at the same time as the LH microcosms (Table 3.9).
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Table 3.9 Bioaugmented microcosm treatment matrix.
Treatment
7-1
Live
Sediment
RAMM
PCB 132
Lactate
Acetone
CCEBC

LH + CCEBC + PCB 132
√
√
√
√
√
√
√

7-2
Bioaugmented Electron
Donor Control
√
√
√
√
√
√

A second set of cultures was prepared to further study the activity of the commercial
culture against PCB 132. Supernatant (10 mL) was transferred from treatment 7-1 to new
bottles. This transfer was performed in the same manner (and at the same time) as the first
transfer from the LH microcosms (section 3.3). In addition, a treatment containing only the
commercial culture and a killed control containing the commercial culture were prepared.
The treatment matrix is shown in Table 3.10.
Table 3.10 Bioaugmented transfer culture treatment matrix.
Treatment
8-1
8-2
LH + CCEBC
CCEBC +
+ PCB 132
PCB 132
Live
√
√
Killed
Sediment
√
√
RAMM
√
√
PCB 132
√
√
Lactate
√
√
Treatment 7-1
√
Supernatant
CCEBC
√
√

8-3
Live
Control
√
√
√

8-4
Killed
Control
√
√
√
√

√

Ten mL of the commercial culture were added to treatment 8-2 (CCEBC + PCB
132) and treatment 8-4 (Killed Control), which is the same volume of culture transferred
from the microcosms to the enrichment bottles. For treatment 8-4 (Killed Control), the
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serum bottles were autoclaved and then the plating and the addition of the sediment were
carried out aseptically. The commercial culture was autoclaved twice (on consecutive days)
for 60 min at 121 ˚C and added to bottles aseptically, prior to the addition of the autoclaved
RAMM.
3.8. Analytical Procedures
3.8.1. Methane
Headspace samples were analyzed for methane on a Hewlett Packard 5890 Series II
GC, equipped with a 1% SP 1000 60/80 Carbopack B column (Supelco, Bellefonte, PA) and
a FID. Headspace samples (0.5 mL) were taken with a gas-tight syringe through the septa
and manually injected. The injector and detector were held at 200 ˚C and the column at 150
˚C. The carrier gas used was hydrogen (30 mL/min). The GC response to this and all other
headspace samples was calibrated to give the total mass of the compound in that bottle.
3.8.2. Hydrogen
Headspace samples were analyzed for H2 on a Hewlett Packard 5890 Series II GC,
equipped with a 10% SP1000 100/120 Carbosieve column (2.0 m x 3.2 mm; Supelco;
Bellefonte, PA) and a thermal conductivity detector. Headspace samples (0.5 mL) were
taken with a gas-tight syringe through the septa and manually injected. The injector and
detector were held at 200 ˚C and the column at 105 ˚C. The carrier gas was nitrogen (15
mL/min) as was the make-up gas (30 mL/min).
3.8.3. Ion Chromatography
Ion chromatography was used to analyze liquid samples for chloride and sulfate.
Samples were either taken in the glove box using aseptic techniques or taken through the
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septa using a syringe. Samples were placed in 2 mL centrifuge tubes and centrifuged for 5
min at 13,000 rpm (Eppendorf 5414D, Westbury, NY). The supernatant was drawn off with
a disposable syringe then run through a 0.2 µm PVDF filter (Pall Life Sciences, East Hills,
NY). Analysis was performed on a Dionex (Sunnyvale, CA) ion chromatography system
equipped with an AS50 autosampler, a CD-25 conductivity detector (suppressor current set
at 24 mA), and a GP50 pump (1 mL/min).
For chloride analysis, an AS5A-5µ column (4 x 150 mm) and a 25 µL sample loop
(25 µL sample injections) were used. Initially an isocratic separation using 2.9 mM Na2CO3
and 3.6 mM NaHCO3 eluent was performed. For the enrichment cultures, the higher initial
lactate concentration resulted in the lactate peak overlapping the chloride peak. In this case,
an isocratic separation using 1 mM NaOH was used. A five point calibration curve was used
for quantification.
For sulfate analysis, an AS9-HC column (4 x 250 mm) with an AG9-HC guard
column (4 x 50 mm) and a 250 µL sample loop (50 µL sample injections) were used.
Isocratic separation using 9.0 mM Na2CO3 eluent was performed. A five point calibration
curve was used for quantification.
3.8.4. Fatty Acids Analysis
Liquid samples were removed from the second enrichment culture by inserting the
needle of a syringe through the septum and withdrawing approximately 1 mL of supernatant.
The samples were centrifuged for 5 min at 13,000 rpm (Eppendorf 5414D, Westbury, NY)
to remove large particulate matter, then filtered through a 0.2 µm PVDF filter.
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Analysis was performed by reverse phase liquid chromatography on a Waters
(Milford, MA) instrument equipped with a 600E System Controller, a 490E Programmable
Multiwavelength Detector (420 nm), and a 717 plus Autosampler. An Aminex HPX-87H
ion exclusion column (300 mm x 7.8 mm, BioRad, Hercules, CA) was used with 0.01 N
H2SO4 as the eluent. Calibration curves for lactate, formate, acetate, propionate, pyruvate,
and butyrate were prepared and used for quantification of fatty acids in the culture samples.
3.8.5. Absorbance
The absorbance of the second enrichment culture was measured using a Milton Roy
Spec 20D spectrophotometer. The modified serum bottles were shaken vigorously to evenly
distribute the microorganisms.

The test tube end of the bottle was inserted into the

spectrophotometer and the absorbance read at 600 nm (Cutter et al., 1998). The absorbance
data are presented as the increase in absorbance, calculated as shown in Equation 3-1.
Increase = Abs600 (t = n) − Abs600 (t = 0)

(3.1)

Due to the natural heterogeneity of this system, the absolute absorbance measurement for
each treatment varied. Presenting the absorbance data in this manner normalizes the data to
the starting timepoint for each treatment. Hereafter any mention of absorbance refers to the
increase in absorbance.
3.8.6. Protein Analysis
Samples from the second enrichment culture, a CE dechlorinating culture, and a
chlorobenzene (CB) dechlorinating culture, were analyzed for protein content immediately
prior to being used to inoculate the electron acceptor experiment treatments. Cells were
lysed by mixing 450 µL of culture fluid with 5 µL of 10 M NaOH, heating to 90 ˚C and then
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cooling to room temperature (Coleman et al., 2002). The lysed cells were prepared using
Compat-Able™ Protein Assay Preparation Reagent Set (Pierce Biotechnology Inc.,
Rockford, IL) according to the manufacturer’s instructions. The BCA™ Protein Assay Kit
(Pierce Biotechnology Inc.) was used according to the manufacturer’s directions.

The

albumin protein standards included in the kit were used to develop a calibration curve.
3.8.7. PCB Sampling and Extraction
Samples of the cultures were taken inside the anaerobic chamber.

For the

microcosms and the first enrichment culture, a small Teflon-coated stir bar was added to
each bottle. Each bottle was opened and placed on a stir plate to provide thorough mixing.
Four 1 mL aliquots were withdrawn from each bottle using an autoclaved wide-bore pipette.
Two of the aliquots were placed in glass sampling jars with Teflon-lined screw caps, prior to
PCB extraction and analysis. The remaining two aliquots were placed in weighing dishes for
dry weight analysis. The serum bottle was re-capped with a sterile septum and crimp sealed.
The sample jars and weighing dishes were removed from the anaerobic chamber and
weighed to determine the wet weight of the sample in each. Fifty mL of acetone was added
to each sample jar, which was then stored in the dark at 5 ˚C until extraction. The weighing
dishes were placed in a drying oven (105 ˚C) overnight and then re-weighed to obtain the
sample dry weight.
PCBs were extracted in acetone and isooctane using the sonication method described
by Dunnivant and Elzerman (1987) and modified to minimize solvent volumes by Germann
(1988). In short, 50 mL of acetone was added to the sample jars immediately after sampling.
The samples were stored in the refrigerator until they could be extracted (within one week).
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Samples were sonicated using a Fisher 300 Sonic Dismembrator (Fisher Scientific) for 5 min
at 0.8 relative output. Samples were placed in an ice water bath during sonication to cool
them and reduce volatilization. The samples were then allowed to stand, covered, for 5 min.
Samples were next vacuum filtered with 0.45 µm paper filters (Pall Gelman). The filtrate
was placed in 250 mL pear-shaped separatory funnels, to which 15 mL isooctane, 70 mL
distilled deionized water, and 15 mL saturated sodium chloride solution was added. The
separatory funnel was shaken vigorously by hand for 3 min and allowed to rest 60 min prior
to decanting.

The aqueous phase was decanted and retained for a second isooctane

extraction. The isooctane layer was poured through a drying column [a chromatographic
column (22mm x 25 cm) packed with glass wool and 10 g dried sodium sulfate]. The
aqueous phase was then returned to the separatory funnel, 15 mL of isooctane added,
shaken, and allowed to separate again. This time the aqueous phase was decanted and
discarded, while the isooctane was passed through the drying column and added to the first
allotment. The drying column was rinsed with isooctane to remove any remaining PCBs and
the volume of the isooctane solution was brought to 60 mL. In preparation for analysis on
the GC, the samples underwent additional clean up and concentration. A 4 mL aliquot was
run through a clean-up column containing 1.5 g deactivated alumina and 0.5 g dried sodium
sulfate. The column was washed with 5 mL of isooctane. The sample was concentrated
under a flow of high purity nitrogen gas, to a final volume of 2.0 mL. Concentrated samples
were stored in 2 mL glass vials with PTFE lined red rubber crimp tops.
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3.8.8. GC/ECD Analysis of PCBs
3.8.8.1. Achiral
Achiral PCB analyses was performed on a Hewlett Packard 6890 GC, equipped with
a 30 m DB-5 column (Agilent Technologies) and a 63Ni electron capture detector (ECD).
The GC parameters were those developed by Germann (1988). The oven was initially held
at 100 ˚C for 2.5 min followed by a temperature ramp of 10 ˚C per min to 150 ˚C. The oven
was held at 150 ˚C for 0.5 min, followed by a second temperature ramp of 1.1 ˚C per min to
225 ˚C. The oven was held at 225 ˚C for 3 min, followed by a final temperature ramp of 10
˚C per min, to a temperature of 260 ˚C. This final temperature was held for 15 min,
resulting in a total run time of 97.7 min. The injector temperature was held constant at 250
˚C, while the detector temperature was set at 325 ˚C. Helium served as the carrier gas, at a
flow rate of 2.0 mL per min and nitrogen served as the anode and makeup gas with rates set
at 6.0 mL per min and 60.0 mL per min, respectively. A split vent flow, at a rate of 57.5 mL
per min, started at 0.75 min. An Agilent 7673 autosampler was used for all injections, which
were 1 µL.
Isooctane blanks were run between all samples from different treatments (typically
every two to five samples) to check for analyte carry over. A PCB check standard, a
prepared sample of known concentration, was run approximately every 12 samples. If the
average GC/ECD response factors varied by more than 10% for the check standard, the
calibration curve was re-run and the new calibration factors were used from that point
onward.
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3.8.8.2. Chiral
Chiral PCB analyses were performed on an Agilent 6850 GC equipped with a
Chirasil-Dex column and an ECD. The injector and detector were held at 210 ˚C and 350
˚C, respectively. The oven was initially held at 60 ˚C for 2.0 min, followed by a temperature
ramp of 10 ˚C per min to a temperature of 150 ˚C. This was immediately followed by a
second temperature ramp of 1 ˚C per min to a final temperature of 200 ˚C, which was held
for 3.0 min. Helium served as the carrier gas and nitrogen served as the anode gas with a
total flow rate of 47.3 mL/min. Nitrogen also served as the makeup gas with a flow of 60
mL/min. Splitless injections were performed using an Agilent 6850 Series autosampler and
1 µL injections. Racemic standards of PCB 132 and PCB 91 were run individually to
determine retention times and confirm column performance.
3.8.9. GC/ECD Analysis of Chlorinated Benzenes
Headspace samples (0.5 mL) were analyzed on an Agilent 5890 Series II Plus GC
equipped with an RTX-5 column (30 m long, 0.53 mm ID, 1.5 µm DF; Restek; Bellefonte,
PA) and an ECD for chlorinated benzenes. The injector and detector were held at 175 ˚C
and 250 ˚C, respectively. The oven was initially held at 50 ˚C for 4 min, followed by a
temperature ramp of 10 ˚C per min to a temperature of 80 ˚C, which was held for 10 min.
This was followed by a second temperature ramp of 10 ˚C per min to a final temperature of
150 ˚C. Injections were splitless. A five point calibration curve was used for quantification.
3.8.10. GC/FID Analysis of Chlorinated Ethenes
Headspace samples (0.5 mL) were analyzed on an Agilent 5890 Series II GC
equipped with a 1% PS1000 60/80 Carbopack-B column (2.4 m x 3.2 mm; Supelco;
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Bellefonte, PA) and an FID for chlorinated ethenes. The injector and detector were held at
200 ˚C. The oven was initially held at 60 ˚C for 2 min, followed by a temperature ramp of
20 ˚C per min to a temperature of 150 ˚C. This was immediately followed by a second ramp
of 10 ˚C per min to a final temperature of 200 ˚C. The final temperature was held for 11
min. The carrier gas was helium (30 mL/min). A five point calibration curve was used for
quantification.
3.9. Molecular Techniques
3.9.1. DNA Extraction and Amplification of 16S rDNA
Samples for genetic analysis were taken aseptically inside the anaerobic chamber.
The samples were placed in 2 mL microcentrifuge tubes and stored in the refrigerator prior
to use. Genomic DNA from bottles containing sediment was extracted using the Ultra
Clean Soil DNA Prep Kit (Mo Bio Laboratories, Inc., Solana Beach, CA), according to the
manufacturer’s instructions, with the following change. Due to the high water content of
the slurries, 2 mL of slurry were sampled and placed in a sterile centrifuge tube. The
samples were then centrifuged (Eppendorf 5414D, Westbury, NY) at 10,000 rpm for 5 min.
The supernatant was discarded and the soil was transferred to the bead solution tubes from
the Soil DNA Prep Kit.

The remainder of the procedure was as outlined in the

manufacturer’s directions.
PCR was used to amplify the 16S rDNA genes from the purified DNA extract, using
the same universal primer sets as Cutter et al. (2001):
• Bacterial 16S rDNA: 1055-1077 forward (5’-ATGGCTGTCGTCAGCT-3’)
• Bacterial 16S rDNA: 1406-1392 reverse (5’-ACGGGCGGTGTGAC -3’);
• Archael 16S rDNA: Arch21F (5’-TTCCGGTTGATCCYCCYGCCGGA-3’); and
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• Arch958R (5’-YCCGGCGTTGAMTCCAATT-3’).
In addition, primers developed by Watts et al. (2005) were used:
• Bacterial 16S rDNA: 14F (5’-AGAGTTGATCCTGGCTCAG-3’); and
• Specific primer: Dehal1265R (5’-GCTATTCCTACCTGCTGTACC-3’).
The reverse primer, Dehal1265R, is specific to two PCB dechlorinators (Cutter et al., 2001;
Wu et al., 2002a) identified to date and was used to determine if these known species, or very
similar related species, were present.
PCR reactions were carried out in a MiniCycler thermocycler (MJ Research,
Waltham, MA). Each PCR reaction contained the following: 20 µL PCR Master Mix (0.06
U/µL Taq, 125 mM KCl, 75 mM TrisCl, 4.0 mM Mg2+, 0.25% Nonidet®-P40, and 500 µM
dNTP), 5 µL DNA extract, 10 pmol of each primer, and sterile Milli-Q water to make the
final volume 50 µL. The temperature program for the reactions was as follows. First there
was an initial denaturing step of 95 ˚C for 3 min, followed by a 30 sec annealing step at 55
˚C, with an initial extension step at 72 ˚C for 2 min. Next there was a 45 sec denaturing step
at 94 ˚C, followed by an annealing step at 55 ˚C for 30 sec, then an extension step at 72 ˚C
for 2 min. This cycle was repeated 35 times. Upon completion, the PCR products were held
at 10 ˚C until removed from the thermocycler.
3.9.2. Quantitative PCR
qPCR was performed using an ABI Prism 7500 RT PCR system (Applied
Biosystems, Foster, CA).

Each reaction contained 6.74 µL DNA free water, 10 µL

TaqMan® Universal PCR Master Mix (Applied Biosystems), 0.06 µL probe (100 µM), 0.6 µL
of each primer (10 µM) and 2 µL of template DNA, yielding a total reaction volume of 20
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µL. For quantification of total Bacterial 16S rRNA the following probe/primer set was used
(Ritalahti et al., 2006):
• Bac1055YF (5’-ATGGYTGTCGTCAGCT-3’)
• Bac1392R (5’-ACGGGCGGTGTGTAC-3’)
• Bac1115Probe (5’-FAM-CAACGAGCGCAACCC-TAMRA-3’)
The following probe/primer set was used for quantification of Dehalococcoides species
(Ritalahti et al., 2006):
• Dhc1200F (5’-CTGGAGCTAATCCCCAAAGCT-3’)
• Dhc1271R (5’-CAACTTCATGCAGGCGGG-3’)
• Dhc1240Probe (5’-FAM-TCCTCAGTTCGGATTGCAGGCTGAA-TAMRA-3’)
Copies of the bvcA gene were quantified using the following probe/primer set (Ritalahti et
al., 2006):
• Bvc925F (5’-AAAAGCACTTGGCTATCAAGGAC-3’)
• Bvc1017R (5’-CCAAAAGCACCACCAGGTC-3’)
• Bvc977Probe (5’-FAM-TGGTGGCGACGTGGCTATGTGG-TAMRA-3’)
Copies of the vcrA gene were quantified using the following probe/primer set (Ritalahti et
al., 2006):
• Vcr1022F (5’-CGGGCGCATGCACTATTTT-3’)
• Vcr1093R (5’-GAATAGTCCGTGCCCTTCCTC-3’)
• Vcr1042Probe (5’-FAM-CGCAGTAACTCAACCATTTCCTGGTAGTGGTAMRA-3’)
Copies of the tceA gene were quantified using the following probe/primer set (Ritalahti et al.,
2006):
• TceA1270F (5’-ATCCAGATTATGACCCTGGTGAA-3’)
• TceA1336R (5’-GCGGCATATATTAGGGCATCTT-3’)
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• TceA1294Probe (5’-FAM-TGGGCTATGGCGACCGCAGG-TAMRA-3’)
Copies of the ardA gene were quantified using the following probe/primer set (Ritalahti,
K.; personal communication):

• ArdA-F: ACTGCGGTTTCMACCCAYMT
• ArdA-Probe: FAM-ACCAACCGGGCTATGTGGGTAAT-TAMRA
• ArdA-R: ATACCGCAGGTCTKGCAGAAK
PCR conditions were as follows: 2 min at 50 ˚C and 10 min at 95 ˚C followed by 40 cycles of
95 ˚C for 15 sec then 58 ˚C for 1 min (Ritalahti et al., 2006). All reactions were prepared in a
dimly lit room on ice to prevent degradation of the fluorescently labeled probes. Reactions
were prepared in triplicate for each sample or standard. Two no template controls were run
(also in triplicate), one with DNA-free water and one with the Tris buffer that was used to
dilute and store the DNA standards. DNA standards were prepared from plasmids carrying
a single copy of the Dehalococcoides strain BAV1 16S rDNA sequence.
3.9.3. PCR and Clone Library Analysis
A clone library was prepared using the TOPO TA Cloning Kit Ver. R (Invitrogen,
Carlsbad, CA). Prior to cloning, nested PCR was used to amplify the Dehalococcoides 16S
rRNA sequences. First, community DNA was amplified using universal bacterial primers
Fp422 and RevP 423. The PCR conditions were as follows: 2 min and 10 sec at 94 ˚C,
followed by 30 cycles of 94 ˚C for 10 sec, 55 ˚C for 45 sec, 72 ˚C for 2 min and 10 sec, with
a final elongation step at 72 ˚C for 6 min. A 1:100 dilution of the amplified 16S rRNA was
used as the template in a second (nested) PCR reaction with Dehalococcoides specific primers
Dhc1F and Dhc 1392R (Hendrickson et al., 2002). The PCR conditions were as follows: 2
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min and 10 sec at 94 ˚C, followed by 30 cycles of 94 ˚C for 30 sec, 52 ˚C for 45 sec, and 72
˚C for 2 min and 10 sec, with a final elongation step of 72 ˚C for 6 min.
The Dhc specific 16S rRNA gene amplicons were ligated into the pCR2.1-TOPO
cloning vector and introduced into competent Escherichia coli cells following the
manufacturer’s directions. Luria Bertani agar plates containing 50 µg of ampicillin per mL
were used to select for transformants (Sambrook and Russell, 2006). Template DNA from
24 white colonies was prepared by touching an isolated colony with a sterilized toothpick
and suspending the cells in 50 µL TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0). Two
microliters of the TE cell suspension were amplified using the Dehalococcoides specific primers
and PCR conditions listed above. The results were viewed on a 2% (wt/vol) agarose gel to
ensure they contained Dhc 16S rRNA inserts. Plasmid DNA was extracted from clones
with Dhc inserts using the QIAprep Spin Miniprep Kit (Qiagen, Valencia, CA) according to
the manufacturer’s instructions.
3.9.4. Sequence Analysis
A combination of four primers (TA3, TA5, Dhc 730F, and Dhc 1164R) was used to
obtain nearly complete 16S rRNA gene sequences for both DNA strands. Sequencing was
performed

at

the

Nevada

Genomics

Center

(http://www.ag.unr.edu/genomics

/default.html) using an ABI 3730 DNA Analyzer (Applied Biosystems, Foster City, CA).
Each sequence obtained was submitted to the National Center for Biotechnology
Information Basic Local Alignment Search Tool to determine phylogenetically related
populations.
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3.9.5. Nucleotide Sequence Accession Numbers
The Dehalococcoides 16S rRNA sequence was submitted to GenBank during the
preparation of this manuscript.
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CHAPTER FOUR
ENRICHMENT FOR AND IDENTIFICATION OF PCB DECHLORINATORS

4.1. Microcosms
The microcosms were the initial experiment prepared for this research. The purpose
of the microcosms was threefold, 1) to determine if the results of previous experiments
(Pakdeesusuk et al., 2003a) could be replicated, 2) to determine if the addition of an electron
donor affected PCB dechlorination, and 3) to begin the process of enriching the
microorganism(s) responsible for PCB dechlorination in Lake Hartwell sediments. The
microcosms were prepared as described in Section 3.2. The treatment preparation is shown
in Table 3.1. PCB dechlorination was monitored using congener specific achiral and chiral
PCB analysis, and chloride analysis. In addition, methane production was monitored to
determine how much electron donor potentially remained available for dechlorination and if
the onset of dechlorination correlated to methanogenesis.
4.1.1. PCB Results
4.1.1.1. Achiral
Congener-specific PCB analysis was performed to identify and monitor the daughter
congeners produced during the dechlorination process. Treatments 1-1 (LH + PCB 132)
and 1-2 (Killed Control) were amended with 500 mg PCB 132 per kg sediment (1385
µmol/kg sed) at t=0. Figures 4.1 and 4.2 show the PCB 132 and dechlorination product
concentrations for treatments 1-1 (LH + PCB 132) and 1-2 (Killed Control), respectively.
The results shown are the averages of triplicate bottles with the error bars
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Figure 4.1 Average PCB dechlorination results for triplicate microcosms in treatment 1-1 (LH + PCB132). Error bars
represent one standard deviation.
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Figure 4.2 Average PCB dechlorination results for triplicate microcosms in treatment 1-2 (Killed Control). Error bars
represent one standard deviation.
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representing one standard deviation.

Treatment 1-3 (Live Control) and treatment 1-4

(Electron Donor Control) did not receive any PCB 132.
As can be seen in Figure 4.1, PCB 132 was dechlorinated to PCB 91, then to
2,2’,4,6’-tetrachlorobiphenyl (PCB 51), and finally to 2,2’,6-trichlorobiphenyl (PCB 19),
resulting in the removal of three chlorines. The PCB 132 concentration in the live treatment
decreased over time, until t=261 d. At t=21 d the PCB 132 concentration was 78 µmol/kg.
At t = 567 the PCB 132 concentration was 77 µmol/kg, which is not statistically different
from the concentration at t = 261 d (Two-way ANOVA with replicaiton, α = 0.05). The
PCB 91 concentration had increased significantly by t = 44 d (Student’s t-test, α = 0.05).
The concentration had increased again at t = 76 d, but decreased at t = 114 d. The PCB 91
concentration remained low throughout the remainder of the incubation period.

This

indicates that initially PCB 132 was converted to PCB 91 faster than PCB 91 was converted
to PCB 51, resulting in an accumulation of PCB 91. By t = 114 d this trend had reversed
and PCB 91 was converted to PCB 51 faster and PCB 91 no longer accumulated. PCB 51
was first seen at t = 44 d and a statistically significant concentration of PCB 51
(241 µmol/kg) was first measured at t = 114 d (Student’s t-test, α = 0.05).

The

concentration of PCB 51 had increased by t = 180 d, then remained unchanged throughout
the remainder of the incubation period. PCB 19 was first seen at t = 44 d and a statistically
significant concentration of PCB 19 (209 µmol/kg) was first measured at t = 114 d
(Student’s t-test, α = 0.05). At t = 261 d the concentration of PCB 19 was 219 µmol/kg and
at t = 567 d it was 452 µmol/kg.

This increase was statistically significant (Two-

wayANOVA with replication, α = 0.05). Increases in daughter products were not seen in
the treatment 1-2 (Killed Control).
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The total PCBs were calculated by summing the molar concentrations of PCB 132,
91, 51, and 19.

The total PCBs measured in treatment 1-1 (LH + PCB 132) varied

throughout the incubation period. This is likely due to the inherent variability in the
sampling, extraction, and analysis procedures. The only time points at which the total PCB
concentrations were statistically different (Two-way ANOVA with replication, α = 0.05)
from the nominal total PCB concentration (1385 µmol/kg) were t = 261 and t = 567 d,
which were less than the nominal total PCB concentration.

In addition to inherent

variability, it is likely that sorption affected these PCB measurements.

Experimental

evidence has shown that approximately 30-50% of PCB 52 was irreversibly sorbed to
sediments (Kan et al., 1997).
The total PCBs measurements in treatment 1-2 (Killed Control) varied throughout
the incubation period. Like treatment 1-1 (LH + PCB 132), the only time points at which
the total PCB concentrations were statistically different (Two-way ANOVA with replication,
α = 0.05) from the nominal total PCB concentration (1385 µmol/kg) were t = 261 and
t = 567 d, which were less than the nominal total PCB concentration. It is likely that
sorption affected these PCB measurements as well because sorption is an abiotic process and
is not expected to be impacted by autoclaving.
In a similar experiment in which microcosms were spiked with the same initial
PCB 132 concentration (500 mg/kg sed), a final PCB 132 concentration of 684 µmol/kg
after 250 days of incubation was reported (Pakdeesusuk et al., 2003a).

The PCB 132

concentration in this experiment at t = 261 d was significantly less (Student’s t-test, α = 0.05)
than the concentration reported previously (Pakdeesusuk et al., 2003a).
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The most striking difference between the two experiments was the increased
production of PCB 19 seen in this experiment. In the current experiment, an increase in the
concentration of PCB 19 was first seen at t = 44 d and a statistically significant
concentration of PCB 19 (209 µmol/kg) was first measured at t = 114 d (Student’s t-test,
α = 0.05). At t = 261 d the concentration of PCB 19 was 219 µmol/kg and at t = 567 d it
was 452 µmol/kg. In contrast, a statistically significant concentration of PCB 19 was never
seen in the earlier microcosm experiment reported by Pakdeesusuk et al. (unpublished data).
Another difference in the results of the two experiments was that the maximum
concentration of PCB 91 seen in this experiment occurred sooner but was less than the
maximum concentration reported earlier (Pakdeesusuk et al., 2003a), 112 µmol/kg at
t = 76 d versus 184 µmol/kg at t = 99 d. Finally, the maximum concentration of PCB 51
reported in the earlier research was 774 µmol/kg at t = 171 d (Pakdeesusuk et al., 2003a)
which is greater than that seen in this experiment (497 µmol/kg at t = 180 d). The lower
concentrations of intermediaries seen in this experiment are likely due to the increased
production of PCB 19, the least chlorinated daughter product observed from PCB 132.
There were some differences in the preparation of the microcosms used in this
research and those reported previously (Pakdeesusuk et al., 2003a).

In the previous

experiments the entire length of a sediment core from Lake Hartwell was homogenized and
used to inoculate the microcosms (Pakdeesusuk et al., 2003a), whereas the microcosms
described in this work were prepared using the most highly contaminated portion of the
sediment core. The total PCB concentration at G30 varied greatly with depth, from 5 to 60
µg/g sediment (Pakdeesusuk et al., 2005). Several studies have shown that the rate of PCB
dechlorination in sediment microcosms is dependent on the concentration of PCBs in the
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sediment (Abramowicz et al., 1993; Fish, 1996; Sokol et al., 1998; Rhee et al., 2001). One of
these studies monitored the number of microorganisms present in the microcosms using the
MPN technique (Rhee et al., 2001). The results of Rhee et al. (2001) show that microbial
population growth was a function PCB concentration. It is possible that in Lake Hartwell
sediments dechlorinating microorganisms are present in greater numbers in the most highly
contaminated sediments. Using the most highly contaminated portion of the sediment core
may have provided a greater initial number of dechlorinating microorganisms and resulted in
the greater extent of dechlorination seen in these microcosms, compared to that reported
previously (Pakdeesusuk et al., 2003a).
In addition, the only potential electron donor supplied in the earlier microcosms
(Pakdeesusuk et al., 2003a) was 250 µL (54.6 meq) of acetone, used as a carrier for the
PCB 132 (unpublished data). In the current experiment, 157 µL (34.3 meq) of acetone plus
15 mg lactate (2.02 meq) were added to each bottle at t = 0. An additional 88 mg (12 meq)
of lactate was added to these microcosms at t = 357 d, resulting in a total of 48.3 meq of
electron donor added. While more total milliequivalents of electron donor were added in the
earlier experiments (Pakdeesusuk et al., 2005), it may be that a significant fraction of the
acetone was fermented to products which were not utilized by the dechlorinating
microorganisms, whereas the lactate added in these experiments may have been more readily
utilized by the consortium. Previous work with methanogenic cultures has shown that one
mole acetone is degraded to two moles methane and one mole carbon dioxide, with acetate
as an intermediate product (Platen and Schink, 1987). There are no reports of either
methane or carbon dioxide being utilized by dechlorinating cultures.
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4.1.1.2. Chiral
PCB 132 and the daughter product, PCB 91, are both chiral, with the potential for
the two enantiomers of each congener to be degraded at different rates in biotic systems.
The results of the chiral analysis for the PCB-amended treatments (treatments 1-1 and 1-2)
are shown in Figures 4.3 for PCB 132 and 4.4 for PCB 91.
As can be seen in Figure 4.3, the EF of PCB 132 remained approximately 0.5
throughout the incubation period in both the live treatment and the killed control. As seen
in Figure 4.4 the EF for PCB 91 in treatment 1-1 (LH + PCB 132) could not be calculated
for the first two time points (t = 0 and t = 44 d) because dechlorination had not begun
(Figure 4.1). Between t = 76 d and t = 567 d the EF of PCB 91 decreased, reaching zero at
t = 567 d (i.e. the first eluting peak was not present). Because there was no production of
PCB 91 in treatment 1-2 (Killed Control) an EF could not be calculated for any of the
sampling time points.
In a similar experiment in which microcosms were spiked with the same initial
PCB 132 concentration (500 mg/kg sed), similar changes in the EF for PCBs 132 and 91
were seen (Pakdeesusuk et al., 2003a). In the previous experiment the EF of PCB 132 also
remained approximately 0.5 throughout the incubation period.

The results of both

microcosms indicate that the reductive dechlorination of PCB 132 was not enantioselective.
This suggests that the microorganism responsible for the dechlorination of PCB 132 utilizes
an enzyme containing a binding site that binds both enantiomers equally. The haloalkanoic
acid dehalogenase from Pseudomaonas sp. strain 113 has been reported to bind both D- and
L-2-haloalkanoic acids equally, resulting in non-enantioselective dechlorination (Nardi-Dei et
al., 1997).
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Figure 4.3 Average enantiomeric fraction of PCB 132 for triplicate microcosms in treatments 1-1 (LH + PCB 132) and 1-2
(Killed Control). Error bars represent one standard deviation.
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Figure 4.4 Average enantiomeric fraction of PCB 91 for triplicate microcosms in treatment 1-1 (LH + PCB 132).
* Indicates that PCB 91 was detected; the EF was zero. Error bars represent one standard deviation.
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In a similar experiment the EF of PCB 91 also decreased, with an initial EF of
approximately 0.45 at t = 77 d and a final EF of less than 0.1 at t = 140 d (Pakdeesusuk et
al., 2003a). In comparison the EF in these microcosms was 0.34 at t = 76 d, 0.16 at
t = 114 d, and 0 at t = 567 d. While the EF did not go to zero in the earlier experiment
(Pakdeesusuk et al., 2003a), it is entirely possible that it would have given a longer incubation
period. The enantioselective dechlorination of PCB 91 seen in both experiments suggests
that the reductive dehalogenase utilized preferentially binds the first eluting enantiomer.
Several haloalkanoic acid dehalogenases have been identified that bind only the L-2haloakanoic acid, including those from Pseudomonas sp., P. dehalogenans, Rhizobium sp.,
Pseudomonas sp. strain CBS3, P. cepacia MBA4, X. autotophicus GJ10, P. putida AJ1, and P. putida
109 (Fetzner and Lingens, 1994).
4.1.2. Methane Production
Methane production, due to fermentation of the electron donors, was monitored for
two reasons. First, it provides a means of determining how much electron donor has been
consumed.

The continued generation of methane provided confirmation that electron

donor remained in the system. Second, earlier research showed a strong correlation between
the onset of methane production and the onset of PCB dechlorination in microcosms
containing Lake Hartwell sediments (Pakdeesusuk et al., 2003b). Thus methane production
was monitored as a potential indicator of the onset of dechlorination in this system.
Cumulative methane production for the microcosms is shown in Figure 4.5.
At t = 0, 2.0 meq (15 mg) of lactate, enough electron equivalents to completely
dechlorinate the PCB 132 and satisfy the sulfate demand (0.93 meq), was added to each
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Figure 4.5 Average cumulative methane produced for triplicate microcosms in treatments 1-1 (LH + PCB 132), 1-2
(Killed Control), 1-3 (Live Control), and 1-4 (Electron Donor Control). Arrows indicate times at which lactate was added
to treatments 1-1 (LH + PCB 132) and 1-4 (Electron Donor Control). Error bars represent one standard deviation.
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bottle in treatments 1-1 (LH + PCB 132) and 1-4 (Electron Donor Control). In addition,
34.3 meq of acetone was added to each bottle in treatments 1-1 (LH + PCB 132), 1-2 (Killed
Control), and 1-4 (Electron Donor Control). The acetone added to treatments 1-1 (LH +
PCB 132) and 1-2 (Killed Control) was the solvent used to deliver the PCB 132. This
provided a total of 36.3 meq of electron donor. An equivalent amount of acetone was added
to treatment 1-4 (Electron Donor Control) because it may also serve as an electron donor.
Methane production leveled off at about t = 100 d at approximately 20 meq (2.5 mmol) per
bottle for treatments 1-1 and 1-4. This corresponds to 55% of the total electron donor
available.

The electron donor utilized to produce methane was unavailable for

dechlorinating the PCBs in the system; therefore, approximately 16.3 meq of electron donor
remained available for dechlorination.
At t = 101 d, treatment 1-3 (Live Control) had produced a statistically insignificant
(Student’s t-test, α = 0.05) amount of methane per bottle (1.2 meq or 0.15 mmol) relative to
treatment 1-2 (Killed Control). Electron donor was not added to treatment 1-3, therefore
this amount represents the electron donor available to the microorganisms from the
sediment in the microcosms, which was insignificant. At t = 101 d, treatment 1-2 (Killed
Control) had produced a statistically insignificant (Student’s t-test, α = 0.05) amount of
methane per bottle (0.20 meq or 0.025 mmol). This indicates that the autoclaving procedure
was effective in killing the methanogenic microbial population in the controls.
A second addition of lactate (11.9 meq or 88.4 mg) was made at t = 357 d, resulting
in a second period of rapid methane production. There was some variation in the total
amount of methane produced after this addition. Methane production in treatment 1-1 (LH
+ PCB 132) increased 10.48 meq (1.31 mmol) per bottle, accounting for 88% of the lactate.
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Treatment 1-4 (Electron Donor Control) had a smaller increase, 9.28 meq (1.16 mmol) per
bottle; accounting for 80% of the lactate added. This second addition of electron donor may
have contributed to the increase in PCB 19 between t = 261 d and t = 567 d.
The onset of methanogenesis occurred at approximately t = 40 d. This coincides
with the first indication of dechlorination seen in the PCB analysis (Figure 4.1), which agrees
with the results of earlier reseach (Pakdeesusuk et al., 2003a). Reports on the relationship of
dechlorination and methanogenesis in dechlorinating cultures have varied greatly. Some
PCB dechlorinating cultures have been reported to be non-methanogenic (Wu et al., 2000;
Ye et al., 1992). In cultures reported to be methanogenic the role of methanogens varied. In
some experiments, methanogens appeared not to be directly involved in dechlorination
(Boyle et al., 1993; May et al., 1992; Sokol et al., 1994a; Pulliam Holoman et al., 1998). Other
experiments indicated that methanogens were directly involved in dechlorination (Ye et al.,
1995; Kim and Rhee, 1999; Kim and Rhee, 1997; Morris et al., 1992).

The role of

methanogens in this system is examined in Chapter 5.
The average electron balance, defined as the ratio of the milliequivalents of products
quantified to donors added, was calculated for treatments 1-1 (LH + PCB 132) and 1-4
(Electron Donor Control; Tables 4.1 and 4.2). The initial lactate and acetone concentrations
were calculated from the known amounts added to the microcosms. The initial sulfate
concentration was calculated using the known concentration of sulfate in the media. All
other initial concentrations were assumed to be zero. The final concentration of methane
was measured by headspace analysis. The final concentrations of PCBs 91 and 51 were
measured by analysis of the medium/sediment slurry. All other final concentrations were
assumed to be zero.
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Table 4.1 Average electron balance for triplicate microcosms in treatment 1-1 (LH +
PCB 132).
Treatment 1-1 (LH + PCB 132)
Added
Final
Electron
Balancea
(meq/bottle)
mmol/bottle meq/bottle mmol/bottle
meq/bottle
Lactate
1.18
14.14
0.00
0.00
14.14
Donor
Acetone
2.24
35.87
0.00
0.00
35.87
2SO4
0.12
0.93
0.00
0.00
0.93
CH4
0.00
0.00
3.63
29.06
29.06
Products H2
0.00
0.00
0.00
0.00
0.00
PCB 91
0.00
0.00
1.04E-04
2.07E-04
0.00
PCB 51
0.00
0.00
2.37E-03
9.50E-03
0.01
Products/Donor =
0.60
a
Initial meq – Final meq, except for SO42-, which was calculated as Final meq – Initial meq
because it was consumed rather than produced.
Table 4.2 Average electron balance for triplicate microcosms in treatment 1-4
(Electron Donor Control).
Treatment 1-4 (Electron Donor Control)
Added
Final
Electron
Balancea
mmol/bottle meq/bottle mmol/bottle meq/bottle (meq/bottle)
Lactate
1.13
13.53
0.00
0.00
13.53
Donor
Acetone
2.30
36.75
0.00
0.00
36.75
2SO4
0.12
0.93
0.00
0.00
0.93
Products CH4
0.00
0.00
3.27
26.18
26.18
H2
0.00
0.00
0.00
0.00
0.00
Products/Donor =
0.54
a
Initial meq – Final meq, except for SO42-, which was calculated as Final meq – Initial meq
because it was consumed rather than produced.
The average electron balance was 0.60 for treatment 1-1 (LH + PCB 132) and 0.54
for treatment 1-4 (Electron Donor Control). This is low, even given the uncertainties in
measuring the known quantities. The initial amount of electron donor available is fairly
certain; the amount of electron donor available from the sediment was negligible. While the
final amount of electron donors was not measured, given that 210 days elapsed between final
addition of lactate and the final sampling it is reasonable to assume that all available lactate
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had been consumed. Acetone, however, is fermented more slowly than lactate and may have
been present. Therefore, either some of the products assumed to be zero were not zero (i.e.,
acetone, sulfate, or hydrogen) or additional metabolic products were not accounted for in
the electron balance. The final concentration of lactate and sulfate were assumed to be zero
for the electron balance calculation. It is possible, though not likely, that one or both were
present at t = 561 d. Possible metabolic processes that were not included in the electron
balance are: fermentation products, such as acetate and propionate; anaerobic electron
acceptors other than carbon dioxide and sulfate [e.g. Fe(III)]; and biomass.

Acetone

accounted for the majority of the electron donor provided and it has been shown that in
methanogenic cultures one mole acetone is degraded to two moles methane and one mole
carbon dioxide, with acetate as an intermediate product (Platen and Schink, 1987). It is
therefore likely that acetate produced from the fermentation of acetone is the product
unaccounted for in the electron balance.
4.1.3. Chloride Analysis
Chloride is produced during reductive dechlorination; therefore, the chloride
concentration was measured, using ion chromatography, as a way to monitor dechlorination
and serve as a guide for when samples should be taken for PCB analysis by GC. The
chloride results are shown in Figure 4.6. As can be seen, the chloride concentration in
treatment 1-1 (LH + PCB 132) began to increase at approximately t = 45 d, and continued
to increase until about t = 180 d. The onset of chloride production correlated to the onset
of dechlorination of PCB 132 (Figures 4.1 and 4.2) and methanogenesis (Figure 4.5).
Chloride continued to increase and dechlorination continued after methane production
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Figure 4.6 Average chloride concentration for triplicate microcosms in treatments 1-1 (LH + PCB 132), 1-3 (Live
Control), and 1-4 (Electron Donor Control). Error bars represent one standard deviation
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ceased.

There was no statistically significant change in the chloride concentration in

treatment 1-3 (Live Control; Single factor ANOVA, α = 0.05).

The concentration of

chloride in treatment 1-4 (Electron Donor Control) decreased significantly (Single factor
ANOVA, α = 0.05). There is no biological reason for this decrease; therefore, the decrease
is due to the inherent variability of the chloride measurements.
The chloride balance for t = 180 is shown in Table 4.3. This sampling point was
chosen for two reasons: first because both chloride and PCB samples had been collected;
and second, the sum of the PCBs measured was equivalent to the amount of PCB 132 added
to the microcosms, indicating that the extraction efficiency for those samples was high. The
ratio of measured chloride to the amount of chloride calculated from the PCB daughter
products was 0.94. This is a strong correlation and indicates that in this system chloride
analysis could be used as a predictor of dechlorinating activity.
Table 4.3 Average chloride balance for triplicate microcosms in treatment 1-1 (LH +
PCB 132) at t = 180 d.
Measured
Measured
Chloride
Increase in
Chloride /
PCB
PCB
Concentration Chloride
Chloride
Concentration Concentration based on PCB Concentration Calculated from
(mg/L)
(mmol/L)
(mmol/L)
(mmol/L)
PCB Conc.
PCB 91
1.64
5.05E-03
5.05E-03
PCB 51
19.66
6.78E-02
1.36E-01
PCB 19
13.87
5.45E-02
1.63E-01
Total
0.30
0.29
0.94
In comparison, the chloride concentration based on PCB measurements at t = 261 d
was 0.08 mmol/L, while the measured increase in chloride concentration at t = 254 d was
0.28 mmol/L. The ratio of measured chloride to the amount of chloride calculated from the
PCB daughter products for this time period was 3.45. The amount of chloride calculated
from the PCB measurements at t = 261 d (0.08 mmol/L) was far less than the amount at
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t = 180 d (0.127 mmol/L). The measured increase in chloride concentration at t = 254 d
(0.28 mmol/L) was similar to that at t = 180 d (0.29 mmol/L). The amount of chloride
calculated from the PCB measurements should have remained the same or increased
between t = 180 d and t = 261 d. The decrease in the amount of chloride calculated from
the PCBs is due to a decrease in the PCB measurements and indicates that PCB extraction
process for the t = 261 d samples was highly inefficient, resulting in a low recovery of the
PCB daughter products. This can be seen in Figure 4.1 as the low concentration of total
PCBs at t = 261 d.
4.1.4. Microcosm Summary
Microcosms inoculated with PCB-contaminated Lake Hartwell sediments were the
initial experiment prepared for this research. The purpose of the microcosms was threefold,
1) to determine if the results of previous experiments (Pakdeesusuk et al., 2003a) could be
replicated, 2) to determine if the addition of an electron donor affected PCB dechlorination,
and 3) to begin the process of enriching the microorganism(s) responsible for PCB
dechlorination in Lake Hartwell sediments. The pattern of dechlorination seen in this
experiment was PCB 132 to PCB 91 to PCB 51 to PCB 19. This is the same pattern seen
previously (Pakdeesusuk et al., 2003a). The extent of dechlorination in these microcosms
was greater than in those reported previously (Pakdeesusuk et al., 2003a), resulting in
increased accumulation of PCB 19. This may be a consequence of the additional electron
donor (lactate) provided in these microcosms.

PCB 132 was dechlorinated in a non-

enantioselective manner, while the EF of PCB 91 decreased throughout the incubation
period. This replicates previous findings (Pakdeesusuk et al., 2003a). The microcosms were
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methanogenic, with the onset of methanogenesis coinciding with the onset of
dechlorination, as seen previously (Pakdeesusuk et al., 2003a).

An electron balance

performed using t = 567 d data did not account for the entire quantity of electron donor
added, indicating that some products were not measured. Chloride was measured and
increases in the chloride concentration correlated with dechlorination. A chloride balance
performed using t = 180 d data showed good correlation between the amount of chloride
measured and the amount of chloride released during dechlorination.
4.2. First Enrichment Culture
After 180 days of incubation, supernatant from treatment 1-1 (LH + PCB 132) was
transferred (10% v/v) to new serum bottles to create two new treatments, treatment 2-1 (LH
+ PCB 132) and 2-2 (Live Control). Treatment 2-1 consisted of inoculum; 0.1% (by weight)
dry, autoclaved sediment; and PCB 132 that had been plated onto the walls of the bottle.
The PCB 132 was plated onto the walls of the bottles to remove acetone as a possible
electron donor. Treatment 2-2 consisted of inoculum and 0.1% (by weight) dry, autoclaved
sediment. These bottles are referred to throughout as the first enrichment culture. Killed
controls were not prepared for the enrichment culture. It is reasonable to assume that as
reductive dechlorination did not occur in the sediment-rich, heterogeneous environment of
the microcosms it would not occur in the enrichment culture either.
preparation is shown in Table 3.2.
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The treatment

4.2.1. PCB Results
4.2.1.1. Achiral
Because the PCB 132 was plated on the inner surface of the serum bottles, the PCB
concentration in suspension was not constant (data not shown). Rather, the concentration
in the media changed as the PCB 132 desorbed from the glass, entered the media, sorbed to
the sediment and biomass, and was dechlorinated. Due to the increase in biomass with time,
the amount of PCBs in suspension also increased. The congener specific PCB analysis
(Figure 4.7) does not include the PCB 132 concentrations because the PCB 132
concentration in the aqueous phase was controlled by sorption kinetics rather than
dechlorination as was seen in the microcosms. A consistent decrease in the PCB 132
concentration, which was seen in the microcosms, did not occur in treatment 2-1 (LH +
PCB 132). Therefore the PCB 132 concentration provides no insight into whether or not
dechlorination occurred in the first enrichment culture and is not shown.
A significant difference between the microcosms and the first enrichment culture is
the lack of PCB 19 in the enrichment culture. At t = 0 d, a small amount of PCB 19 was
present in treatment 2-1 (LH + PCB 132) due to carry over from the microcosms in the
supernatant used to inoculate the enrichment culture. The PCB 19 concentration in the first
enrichment culture remained constant over the entire incubation period; whereas, in the
microcosms an increase in PCB 19 (100 µmol/kg sed, Figure 4.1) was first observed at
t = 76 d and continued to increase through t = 180 d of the incubation period.
It is thought that a number of dechlorinating microbial populations exist, each with a
specific pattern of dechlorination (Bedard and Quensen, 1995). Research supporting this
theory has shown that different patterns of dechlorination are typically seen in enrichment
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Figure 4.7 Average PCB daughter product concentrations for triplicate bottles in treatment 2-1 (LH + PCB 132) of the
first enrichment culture. Error bars represent one standard deviation.
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cultures developed from different sediments (Wu and Wiegel, 1997; Quensen et al., 1990;
Williams, 1994; Sokol et al., 1994b; Wu et al., 1996). Incubation of the same sediment under
different conditions (i.e. different temperatures, electron donors, or atmospheric
compositions, the presence of inhibitors or amendments) has resulted in different
dechlorination patterns (Wu et al., 1997a; Wu et al., 1997b; Kim and Rhee, 1999; Sokol et al.,
1994a; Rhee et al., 1993b; Ye et al., 1995; Wu et al., 2000). Microcosms inoculated with
Baltimore Harbor sediment exhibited both meta- and ortho-dechlorinating activity against
PCB 65. Sequential transfer into medium without sediment resulted in the loss of the metadechlorinating activity (Cutter et al., 1998). Based on this, it appears likely that two microbial
populations were present in the microcosms, one of which mediated the dechlorination of
PCB 132 to PCB 91 then to PCB 51, while the second population mediated the
dechlorination of PCB 51 to PCB 19. Reasons for the loss of the second population include
a smaller population size that resulted in that population being diluted out, or that the
second population may be dependent upon an unknown component of the sediment.
Further research is needed to determine why the PCB 51 dechlorinating population was lost
and if it can be enriched for under different conditions.
In order to compare the extent of dechlorination that occurred in the microcosms
(treatment 1-1) and the first enrichment culture (treatment 2-1) the sum of the daughter
products (PCBs 91, 51, and 19) as a percentage of the PCB 132 added was calculated. As
can be seen in Figure 4.8, a greater percentage of the PCB 132 was converted to daughter
products in the microcosms than in the first enrichment culture.

While the rate of

dechlorination decreased in the first enrichment culture, the dechlorinating activity was not
entirely lost after a major dilution (i.e., due to the small amount of liquid and even smaller
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Figure 4.8 Average sum of the daughter products (PCB 91 + 51 + 19) of triplicate bottles as a percentage of the total
moles of PCB added to the cultures. Error bars represent one standard deviation.
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amount of sediment transferred from the microcosms), accompanied by a substantial
reduction in the amount of sediment present from approximately 8.5% (wt/vol) to 0.1%
(wt/vol).
4.2.1.2. Chiral
The results of the chiral analysis of PCB 132 and 91 are shown in Figures 4.9 and
4.10, respectively. While the achiral PCB results did not provide useful data for PCB 132
due to sorption issues (Section 4.2.1.1), chiral analysis of PCB 132 was not affected. The
chiral results are presented as the EF (or the ratio of the two enantiomers), therefore they are
unaffected by the fluctuations in the total PCB 132 measurements seen in the achiral
analysis. The results of the chiral analysis of the first enrichment culture are similar to those
of the microcosms. As can be seen in Figure 4.9, the chiral signature of PCB 132 remained
racemic throughout the experiment. Figure 4.10 shows that the EF of PCB 91 decreased
with time until it reached 0.06 at t = 186 d and then reversed and increased to 0.19 at
t = 294. The EF of PCB 91 at t = 294 d was significantly greater than the EF at t = 105,
134 d, and 186 d (Single factor ANOVA, α = 0.05; Tukey’s test, α = 0.05). This is the first
report of enantioselectivity changing during the course of incubation without associated
changes in incubation conditions.
This pattern differs from that seen in the microcosms (Figure 4.4) and earlier
research (Pakdeesusuk et al., 2003a), where the EF of PCB 91 decreased over the course of
the incubation. Previous research demonstrated that changes in EF for PCBs 84, 91, 95, and
149 had occurred in soils from Savannah River Site Chemical, Metal, and Pesticide pits that
had undergone incomplete bioremediation (Hall, 2004). The effect of various amendments
on further reductive dechlorination in these soils was tested. In microcosms amended with
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Figure 4.9 Average enantiomeric fraction of PCB 132 for triplicate bottles in treatment 2-1 (LH + PCB 132) of the first
enrichment culture. Error bars represent one standard deviation.
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Figure 4.10 Average enantiomeric fraction of PCB 91 for triplicate bottles in treatment 2-1 (LH + PCB 132) of the first
enrichment culture. Error bars represent one standard deviation.
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PCB 132 and PCB 132 plus molasses, the EFs of PCBs 95 and 149 changed significantly
over time and the enantioselectivity was reversed from that seen in the soil (Hall, 2004). In
microcosms with no amendments and those amended with manure at a ratio of 3:1 (soil to
manure) the EF of 149 changed significantly over time and the enantioselectivity was
reversed from that seen in the soil (Hall, 2004). A study of five different PCB-degrading
bacteria and a variety of amendments demonstrated that the enantioselectivity was
dependent on both the species of bacteria and the amendment (Singer et al., 2002). These
studies indicate that the enantioselectivity of a microbial population may be different under
different growing conditions. While there were no new compounds added to the first
enrichment culture that would explain the change in enantioselectivity, it is possible that
changes in other conditions, such as the depletion of electron donor, increased microbial
populations, or changes in structure of the microbial community may have triggered the
change. Additional research is needed to determine if these results can be replicated and the
underlying causes of the change in enantioselectivity.
4.2.2. Methane and Organic Acids Production
Methane production for the first enrichment culture is shown in Figure 4.11. At
t = 0, 19.9 meq (147.92 mg) of lactate was added to each bottle in treatment 2-1 (LH +
PCB 132). At t = 147 d, prior to the second lactate addition, treatment 2-1 (LH + PCB 132)
had produced 12.48 meq (1.56 mmol) of methane, accounting for 63% of the lactate added.
This is similar to the percentage of electron donor converted to methane in the microcosms.
The electron donor utilized to produce methane was unavailable for dechlorinating the PCBs
in the system; therefore approximately 7.42 meq of electron donor could have been utilized
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Figure 4.11 Average cumulative methane production for triplicate bottles in treatments 2-1 (LH + PCB 132) and 2-2 (Live
Control). Arrows indicate times at which lactate was added to treatments 2-1 (LH + PCB 132) and 2-2 (Electron Donor
Control). Error bars represent one standard deviation.
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for dechlorination. A second addition of lactate, 22.74 meq per bottle (170 mg), was made
at t = 147 d to treatment 2-1 (LH + PCB 132). This resulted in the production of an
additional 9.2 meq of methane (1.15 mmol) in treatment 2-1 (LH + PCB 132), representing
40% of the lactate added. The remaining 13.54 meq of electron donor were available for
dechlorination.
No electron donor was added to treatment 2-2 (Live Control).

At t = 142 d,

treatment 2-2 (Live Control) had produced a statistically insignificant (Student’s t-test,
α = 0.05) amount of methane. Thus, the amount of electron donor present in the sediment,
plus any carried over during the transfer from the microcosms, was insignificant.
Methane production in the first enrichment culture was similar to that in the
microcosms, although the rate of production was lower in the enrichment culture. The
onset of methanogenesis corresponded to the onset of dechlorination, as seen in the
microcosms. Less of the second dose of electron donor was converted to methane in the
first enrichment culture compared to the microcosms (40% versus 88%). Theoretically, that
meant that more electron donor was available for dechlorination in the first enrichment
culture. However, daughter products did not increase after the second addition of lactate.
The average electron balance, defined as the ratio of the milliequivalents of products
to donors, calculated for treatment 2-1 (LH + PCB 132) is presented in Table 4.4. The
initial lactate concentration was calculated from the known amount added to the first
enrichment culture.

The initial sulfate concentration was calculated using the known

concentration of sulfate in the media. All other initial concentrations were assumed to be
zero. The final concentration of methane was measured using headspace analysis. The final
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concentrations of PCBs 91 and 51 were measured by analysis of the medium/sediment
slurry. All other final concentrations were assumed to be zero.
Table 4.4Average electron balance for triplicate bottles in treatment 2-1 (LH + PCB
132).
Treatment 2-1 (LH + PCB 132)
Electron Balancea
Added
Final
(meq/bottle)
mmol/ bottle meq/ bottle mmol/ bottle meq/bottle
Donor
Lactate
3.55
42.60
0.00
0.00
42.60
2SO4
0.12
0.93
0.00
0.00
0.93
CH4
0.00
0.00
2.71
21.67
21.67
Products
PCB 91
0.00
0.00
1.35E-03
2.70E-03
0.00
PCB 51
0.00
0.00
1.44E-03
5.77E-03
0.01
Products/Donor =
0.53
a
Initial meq – Final meq, except for SO42-, which was calculated as Final meq – Initial meq
because it was consumed rather than produced.
The average electron balance was 0.53 for treatment 2-1 (LH + PCB 132; Table 4.4).
This is low, even given the uncertainties in measuring the known quantities. The initial
amount of electron donor available is fairly certain. The quantity of electron donor available
from the sediment was negligible, especially given the small amount of sediment added, and
the amount of electron donor added is known. The final concentrations of lactate and
sulfate were assumed to be zero for the electron balance calculation. It is possible that one
or both were present at t = 294 d. Possible metabolic processes that were not included in
the electron balance are: fermentation products, such as acetate and propionate; anaerobic
electron acceptors other than carbon dioxide and sulfate [e.g. Fe(III)]; and biomass.
The electron balance was not calculated for treatment 2-2 (Live Control) because
there was no electron donor added and the methane production results indicated that there
was an insignificant amount of electron donor present in the treatment.
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Lactate, acetate, and propionate were not quantified for the first enrichment culture.
Retention time standards were determined for them on the IC while trying to resolve
problems with the chloride analysis (see Section 4.2.3). At various times throughout the
incubation period each of the three fatty acids was detected.
4.2.3. Chloride Analysis
Measuring the chloride concentration by ion chromatography in the first enrichment
culture was problematic. The rapid conversion of the lactate to metabolites (acetate and
propionate) in this culture resulted in significant coelution of the metabolites with chloride.
Several attempts were made to resolve these issues. First the column was cleaned to remove
any metallic contamination that may have been impacting the results. The media used
contains several metals (see Section 3.1) which may have been retained and built-up on the
column.

Several elution gradients utilizing the sodium carbonate/sodium bicarbonate

mixture that was used effectively with the microcosms were attempted. When these failed
the IC manufacturer was contacted.

The manufacturer recommended 5 mM sodium

hydroxide as the eluent for chloride analysis. The manufacturer’s recommendation was
tested but did not resolve the issue. A 1 mM sodium hydroxide eluent was tested but did
not resolve the issue.

All efforts to improve separation were not successful and the

measurement of chloride was discontinued.
4.2.4. First Enrichment Culture Summary
The first enrichment culture was the first attempt to transfer a PCB dechlorinating
culture derived from Lake Hartwell sediments into mineral media containing minimal
sediment. In addition, a new mode of delivering the PCB 132, by plating it onto the sides
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and bottom of the serum bottle, was tested. The dechlorination of PCB 132 to 91 to 51 was
maintained in the first enrichment culture. The dechlorination of PCB 51 to 19 was lost. It
is hypothesized that two different microbial populations were responsible for the different
dechlorinating activities and that the population that mediated the reduction of PCB 51 to 19
was lost during the transfer. The extent of dechlorination was less in the first enrichment
culture with 20% of the PCB 132 added converted to daughter products at t = 294 d
compared to 46% at t = 261 d in the microcosms. The dechlorination of PCB 132 was
racemic throughout the incubation of the first enrichment culture. The EF of PCB 91
decreased from t = 0 through t = 105 d, remained steady from t = 105 d through t = 186 d,
then increased significantly at t = 294 d. This pattern differed from the microcosms where
the EF of PCB 91 decreased to zero. The first enrichment culture was methanogenic, with
slightly less of the electron donor added being converted to methane. An electron balance
performed using t = 294 d data did not account for the entire amount of donor added,
indicating that some products were not measured. Chloride analysis was attempted, but the
higher concentration of lactate in the first enrichment culture interfered with the analysis.
The interference could not be resolved and measurement of chloride was discontinued.
4.3. Second Enrichment Culture
After 186 days of incubation, supernatant from the first enrichment culture was
transferred (10% v/v) to new serum bottles to create three new treatments, 3-1 (LH +
PCB 132), 3-2 (Live Control), and 3-3 (Electron Donor Control). Treatment 3-1 (LH +
PCB 132) consisted of inoculum, RAMM, lactate as an electron donor, and PCB 132 that
had been plated onto the walls of the bottle. Treatment 3-2 (Live Control) consisted of
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inoculum and RAMM. Treatment 3-3 (Electron Control Donor) consisted of inoculum,
RAMM, and lactate as an electron donor. These bottles are referred to throughout this
document as the second enrichment culture. The results for these three treatments are
presented below. Killed controls were not prepared for the enrichment culture. It is
reasonable to assume that as reductive dechlorination did not occur in the sediment-rich,
heterogeneous environment of the microcosms it would not occur in the enrichment culture
either.
4.3.1. PCB Results
4.3.1.1. Achiral
Because the serum bottles for the second enrichment culture were also plated with
PCB 132, the congener specific results are presented in the same manner as for the first
enrichment culture. Early in the incubation period, one of the bottles from treatment 3-1
(LH + PCB 132) burst from accumulation of gases (presumably methane and carbon
dioxide), leaving only two bottles in the treatment. The results for that treatment are
therefore the average of the two remaining bottles. The congener specific analysis is shown
in Figure 4.12.
In the second enrichment culture, small but statistically significant (Two-way
ANOVA with replication, α = 0.05) amounts of daughter products were detected at the first
sampling (t = 35 d).

The quantities of daughter products did not change significantly

between t = 35 d and t = 65 d (Two-way ANOVA with replication, α = 0.05). Another
small but significant (Two-way ANOVA with replication, α = 0.05) increase in daughter
products occurred between t = 65 d and t = 96 d. Because of the long delay between the
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Figure 4.12 Average PCB daughter product concentrations for duplicate bottles in treatment 3-1 (LH + PCB 132) of the
second enrichment culture.
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initial increase in daughter products seen at t = 35 d and the next significant increase at
t = 96 d, it seems unlikely that the increase at t = 35 d was due to active dechlorination. It is
more likely that at t = 35 d an equilibrium between the aqueous media and the biomass
added in the inoculum had been established and PCBs 91 and 51 had desorbed from the
biomass and entered the aqueous phase.
Although statistically significant increases in daughter products were seen at t = 35 d
and t = 95 d, relatively high concentrations were not seen until t = 123 d. Thus the lag time
was much longer than in the first enrichment culture where relatively high concentrations
were seen at t = 45 d. This may be due to the absence of sediment in the second enrichment
culture. At t = 123 d, more PCB 51 was present than PCB 91, indicating that the conversion
from PCB 91 to PCB 51 occurred more rapidly than the conversion of PCB 132 to PCB 91,
from the onset of dechlorination. In the first enrichment culture and microcosms, the
PCB 91 concentration was higher than the PCB 51 concentration initially.
It is interesting to note that the amount of daughter products produced in both
bottles of treatment 3-1 (LH + PCB 132) was very similar even though the amount of
PCB 132 present in the aqueous phase varied significantly between the bottles (Figure 4.13).
The most likely explanation for the difference between the two bottles is differences in the
plating; however, the same procedures were followed.
In order to compare the extent of dechlorination that occurred in the microcosms,
first enrichment culture, and second enrichment culture, the sum of the daughter products
(PCBs 91, 51, and 19) as a percentage of the PCB 132 added was calculated. As can be seen
in Figure 4.14, a greater percentage of the PCB 132 was converted to daughter products in
the microcosms and in the first enrichment culture than in the second enrichment culture.
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Figure 4.13 Average PCB 132 concentrations of duplicate samples in the individual bottles of treatment 3-1 (LH + PCB
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Figure 4.14 Average sum of the daughter products (PCB 91 + 51 + 19) of triplicate bottles (Microcosms and First
Enrichment Culture) or duplicate bottles (Second Enrichment Culture) as a percentage of the total moles of PCB added
to the cultures. Error bars represent one standard deviation.
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This was expected, given that no sediment was added to the second enrichment culture and
research has shown that PCB dechlorinators are difficult to grow in the absence of sediment
(Bedard and Quensen, 1995; Wu and Wiegel, 1997; Morris et al., 1992). While the rate of
dechlorination decreased in the second enrichment culture, the dechlorinating activity was
maintained after a major dilution (i.e., during transfer from the first enrichment culture) and
in the absence of sediment.
In addition, the lag phase was much longer in the second enrichment culture than in
the microcosms or first enrichment culture. This is unusual because lag times typically
decrease as the dechlorinating culture is enriched for in successive transfers. The JN culture
demonstrated this more typical behavior, with the lag time decreasing between the third
transfer on autoclaved sediment and the next transfer which did not contain sediment
(Bedard et al, 2006). Two differences between the LH culture and the JN cultures likely
contributed to the longer lag time seen in the LH second enrichment culture.

First,

treatments 2-1 (LH + PCB 132) and 3-1 (LH + PCB 132) were inoculated with supernatant
from the previous culture (Section 3.3). This was done to limit the amount of sediment
transferred in the inocula.

In addition, it likely resulted in a lower number of

microorganisms in the inocula because most of the microbes would be expected to be
attached to the sediment.

Second, the JN culture was transferred three times with

autoclaved sediment prior to being transferred into media without sediment (Bedard et al.,
2006). In contrast, the LH culture was transferred once with autoclaved sediment prior to
being transferred into media without sediment. This likely resulted in a larger dechlorinating
population in the inocula of the sediment-free JN culture than in the LH sediment-free
culture (treatment 3-1).
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PCB concentration has been shown to affect the rate and extent of dechlorination
(see section 2.2.1.2). This phenomenon has typically been studied in situ or in cultures
containing sediment (Abramowicz et al., 1993; Fish, 1996; Quensen et al., 1988; Rhee et al.,
1993c; Sokol et al., 1995; Sokol et al., 1998), making comparison with these reported results
less helpful. However, other studies exist that may shed light on these results. For example,
PCB 61 was added to the DF-1 culture solublized in acetone with a nominal concentration
of 350 µM (102 mg/L) (Wu et al., 2000). Measured concentrations of PCB 61 in the DF
culture corresponded well with the nominal concentration. PCB 65 was added to the o-17
culture solubilized in acetone with a nominal concentration of 173 µM (50.5 µg/mL) (Cutter
et al., 1998). Measured concentrations of PCB 65 corresponded well with the nominal
concentration. The nominal concentration of PCB 132 in the second enrichment culture
was 158 µM. The highest aqueous concentration of PCB 132 measured in bottle #1 of
treatment 3-1 (LH + PCB 132) was 46.1 µM (16.7 µg/mL) or 29% of the nominal
concentration. The highest concentration measured in bottle #2 was 9.2 µM (3.34 µg/mL)
or 6% of the nominal concentration. Plating the PCB 132 on the sides and bottom of the
serum bottles greatly reduced the concentration of PCB 132 in the aqueous phase compared
to adding the PCBs solubilized in acetone as was done in the other studies. In addition the
concentrations in the bottles #1 and #2 of treatment 3-1 (LH + PCB 132) are 6 and 30
times, respectively, lower than the PCB concentration of the DF-1 culture and 3 and 15
times, respectively, lower than the PCB concentration of the o-17 culture. Further study is
needed to determine whether PCB concentration affects reductive dechlorination in
sediment-free cultures in the same manner it appears to affect sediment-containing cultures.
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4.3.1.2. Chiral
The results of the chiral analysis of the second enrichment culture are similar to
those of the microcosms and the first enrichment culture (Figures 4.15 and 4.16). The chiral
signature of PCB 132 remained racemic throughout the experiment. Sufficient PCB 91 was
present in the culture to determine the EF beginning at t = 96 d. At that time point, and for
all subsequent time points, the calculated EF was zero; the first peak was not seen in any of
the samples for these time points.
This pattern differs from that seen in the microcosms (Figure 4.4) and earlier
research (Pakdeesusuk et al., 2003a) where the EF of PCB 91 decreased over the course of
the incubation until it reached zero. In the second enrichment culture the EF of PCB 91
was zero as soon as the concentration of PCB 91 was high enough to be detected. This may
be due to the fact that the amount of PCB 91 in the aqueous phase was much lower in the
second enrichment culture than in the microcosms (Figure 4.14). It also differs from that
seen in the first enrichment culture (Figure 4.10) where the EF of PCB 91 decreased and
then increased again. Because chiral analysis of treatment 3-1 (LH + PCB 132) was not
performed after t = 154 d it is unknown if the enantioselectivity would have reversed as seen
in treatment 2-1 (LH + PCB 132). Additional research is needed to determine if the results
seen in treatment 2-1 (LH + PCB 132) would have occurred in treatment 3-1 (LH +
PCB 132).
4.3.2. Methane and Organic Acids Production
Methane production for the second enrichment culture is shown in Figure 4.17.
Multiple additions of lactate were made to treatments 3-1 (LH + PCB 132) and 3-3
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Figure 4.15 Average enantiomeric fraction of PCB 132 for duplicate bottles in treatment 3-1 (LH + PCB 132) of the
second enrichment culture. Error bars represent one standard deviation.
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Figure 4.16 Average enantiomeric fraction of PCB 91 for duplicate bottles in treatment 3-1 (LH + PCB 132) of the second
enrichment culture. * Indicates that PCB 91 was detected; the EF was zero. Error bars represent one standard
deviation.
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Figure 4.17 Average cumulative methane production for duplicate bottles in treatments 3-1 (LH + PCB 132), 3-2 (Live
Control), and 3-3 (Electron Donor Control) of the second enrichment culture. Arrows indicate times at which lactate
was added to treatments 3-1 (LH + PCB 132) and 3-3 (Electron Donor Control). Error bars represent one standard
deviation.
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(Electron Donor Control) in attempt to stimulate dechlorination. The lactate additions
along with the corresponding increase in methane are shown in Table 4.5.

At t = 0,

8.82 meq lactate (65.39 mg) was added to treatments 3-1 and 3-3. Prior to the second
addition of lactate to treatments 3-1 (LH + PCB 132) and 3-3 (Electron Donor Control) at
t = 79 d, treatment 3-3 (Electron Donor Control) had produced the most methane with
8.94 meq (1.12 mmol) per bottle. This represents 101% of the lactate added initially. That
this exceeds 100% of the available donor is most likely due to variability in the
measurements. Treatment 3-1 (LH + PCB 132) showed less production, 6.34 meq methane
(0.79 mmol) per bottle. This represents 72% of the initial electron donor added. This is
similar to but slightly higher than the percentage of electron donor converted to methane in
the microcosms (treatment 1-1) and first enrichment culture (treatment 2-1). Treatment 3-2
(Live Control) produced the least amount of methane of the three treatments with 2.02 meq
(0.253 mmol) per bottle.
Table 4.5 Average lactate additions and the average amount of methane produced
during that time period expressed as milliequivalents per bottle, mmols per bottle,
and as a percentage of the lactate addition.
Percent of Cumulative
Cumulative Lactate
Lactate Converted to
Added
Cumulative Methane Produced
Methane
Time
Average
Treatment 3-1
Treatment 3-3 Treatment Treatment
meq
mg
meq
mmol
meq
mmol
3-1
3-3
0
8.82
65.39
0.00
0.00
0.00
0.00
79
21.29
157.88
6.34
0.79
8.94
1.12
72%
101%
97
29.09
215.73
14.04
1.76
19.10
2.39
66%
90%
112
38.40
284.75
21.54
2.69
27.98
3.50
74%
96%
134
50.14
371.79
28.70
3.59
34.79
4.35
75%
91%
168
59.09
438.17
37.14
4.64
45.05
5.63
74%
90%
190
69.87
518.09
46.29
5.79
55.03
6.88
78%
93%
206
78.08
578.95
55.86
6.98
65.51
8.19
80%
94%
247
66.64
8.33
74.41
9.30
85%
95%
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In each successive transfer of the LH culture, more of the initial electron donor
addition was converted to methane. The electron donor utilized to produce methane was
unavailable for dechlorinating the PCBs. The increase in methane production with each
transfer corresponds to the decrease in the extent of dechlorination (Figure 4.14). In
treatment 3-1 approximately 3.02 meq of the initial electron donor addition could have been
utilized for dechlorination.
The concentration of organic acids in the second enrichment culture was measured.
The purpose of this was twofold. First, it provided a more efficient method of determining
when to add electron donor by measuring the lactate concentration directly. It is likely that
the lactate was first fermented and then the fermentation products were utilized by the
methanogens, creating a delay between the consumption of lactate and the production of
methane.

Measuring the lactate concentration directly was faster than waiting for the

methane production to plateau.

Second, it yielded information on the intermediate

metabolic products from lactate. This information sheds light on the bacterial community in
the cultures. Figure 4.18 shows the average organic acid concentrations for bottle #1 and
bottle #2 of treatment 3-1 (LH + PCB 132). While the PCB concentrations of the two
bottles were very different (Figure 4.13), the electron donor consumption was similar. The
lactate added to the bottles was fermented to acetate and propionate, which were both
subsequently consumed. There was little accumulation of either acetate or propionate,
however, suggesting that the lactate fermentation occurred at a slower rate than the
consumption of acetate and propionate. The lactate fermentation seen is consistent with
both the acrylate and the succinate-propionate pathways (White, 2000). Members of the
genus Clostridium are known to ferment lactate via the acrylate pathway (White, 2000).
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Figure 4.18 Average lactate consumed, acetate and propionate concentrations for duplicate bottles in treatment 3-1 (LH
+ PCB 132) of the second enrichment culture. Arrows indicate times at which lactate was added. Error bars represent
one standard deviation.
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A number of bacteria, including Propionibacterium, ferment lactate via the succinatepropionate pathway (White, 2000). Propionate can be fermented to H2, carbon dioxide, and
acetate. Hydrogen is commonly used as an electron donor for reductive dechlorination by a
number of species (Cupples et al., 2003; Maymó-Gatell et al., 1997; Sung et al., 2006; Adrian
et al., 2000; He et al., 2003). Identified PCB dechlorinators utilize acetate (Cutter et al.,
2001) and formate (Wu et al., 2000) as electron donors. Experiments to further elucidate the
effects of electron donor on dechlorination by these cultures are described in Section 5.2.
The average electron balance, defined as the ratio of the milliequivalents of products
to donors, was calculated for treatments 3-1 (LH + PCB 132) and 3-3 (Electron Donor
Control), as depicted in Tables 4.6 and 4.7. The initial lactate concentration was calculated
from the known amount added to the second enrichment culture.

The initial sulfate

concentration was calculated using the known concentration of sulfate in the media. All
other initial concentrations were assumed to be zero. The final concentration of methane
was measured using headspace analysis. The final concentrations of PCBs 91 and 51 were
measured by analysis of the medium. The final concentrations of lactate, acetate, and
propionate were measured through analysis of the medium. All other final concentrations
were assumed to be zero.
The average electron balance was 0.80 for treatments 3-1 (LH + PCB 132) and 3-3
(Electron Donor Control; Tables 4.6 and 4.7). This is higher than the electron balance
calculated for the microcosms and first enrichment culture. However it is still low, even
given the uncertainties in measuring the known quantities. The initial amount of electron
donor available is fairly certain. The final amounts of electron donors were measured.
Therefore either some of the products assumed to be zero were not zero or additional
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Table 4.6 Average electron balance of duplicate bottles for treatment 3-1 (LH + PCB
132).
Treatment 3-1 (LH + PCB 132)
Added
Final
Electron
Balancea
mmol/bottle meq/bottle mmol/bottle meq/bottle (meq/bottle)
Donor
Lactate
10.82
129.88
0.00
0.00
129.88
Acetate
0.00
0.00
0.90
7.24
7.24
Proprionate
0.00
0.00
0.00
0.00
0.00
SO420.12
0.93
0.00
0.00
0.93
Products
CH4
0.00
0.00
11.98
95.84
95.84
H2
0.00
0.00
0.00
0.00
0.00
PCB 91
0.00
0.00
2.76E-04
5.53E-04
0.00
PCB 51
0.00
0.00
3.61E-04
1.44E-03
0.00
Products/Donor =
0.80
a
2Initial meq – Final meq, except for SO4 , which was calculated as Final meq – Initial meq
because it was consumed rather than produced.
Table 4.7 Average electron balance of triplicate bottles for treatment 3-3 (Electron
Donor Control).
Treatment 3-3 (Electron Donor Control)
Added
Final
Electron
Balancea
mmol/bottle meq/bottle mmol/bottle meq/bottle (meq/bottle)
Donor
Lactate
10.84
130.12
0.00
0.00
130.12
Acetate
0.00
0.00
0.00
0.00
0.00
Proprionate
0.00
0.00
0.00
0.00
0.00
SO420.12
0.93
0.00
0.00
0.93
Products
CH4
0.00
0.00
12.83
102.63
102.63
H2
0.00
0.00
0.00
0.00
0.00
Products/Donor =
0.80
a
Initial meq – Final meq, except for SO42-, which was calculated as Final meq – Initial meq
because it was consumed rather than produced.
metabolic products were not accounted for in the electron balance. Lactate, acetate, and
propionate were the only peaks quantified from the 60 min chromatogram, which is a
sufficiently long run time to detect longer chain organic acids such as butryrate, caproate,
and valerate, if they were present.

The final concentrations of hydrogen and sulfate were

assumed to be zero for the electron balance calculation. It is possible, though not likely, that
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one or more were present at t = 282 d. A possible metabolic product that was not included
in the electron balance is biomass.
The electron balance was not calculated for treatment 3-2 (Live Control) because
there was no electron donor added and the methane production results showed that there
was an insignificant amount of electron donor present in the treatment.
4.3.3. Absorbance and Visual Observations of Growth
The absorbance of the second enrichment culture was measured as a surrogate for
microbial growth. Prior to the second enrichment culture the measurement of absorbance
was not feasible due to the presence of sediment. Figure 4.19 shows the absorbance for the
second enrichment culture.
Treatments 3-1 (LH + PCB 132) and 3-3 (Electron Donor Control) show an
increase in absorbance and, therefore, biomass with time. The absorbance of treatment 3-2
(Live Control), which received no electron donor additions, decreased perhaps as a result of
biomass decay. The absorbance of treatment 3-3 (Electron Donor Control) appears to have
increased more rapidly than the absorbance of treatment 3-1 (LH + PCB 132); however, at
t = 282 d the absorbances of the two treatments were not statistically different (Student’s
t-test, α = 0.05).
Over the course of the incubation the appearance of the bottles in treatment 3-1,
which were plated with PCB 132, changed. When the PCB 132 was first plated on the walls
of the bottles it looked like small, white, waxy patches on the sides of the bottles. Over time
these patches took on a grayish color, which darkened as the experiment progressed. It was
presumed that this discoloration was due to the formation of a microbial biofilm at the
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Figure 4.19 Average absorbance for duplicate bottles in treatments 3-1 (LH + PCB 132), 3-2 (Live Control), and 3-3
(Electron Donor Control) of the second enrichment culture. Error bars represent one standard deviation.
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PCB 132-media interface. These visual changes were not observed in any of the bottles of
treatments 3-2 (Live Control) or 3-3 (Electron Donor Control).
4.3.4. Second Enrichment Culture Summary
The second enrichment culture was the first attempt to transfer a PCB
dechlorinating culture derived from Lake Hartwell sediments into mineral media without
sediment. Dechlorinating activity was maintained after the transfer to sediment-free media.
The pattern of dechlorination, PCB 132 to PCB 91 to PCB 51, was the same as seen in the
first enrichment culture. The extent of dechlorination was less than that seen in the first
enrichment culture. Chiral PCB analysis indicated that PCB 132 was dechlorinated in a nonenantioselective manner. The EF of PCB 91 was zero at the first time point where PCB 91
was detected (t = 96 d) and remained zero through t = 154 d, when chiral analysis was
halted. Unlike the first enrichment culture a reversal in the enantioselectivity of PCB 91
dechlorination was not seen. Organic acids were measured to allow for faster determination
of when electron donor was depleted and to provide information on the fermentation
products from lactate. Lactate was fermented to acetate and propionate. Because the
second enrichment culture was sediment-free, absorbance could be used as an indicator of
microbial growth. The absorbance of treatments 3-1 (LH + PCB 132) and 3-3 (Electron
Donor Control) increased over the incubation period indicating that biomass increased with
time.
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4.4. Identification of the PCB-Dechlorinating Microorganism
4.4.1. Species Specific PCR
Targeted PCR was used to make an initial screening of genomic DNA from the first
enrichment culture, to determine the presence of known dechlorinating organisms. Primers,
designed to amplify Dehalococcoides species and the DF-1/o-17 group (see section 3.9.1), were
used as these organisms were considered the most likely to be present in the LH culture and
capable of dechlorinating PCBs. Figure 4.20 shows the PCR products of these targeted PCR
reactions. DNA from a commercially available mixed culture containing Dehalococcoides was
used as a positive control for the Dehalococcoides-specific primers (lane 4). This DNA also
served as a negative control for the DF-1/o-17 specific primers (lane 9), as these primers
should not target Dehalococcoides DNA. A positive control for the DF-1/o-17 specific primers
was not available. A band of the appropriate size was present in each of the Dehalococcoides
targeted reactions containing genomic DNA (lanes 1-4). This indicates that Dehalococcoides
was present in the commercial culture (lane 4) as expected and in the LH culture (lanes 1-3).
No band was present in the no template control using the Dehalococcoides-specific primers
(lane 5), indicating that contamination was not present. No bands can be seen for any of the
PCR reactions with the DF-1/o-17 specific primers (lanes 6-9), indicating that DF-1/o-17 or
a closely related species was not present in the LH culture (lanes 6-8) or the commercial
culture (lane 9). There was also no band in the no template control (lane 10), indicating that
contamination was not present.

111

112
Figure 4.20 Dehalococcoides and DF-1/o-17 specific PCR products. Lanes 1-5 used Dehalococcoides specific primers;
lanes 1-3 template DNA from treatment 2-1 (LH + PCB 132); lane 4 template DNA from Dehalococcoides-containing
commercial culture; lane 5 no template control. Lanes 6-10 used DF-1/o-17 specific primers; lanes 6-8 template DNA
from treatment 2-1 (LH + PCB 132); lane 9 template DNA from Dehalococcoides-containing commercial culture; lane 10
no template control.
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4.4.2. Quantitative PCR
qPCR was used to quantify Dehalococcoides 16S rRNA genes and total bacterial 16S
rRNA genes in the second enrichment culture. Figure 4.21 compares the number of copies
of Dehalococcoides 16S rRNA genes per mL culture in treatments 3-1 (LH + PCB 132) and 3-3
(Electron Donor Control). Because of difficulties amplifying the DNA extracted from the
t = 219 d and t = 282 d samples these time points are not shown. The samples collected for
DNA analysis at t = 219 d and t = 282 d were stored in the refrigerator for 4 – 6 months
prior to extracting the DNA. qPCR results using universal bacterial primers were lower than
the results for the t = 184 d samples, indicating the presence of fewer bacteria at the later
time points. Two additional DNA extractions were performed using duplicate samples. For
one of the additional DNA extractions the protocol for extracting DNA from difficult
samples was used per the manufacturer’s direction. qPCR using the second and third DNA
extractions yielded results similar to those of the first qPCR. The concentration of DNA in
the extracts was quantified using absorbance. The concentration of DNA in all of the
t = 219 d and t = 282 d extracts was far lower than in the t = 184 d extracts. It appears that
storing the enrichment culture samples in the refrigerator for a long period of time prior to
extracting the DNA resulted in poor DNA extractability.
The number of Dehalococcoides present increased as PCB 132 was dechlorinated, while
the numbers remained constant in the non-PCB amended control. This indicated clearly
that PCBs are required for growth of Dehalococcoides in the LH culture. Using the number of
Dehalococcoides 16S rRNA gene copies (3.38 x 106) and calculating the amount of chloride
released due to the production of daughter products (3.06 µmol/L; Figure 4.12) the
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Figure 4.21 The concentration of Dehalococcoides 16S rRNA in treatments 3-1 (LH + PCB 132) and 3-3 (Electron Donor
Control) of the second enrichment culture. Error bars represent one standard deviation.
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yield was estimated to be 1.1 x 109 ± 9.6 x 108 Dehalococcoides cells per µmol of chlorine
removed (Table 4.8). This assumes one 16S rRNA gene copy per cell (He et al., 2003). This
yield is very similar to the yield of the JN culture, 9.25 x 108 Dehalococcoides cells per µmol of
chlorine removed (Bedard et al., 2007), and corresponds well with the reported cell yield of
Dehalococcoides strain GT (2.5 x 108 Dehalococcoides cells per µmol of chlorine removed) when
grown using VC as the electron acceptor (Sung et al., 2006), and Dehalococcoides strain VS
(5.2 x 108 Dehalococcoides cells per µmol of chlorine removed) when grown using VC as the
electron acceptor (Cupples et al., 2003).
Although the number of Dehalococcoides increased when PCB 132 was dechlorinated,
they remained a small percentage of the total bacterial population.

At t = 184 d,

Dehalococcoides rRNA copies represented 2.2% of the total bacterial 16S rRNA gene copies in
treatment 3-1 (LH + PCB 132). This is less than the percentage of Dehalococcoides rRNA
copies (approximately 12.5%) in the JN culture (Bedard et al., 2007). Additional research is
needed to develop methods of further enriching or isolating the Dehalococcoides strain(s) in the
LH culture.
4.4.3. Reductive Dehalogenase Genes
qPCR was perfomed using reductive dehalogenase specific primers and probes for
three known reductive dehalogenase genes, tceA, bvcA, and vcrA, and one putative ancestral
reductive dehalogenase gene, ardA.

The ardA gene was sequenced from the BAV1

enrichment culture; however, this gene is located in a hypervariable region which was not
present in the pure culture when it was sequenced (Ritalahti, K; personal communication).
DNA samples from treatments 3-1 (LH + PCB 132) and 3-3 (Electron Donor Control) at
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Table 4.8 Estimated yield for each bottle in treatment 3-1 (LH + PCB 132) and the average of both bottles.

Bottle #1
Bottle #2
Average

PCB 91
PCB 51
(µmol/L) (µmol/L)
0.25
1.12
0.20
1.72
0.23
1.42

Total
Daughter
Products
(µmol/L)
1.36
1.93
1.64

Calculated
Chloride
Released
(µmol/L)
2.48
3.65
3.06

Dehalococcoides
16S rRNA
(copies per mL)
4.79E+06
1.76E+06
1.69E+06
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Yield
(Dehalococcoides cells /
µmol chlorine removed)
1.93E+09
4.81E+08
5.52E+08

Total Bacterial
16S rRNA
(copies per mL)
9.53E+07
5.51E+07
7.52E+07

t = 184 d were used as the template for the qPCR. The ardA gene was detected in all four
samples, with copies being more numerous in the treatment 3-1 (LH + PCB 132) samples.
The number of ardA gene copies (1.50 x 106) in treatment 3-1 (LH + PCB 132) was
approximately half the number of Dehalococcoides 16S rRNA gene copies (3.38 x 106). This
indicates that two different strains or species of Dehalococcoides were present in the second
enrichment culture, one that contained the ardA gene and one that did not. It is possible
that one strain mediates the dechlorination of PCB 132 to PCB 91, while the other strain
mediates the dechlorination of PCB 91 to PCB 51. This is logical given that the conversion
of PCB 132 to 91 was non-enantioselective while the conversion of PCB 91 to 51 was
enantioselective, however it is not proof. The tceA, bvcA, and vcrA genes were not detected
in any of the samples.
Many of the Dehalococcoides strains that have been isolated have been tested to
determine whether or not they carry known reductive dehalogenase genes (Table 4.9).
Dehalococcoides strains 195, BAV1, GT, VS, FL2, and KB-1/PCE are all known to carry one
or more of the reductive dehalogenase genes tceA, bvcA, or vcrA (Magnuson et al., 2000;
Krajmalnik-Brown et al., 2004; Sung et al., 2006; Müller et al., 2004; He et al., 2005; Waller et
al., 2005). Therefore, it is unlikely that any of these strains are responsible for the PCB
dechlorinating activity seen in the LH culture. Strain CBDB1 does not carry the tceA or bvcA
genes (Krajmalnik-Brown et al., 2004; Hölscher et al., 2004) and has not been tested for the
vcrA gene. The KB-1/VC culture does not carry the bvcA gene (Waller et al., 2005) and has
not been tested for the tceA or vcrA genes. It is possible that the LH culture contains strain
CBDB1 and/or the KB-1/VC culture. Strain CBDB1 is known to dechlorinate chlorinated
benzenes via organohalide respiration (Adrian et al., 2000). The KB-1/VC culture is known
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Table 4.9 Presence/absence of reductive dehalogenase genes in Dehalococcoides isolatesa
Isolates
strain 195 strain BAV1
strain GT
strain VS
strain FL2 strain CBDB1
KB-1/VC
(Cornell)
(Pinellas)
(Pinellas)
(Victoria)
(Pinellas)
(Pinellas)
KB-1/PCE
(Pinellas)
b
tceA
+ (2)
- (5)
- (4)
Nt
+ (8)
- (6)
+ (7)
nt
bvcA
- (1)
+ (1)
- (4)
nt
- (1)
- (1)
+ (7)
- (7)
vcrA
- (5)
- (5)
+ (4)
+ (3)
- (5)
nt
+ (7)
nt
a
(+) Gene present in strain. (-) Gene has been tested for and was not found in strain. (nt) Gene has not been tested for in this
strain.
b
References: (1) (Krajmalnik-Brown et al., 2004); (2) (Magnuson et al., 2000); (3) (Müller et al., 2004); (4) (Sung et al., 2006); (5)
(Ritalahti et al., 2006); (6) (Hölscher et al., 2004); (7) (Waller et al., 2005); (8) (He et al., 2005).
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to dechlorinate TCE, cis-DCE, and VC via organohalide respiration (Duhamel et al., 2002).
Experiments performed to determine whether or not the LH culture can dechlorinate
chlorinated benzenes and chlorinated ethenes are described in Chapter 5.
4.4.4. 16S rRNA Clone Library and Sequencing
Dehalococcoides specific primers were used to amplify nearly complete 16S rRNA
sequences from genomic DNA extracted from treatment 3-1 (LH + PCB 132).

The

amplified sequences were cloned and seven clones (C1, C3, C5, C7, C11, C17, and C18) were
sequenced. The minimum identity between the sequences was 99.72%, indicating that all of
the sequences represent the same organism. The LH 16S rRNA sequence most closely
matched the sequences of all known Dehalococcoides strains (>98%), including the JN culture
and D. ethenogenes strain 195.
4.4.5. Identification of the PCB-Dechlorinating Microorganism Summary
Genetic techniques were used to identify the presence of Dehalococcoides in the first
and second enrichment cultures. qPCR showed that the number of Dehalococcoides present in
treatment 3-1 (LH + PCB 132) increased as PCB 132 was dechlorinated, while the numbers
remained constant in treatment 3-3 (Electron Donor Control). This indicated that PCBs
were required for growth of Dehalococcoides in the LH culture.

qPCR using reductive

dehalogenase specific primers and probes for reductive dehalogenase genes showed that the
ardA gene was present, but the tceA, bvcA, and vcrA genes were not.

There were

approximately half as many copies of the ardA gene as there were Dehalococcoides 16S rRNA
copies, indicating the presence of two organisms, one of which contained the ardA gene
while the other did not. Dehalococcoides specific primers were used to amplify and clone nearly
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complete 16S rRNA sequences from the LH second enrichment culture. The sequences
were nearly identical.

The LH 16S rRNA sequence most closely matched all known

Dehalococcoides strains (>98%).
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CHAPTER FIVE
CHARACTERIZATIONOF THE LH PCB DECHLORINATING CULTURE

Electron acceptor, electron donor, and inhibitor experiments were conducted to
further characterize the LH PCB-dechlorinating culture. Genetic techniques identified two
Dehalococcoides strains as the dechlorinating microorganisms in the LH culture. Due to the
high similarity of 16S rRNA of the various Dehalococcoides strains, current genetic techniques
cannot identify individual strains (Cheng and He, 2009; Bedard et al., 2007; Duhamel et al.,
2004). Differences in the electron donors and acceptors utilized can aid in distinguishing
between Dehalococcoides strains. The ability of the LH culture to utilize chlorinated benzenes
and chlorinated ethenes as alternative electron acceptors was tested. The ability of the LH
culture to utilize other electron donors, as well as their effect on dechlorination, was tested.
Inhibitor experiments were performed to help elucidate the community structure within the
LH culture and to attempt to further enrich for the dechlorinating organisms.
5.1. Alternate Electron Acceptors
Dehalococcoides strains are known to utilize a variety of chlorinated compounds as
electron acceptors (Table 2.1).

The LH culture was tested to determine if it would

dechlorinate several chlorinated benzenes and/or chlorinated ethenes. These two classes of
compounds were chosen because they are known to be dechlorinated by various
Dehalococcoides strains. The activity of Dehalococcoides strains on CEs has been studied more
extensively than any other class of chlorinated compounds. While less is known about the
activity of Dehalococcoides on CBs, they are structurally similar to PCBs and are, therefore,
likely candidates to be dechlorinated by the LH culture.
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5.1.1. Chlorobenzene Cultures
Four chlorinated benzenes, 1,2,4-triCB; 1,2-diCB; 1,3-diCB; and 1,4-diCB were
selected to test. 1,2,4-triCB is dechlorinated by Dehalococcoides strain CBDB1 (Adrian et al.,
2000), and the three dichlorobenzenes are all possible daughter products that may undergo
further dechlorination. Dehalococcoides strain CBDB1 also dechlorinates 1,2,3-triCB, 1,2,3,4tetraCB, 1,2,3,5-tetraCB, and 1,2,4,5-tetraCB (Adrian et al., 2000), but does not dechlorinate
hexachlorobenzene or pentachlorobenzene. The VJ culture has only been tested against
1,2,4-triCB; 1,2-diCB; 1,3-diCB; and 1,4-diCB (Elango et al., 2010). These congeners were
selected in order for the VJ culture to serve as a positive control for reductive dechlorination
of chlorinated benzenes.
Figures 5.1 through 5.3 show the chlorinated benzene and daughter product
concentrations in treatments 4-1 (CB LH Culture), 4-2 (CB Positive Control; Section 3.4),
and 4-3 (CB Media Control). Figure 5.4 shows the average concentration of 1,2,4-triCB in
treatments 4-1 (CB LH Culture), 4-2 (CB Positive Control), and 4-3 (CB Media Control).
Table 5.1 lists the final concentration (t = 160 d) of the chlorinated benzenes added and the
percent decrease over the course of incubation. In addition, the final concentrations of CB
and benzene, the potential daughter products due to dechlorination, are shown. All three
treatments show loss of the chlorinated compounds due to diffusion through the septa.
Although these treatments were incubated with the liquid in contact with the septa to
minimize these losses, they were observed in all three treatments.
The only treatment in which 1,2,4-triCB was completely dechlorinated was treatment
4-2 (CB Positive Control), the positive control. The quantity of 1,2,4-triCB in treatment 4-1
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Figure 5.1 Average concentration of chlorinated compounds in triplicate serum bottles for treatment 4-1 (CB LH
Culture). Error bars represent one standard deviation.
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Figure 5.2 Average concentration of chlorinated compounds in triplicate serum bottles for treatment 4-2 (CB Positive
Control). Error bars represent one standard deviation.
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Figure 5.3 Average concentration of chlorinated compounds in triplicate serum bottles for treatment 4-3 (CB Media
Control). Error bars represent one standard deviation.
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Figure 5.4 Average concentration of 1,2,4-triCB in triplicate serum bottles for treatments 4-1 (CB LH Culture), 4-2 (CB
Positive Control), and 4-3 (CB Media Control). Error bars represent one standard deviation.
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Table 5.1 Final concentration of chlorinated compounds, percent decrease over the course of incubation and daughter
products produced in treatments 4-1 (CB LH Culture), 4-2 (CB Positive Control), and 4-3 (CB Media Control). Values
are the average concentration of triplicate bottles. The error is one standard deviation.
1,2,4-triCB
1,2-diCB
1,3-diCB
1,4-diCB
CB
Benzene Methane
µmol/bottle µmol/bottle µmol/bottle µmol/bottle µmol/bottle
µmol/
µmol/
Treatment
% change
% change
% change
% change
bottle
bottle
4-1 (CB LH Culture)
0.21
0.38
0.50
0.96
0.10
0.00
2051
-88%
-67%
-64%
-67%
4-2 (CB Positive Control)
0.00
0.25
0.75
1.23
0.59
0.00
1596
-100%
-87%
-68%
-72%
4-3 (CB Media Control)
0.17
0.47
0.67
1.26
0.10
0.00
1.3
-91%
-73%
-70%
-73%
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(CB LH Culture) was statistically the same (Student’s t-test, α = 0.05) as that in treatment 4-3
(CB Media Control), indicating that the loss of 1,2,4-triCB in treatment 4-1 (CB LH Culture)
was due to diffusion through the septa not dechlorination. Treatment 4-2 (CB Positive
Control) had complete removal of 1,2,4-triCB and almost complete removal of 1,2-diCB
(87%). In addition, treatment 4-2 (CB Positive Control) was the only treatment to show a
significant increase (Single factor ANOVA, α = 0.05) in CB at t = 160 d (0.59 µmol/bottle),
indicating that it was the only treatment in which reductive dechlorination occurred. In
treatment 4-2 (CB Positive Control) 1,2,4-triCB was dechlorinated to 1,2-diCB, which was
further dechlorinated to CB. This is the same dechlorination pattern seen in previous
studies of the VJ Culture (Elango et al., 2010). The decreases in CBs in treatment 4-1 (CB
LH Culture) mirror those in treatment 4-3 (CB Media Control), indicating that these
decreases were due to diffusion through the septa, rather than dechlorination.
Two Dehalococcoides strains are known to dechlorinate 1,2,4-triCB. Dehalococcoides
strain CBDB1 utilizes 1,2,4-triCB as a terminal electron acceptor, deriving energy from the
process (Adrian et al., 2000). Dehalococcoides ethenogenes strain 195 dechlorinates 1,2,4-triCB
cometabolically (Fennell et al., 2004). The LH culture was not able to dechlorinate any of
the chlorinated benzenes tested, including 1,2,4-triCB.

This indicates that neither of

Dehalococcoides strains in the LH culture is strain CBDB1 or D. ethenogenes strain 195.
Figures 5.5 and 5.6 show the cumulative lactate consumed, as well as the transient
acetate and propionate concentrations, and methane produced in treatments 4-1 (CB LH
Culture) and 4-2 (CB Positive Control), respectively.

While chlorinated benzenes and

methane were quantified at t = 160 d, organic acids were not quantified at t = 160 d. In
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Figure 5.5 Average cumulative lactate consumed, transient acetate and propionate concentrations, and methane
produced in triplicate serum bottles for treatment 4-1 (CB LH Culture). Error bars represent one standard deviation.
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Figure 5.6 Average cumulative lactate consumed, transient acetate and propionate concentrations, and methane
produced in triplicate serum bottles for treatment 4-2 (CB Positive Control). Error bars represent one standard
deviation.

130

both treatments the lactate added was converted to acetate and propionate.

Methane

accumulation at t = 160 d was 2.05 ± 0.47mmol/bottle in treatment 4-1 (CB LH Culture)
and 1.60 ± 1.40 mmol/bottle in treatment 4-2 (CB Positive Control). The presence of
acetate and propionate along with the production of methane in treatment 4-1 (CB LH
Culture) indicates that the fermenters and methanogens in the mixed LH culture were not
inhibited by the CBs.

The LH culture cannot dechlorinate CBs under these culture

conditions, however.
The average electron donor balance, defined as the ratio of the milliequivalents of
products quantified to donor added, was calculated for treatments 4-1 (CB LH Culture) and
4-2 (CB Positive Control; Tables 5.3 and 5.4).

The initial lactate concentrations were

calculated from the known amounts added to the bottles. The initial sulfate concentration
was calculated using the known concentration of sulfate in the media. All other initial
concentrations were assumed to be zero.

The concentrations of lactate, acetate, and

propionate were not measured at t = 160 d.

Therefore, the balance was calculated at

t = 97 d for this experiment. The final methane concentration was measured by headspace
analysis on t = 97 d. The final concentrations of lactate, acetate, and propionate were
measured by HPLC. The concentration of CB was measured by GC/ECD.
The average electron donor balance was 2.00 for treatment 4-1 (CB LH Culture) and
1.66 for treatment 4-2 (CB Positive Control). This is high, even given the uncertainties in
measuring the known quantities.

The majority of the electron donor was present as

propionate and methane at t = 97 d. It is possible that the measurement of either one of
these compounds was inaccurate, causing the high electron donor balance. It is also possible
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that the initial concentrations of organic acids were not zereo, because the inocula also
received repeated additions of lactate.
Table 5.2 Average electron donor balance for treatment 4-1 (CB LH Culture).
Initial
Final
Equivalents
meq/
Balancea
meq/bottle
mmol/ bottle meq/ bottle mmol/ bottle bottle
Donor
Lactate
0.79
9.46
0.00
0.00
9.46
Acetate
0.00
0.00
0.00
0.03
0.03
Propionate
0.00
0.00
0.64
7.63
7.63
2Products
SO4
0.12
0.93
0.00
0.00
0.93
CH4
0.00
0.00
1.29
10.34
10.34
CB
0.00
0.00
0.00
0.00
0.00
Products/Donor = 2.00
a
Initial meq – Final meq, except for SO42-, which was calculated as Final meq – Initial
meq because it was consumed rather than produced.
Table 5.3 Average electron donor balance for treatment 4-2 (CB Positive Control).
Initial
Final
Equivalents
Balance
mmol/
meq/
mmol/
meq/
(meq/bottle)
bottle
bottle
bottle
bottle
Donor
Lactate
0.74
8.90
0.00
0.00
8.90
Acetate
0.00
0.00
0.28
2.26
2.26
Propionate
0.00
0.00
0.74
8.83
8.83
2Products
SO4
0.12
0.93
0.00
0.00
0.93
CH4
0.00
0.00
0.35
2.78
2.78
CB
0.00
0.00
0.00
0.00
0.00
Products/Donor = 1.66
a
2Initial meq – Final meq, except for SO4 , which was calculated as Final meq – Initial meq
because it was consumed rather than produced.
5.1.2. Chloroethene Cultures
PCE, TCE, cis-DCE, and VC were the chlorinated ethenes tested. All of the known
strains of Dehalococcoides, except strain CBDB1, can utitilize one or more of these compounds
as their terminal electron acceptor (Table 2.1). Figures 5.7 through 5.9 show the chlorinated
ethene and ethene concentrations for treatments 4-4 (CE LH Culture), 4-5 (CE Positive
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Figure 5.7 Average concentration of chlorinated compounds in triplicate serum bottles for treatment 4-4 (CE LH
Culture). Error bars represent one standard deviation.
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Figure 5.8 Average concentration of chlorinated compounds in triplicate serum bottles for treatment 4-5 (CE Positive
Control). Error bars represent standard deviation.
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Figure 5.9 Average concentration of chlorinated compounds in triplicate serum bottles for treatment 4-6 (CE Media
Control). Error bars represent standard deviation.
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Control), and 4-6 (CE Media Control). Table 5.4 lists the final concentrations (t = 160 d) of
the chlorinated ethenes added and the percent decrease over the course of incubation. In
addition, the final concentration of ethene, which is the terminal daughter product from
dechlorination, is shown. All three treatments show loss of the chlorinated compounds due
to diffusion through the septa. These cultures were incubated in the same manner as the CB
cultures to minimize losses. Treatment 4-5 (CE Positive Control) had almost complete
removal of PCE and TCE, which decreased 97% and 99%, respectively. cis-DCE and VC
show smaller decreases, 16% and 41% respectively. cis-DCE and VC are intermediate
products in the dechlorination of PCE and TCE to ethene. With time it is expected that the
cis-DCE and VC would also have been dechlorinated to ethene. Treatment 4-4 (CE LH
Culture) behaved almost identically to treatment 4-6 (CE Media Control), indicating that all
of the loss of CEs observed was due to diffusion through the septa rather than
dechlorination. No ethene was produced in treatment 4-4 (CE LH Culture), a further
indication that no reductive dechlorination occurred.
Multiple Dehalococcoides strains are known to dechlorinate chlorinated ethenes.
Dehalococcoides ethenogenes strain 195 (Maymó-Gatell et al., 1999), Dehalococcoides strains BAV1
(He et al., 2003), GT (Sung et al., 2006), VS (Müller et al., 2004), FL2 (He et al., 2005),
KB-1/VC (Duhamel et al., 2004), and MB (Cheng and He, 2009) utilize one or more of the
chlorinated ethenes tested in this experiment as terminal electron acceptors and derive
energy from the process (Table 2.2).

In addition,

Dehalococcoides ethenogenes strain 195

(Maymó-Gatell et al., 1999), Dehalococcoides strains BAV1 (He et al., 2003), VS (Müller et al.,
2004), and FL2 (He et al., 2005) dechlorinate one or more of the chlorinated ethenes tested

136

Table 5.4 Final concentration of chlorinated compounds, percent decrease over the course of incubation and daughter
products produced in treatments 4-4 (CE LH Culture), 4-5 (CE Positive Control), and 4-6 (CE Media Control)
PCE
TCE
cDCE
VC
Ethene
Methane
µmol/bottle µmol/bottle µmol/bottle µmol/bottle
Treatment
% change
% change
% change
% change µmol/bottle µmol/bottle
4-4 (CE LH Culture)
2.52
0.92
2.16
1.61
0.00
71.48
-50%
-49%
-35%
-20%
4-5 (CE Positive Control)
0.14
0.02
2.80
1.18
3.56
34.05
-97%
-99%
-16%
-41%
4-6 (CE Media Control)
2.70
1.01
2.42
1.35
0.00
0.00
-51%
-48%
-27%
-32%
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in this experiment co-metabolically (Table 2.2). The LH culture was not able to dechlorinate
any of the chlorinated ethenes tested. This indicates that neither of Dehalococcoides strains in
the LH culture is D. ethenogenes strain 195, Dehalococcoides strain BAV1, strain GT, strain VS,
strain FL2, or strain KB-1/VC. In combination with the results of the chlorinated benzene
treatments (Section 5.1.1) this indicates that the Dehalococcoides strains in the LH culture are
novel strains that have not been identified before.
The cumulative lactate consumed, transient acetate and propionate concentrations,
and methane produced are shown in Figures 5.10 and 5.11 for treatments 4-4 (CE LH
Culture) and 4-5 (CE Positive Control), respectively. In both treatments the lactate was
fermented to acetate and propionate. Treatment 4-5 (CE Positive Control) produced very
little methane (0.03±0.00 mmol/bottle, t = 160 d). Treatment 4-4 (CE LH Culture) also
produced very little methane (0.07±0.03 mmol/ bottle, t = 160 d), which was unexpected.
In addition, while lactate was fermented to acetate and propionate, neither of the
fermentation products was consumed in treatment 4-4 (CE LH Culture). In contrast, acetate
and propionate never accumulated in the second enrichment culture (Figure 4.18). The LH
culture is methanogenic and typically produces substantial quantities of methane (Figures
4.5, 4.10, and 4.13). This indicates that the presence of CEs inhibited the methanogens in
the culture. This also accounts for the accumulation of acetate in treatment 4-4 (CE LH
Culture) as the majority of acetate seen in treatment 3-1 (LH + PCB 132) was accounted for
by methane in the final electron donor balance.
Chloroethenes may have also inhibited the dechlorinating members of the LH
culture. Inhibition of dechlorination of one chlorinated compound by another chlorinated
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Figure 5.10 Average cumulative lactate consumed, transient acetate and propionate concentrations, and methane
produced in triplicate serum bottles for treatment 4-4 (CE LH Culture). Error bars represent standard deviation.
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Figure 5.11 Average cumulative lactate consumed, transient acetate and propionate concentrations, and methane
produced in triplicate serum bottles for treatment 4-5 (CE Positive Control). Error bars represent standard deviation.
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compound has been documented for several dechlorinating species.

Aroclor 1260

(800 mg/L) and PCB 30 (44.6 mg/L) inhibited dechlorination of PCB 65 by the o-17 mixed
culture (May et al., 2006). Chloroform (0.450 mg/L) and 1,1,1-trichlorethane (0.7-3.0 mg/L)
inhibited the dechlorination of TCE, cis-DCE, and VC by the KB-1/TCE subculture
(Duhamel et al., 2002). Chloroform also inhibited the dechlorination of chlorinated ethenes
by Dehalococcoides ethenogenes strain 195 (Maymó-Gatell et al., 2001). PCE, TCE, cis-DCE, and
VC were added to treatment 4-4 (CE LH Culture) at concentrations ranging from 0.78 –
3.85 mg/L (Table 3.6). This is similar to the CF and 1,1,1-trichloroethane concentrations
that inhibited dechlorination by the KB-1/TCE subculture (Duhamel et al., 2002), but less
than the PCB concentrations that inhibited the o-17 mixed culture (May et al., 2006).
Additional research is needed to determine if the PCB-dechlorinating activity of the LH
culture is inhibited by chlorinated ethenes.
The average electron donor balance for treatments 4-4 (CE LH Culture) and 4-5 (CE
Positive Control; Tables 5.5 and 5.6) was calculated in the same manner as the electron
donor balance for the CB amended treatments. The average electron donor balance was
1.47 for treatment 4-4 (CE LH Culture) and 1.44 for treatment 4-5 (CE Positive Control).
This is high, even given the uncertainties in measuring the known quantities. The majority
of the electron donor was present as acetate and propionate at t = 97 d. Only a small
quantity of methane was produced in either treatment. This indicates that the HPLC
quantification of the organic acids was inaccurate, resulting in the high electron donor
balance. The samples from treatments 4-1 (CB LH Culture) and 4-2 (CB Positive Control)
were analyzed for fatty acids at the same time as those from treatments 4-4 (CE LH Culture)
and 4-5 (CE Positive Control). It is likely that the same inaccuracy occurred in those
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samples, resulting in the high electron donor balances for treatments 4-1 (CB LH Culture)
and 4-2 (CB Positive Control) discussed previously.
Table 5.5 Average electron donor balance for treatment 4-4 (CE LH Culture).
Initial
Final
Equivalents
Balance
mmol/bottle meq/bottle mmol/bottle meq/bottle (meq/bottle)a
Donor
Lactate
0.76
9.14
0.00
0.00
9.14
Acetate
0.00
0.00
0.46
3.67
3.67
Propionate
0.00
0.00
0.72
8.64
8.64
Products
SO420.12
0.93
0.00
0.00
0.93
CH4
0.00
0.00
0.03
0.21
0.21
CB
0.00
0.00
0.00
0.00
0.00
Products/Donors = 1.47
a
Initial meq – Final meq, except for SO42-, which was calculated as Final meq – Initial meq
because it was consumed rather than produced.
Table 5.6 Average electron donor balance for treatment 4-5 (CE Positive Control).
Initial
Final
Equivalents
Balance
mmol/bottle meq/bottle mmol/bottle meq/bottle (meq/bottle)a
Donor
Lactate
0.76
9.10
0.00
0.00
9.10
Acetate
0.00
0.00
0.42
3.36
3.36
Propionate
0.00
0.00
0.72
8.62
8.62
2Products
SO4
0.12
0.93
0.00
0.00
0.93
CH4
0.00
0.00
0.03
0.23
0.23
CB
0.00
0.00
0.00
0.01
0.01
Products/Donors = 1.44
a
Initial meq – Final meq, except for SO42-, which was calculated as Final meq – Initial meq
because it was consumed rather than produced.
5.1.3. Alternate Electron Acceptor Summary
The LH culture was unable to dechlorinate any of the chlorinated compounds tested.
This suggests that the two Dehalococcoides strains in the LH culture are novel strains; all of the
previously identified Dehalococcoides strains dechlorinate one or more of the chlorinated
compounds tested. In addition, chlorinated ethenes inhibited methanogenesis in the LH
culture.
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5.2. Effect of Electron Donors
A variety of electron donors were tested to determine the effects on the LH culture.
Research has shown that different electron donors can affect the rate of PCB dechlorination
(Pulliam Holoman et al., 1998; Wu et al., 2000). The o-17 (Cutter et al., 1998) and DF-1 (Wu
et al., 2000) PCB-dechlorinating cultures were initially grown on a mixture of sodium acetate,
sodium propionate, and sodium butyrate. Acetate alone and hydrogen (with carbon dioxide
as a carbon source) were tested to determine their effects on the o-17 culture (Cutter et al.,
2001). Dechlorination was greatest when the o-17 culture was fed 20 mM acetate (Cutter et
al., 2001). Acetate, butyrate, crotonate, formate, fumuarate, lactate, malate, propionate,
pyruvate, and succinate were tested to determine their effects on the DF-1 culture (Wu et al.,
2000). Dechlorination was greatest when the DF-1 culture was fed fumarate as the electron
donor (Wu et al., 2000). In addition, which electron donors are utilized by the culture, as
well as the products produced, give insight into the species present and their potential roles
in the culture. This knowledge can be used in the future to develop better methods for
cultivating the LH PCB dechlorinators.
As seen in the results for the second enrichment culture (Figure 4.18 which shows
the cumulative lactate added and the transient acetate and propionate concentrations in
treatment 3-3), when the LH culture was provided with lactate small quantities of acetate and
propionate were detected intermittently. The potential pathways for consumption of lactate
and its products are shown in Figure 5.12.

Lactate can be fermented to acetate and

propionate (pathway L1) through the acrylate or succinate-propionate pathway (White,
2000).

Succinate was not detected in the second enrichment culture, indicating that

propionate was produced through the acrylate pathway. Lactate can also be fermented to
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Figure 5.12 Potential pathways for microbial consumption of lactate, propionate,
acetate, and hydrogen.
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acetate and carbon dioxide (pathway L2) (Tang et al, 1988), or oxidized to acetate using
sulfate as an electron acceptor (pathway L3) (White, 2000).
Propionate and acetate did not accumulate in the second enrichment culture,
suggesting that they were utilized rapidly by other species in the mixed culture. Propionate
can be fermented to acetate and carbon dioxide (pathway P1) (Stams et al., 1998).
Propionate can be oxidized to acetate using sulfate as an electron acceptor (pathway P2)
(Wallrabenstein et al., 1994). Methanogens, such as Methanosarcina and Methanotrhix, utilize
acetate as an electron donor (pathway A1), producing methane and carbon dioxide (White,
2000). Acetate, carbon dioxide, and hydrogen can be converted to propionate by the SRBs,
Desulfobulbus (pathway A2) (Stams et al., 1998).
While H2 was not measured in the second enrichment culture, it is produced during
ATP synthesis by substrate-level phosphorylation and can be assumed to have been present.
Hydrogen can serve as the electron donor for dechlorination of PCBs (pathway H1) (Cutter
et al., 2001). Hydrogen plus carbon dioxide can be converted to methane (pathway H2)
(Schink, 1997) by methanogens or to acetate (pathway H3) (Schink, 1997) by acetogens.
Lactate, acetate, propionate, and H2 were present in the second enrichment culture
and could have served as the electron donor for the dechlorinating organisms. These
electron donors were tested to determine the effect on the LH culture and dechlorination of
PCBs. For each electron donor, two treatments were prepared, one amended with PCB 132
and a control treatment without. In addition a live control treatment without any electron
donor or PCB 132 was prepared.
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5.2.1. PCB Results
The average concentration of daughter products (PCB 91 and 51) in treatments 5-1
(Lactate + PCB 132), 5-2 (Acetate + PCB 132), 5-3 (Propionate + PCB 132), and 5-4
(Hydrogen + PCB 132) are presented in Figure 5.13. At t = 386 d the concentrations in the
treatments were statistically different (Two-way ANOVA with replication, α = 0.05).
Treatment 5-3 (Propionate + PCB 132) had produced the most daughter products, followed
by treatment 5-1 (Lactate + PCB 132). Treatment 5-4 (Hydrogen + PCB 132) had the
second lowest concentration of daughter products, while treatment 5-2 (Acetate + PCB 132)
had the lowest concentration. From these results it appeared that dechlorination was highest
with propionate as the electron donor.

This was unexpected as none of the known

dechlorinating cultures utilize propionate preferentially. The dechlorinating activity of the
other known PCB dechlorinators, o-17 and DF-1, was greatest when grown on acetate
(Cutter et al., 2001) and fumarate (Wu et al., 2000), respectively. The Dehalococcoides strains
MB (Cheng and He, 2009), CBDB1 (Adrian et al., 2000), VS (Cupples et al., 2003), GT
(Sung et al., 2006), and BAV1 (He et al., 2003), and Dehalococcoides ethenogenes strain 195
(Maymó-Gatell et al., 1997) all utilize hydrogen as the electron donor and acetate as a carbon
source. However, propionate was an effective electron donor for an enrichment culture
containing Dehalococcoides ethenogenes strain 195 (Fennell et al., 1997).
A review of the amount of electron donor added to each treatment showed that at
t = 386 d treatment 5-1 (Lactate + PCB 132) had received 150.42 meq of lactate, treatment
5-2 (Acetate + PCB 132) had received 144.83 meq of acetate, treatment 5-3 (Propionate +
PCB 132) had received 136.46 meq of propionate, and treatment 5-4 (Hydrogen + PCB 132)
had received 20.04 meq of hydrogen. Thus, treatments 5-1 (Lactate + PCB 132), 5-2
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Figure 5.13 Average PCB daughter product concentrations for triplicate bottles in treatments 5-1 (Lactate + PCB 132),
5-2 (Acetate + PCB 132), 5-3 (Propionate + PCB 132), and 5-4 (Hydrogen + PCB 132). Error bars represent one standard
deviation.
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(Acetate + PCB 132), and 5-3 (Propionate + PCB 132) had received approximately seven
times as much electron donor as treatment 5-4 (Hydrogen + PCB 132) at t = 386 d. To
normalize for this, the PCB results were plotted as a function of meq of electron donor
consumed (Figure 5.14) rather than as a function of time. The concentration of daughter
products in treatment 5-4 (Hydrogen + PCB 132) was 0.50 µmol/L after consuming
20.40 meq of hydrogen. In contrast the daughter product concentration in treatment 5-1
(Lactate + PCB 132) was 0.38 µmol/L after consuming twice as much electron donor
(42.90 meq lactate). No daughter products were detected in treatment 5-2 (Acetate +
PCB 132) after consuming twice as much electron donor (45.94 meq acetate) as the
maximum in treatment 5-4 (Hydrogen + PCB 132). A PCB sample with a corresponding
amount of electron donor was not analyzed for treatment 5-3 (Propionate + PCB 132).
Assuming a linear relationship between the amount of electron donor consumed and the
daughter product concentrations, the daughter product concentration can be predicted based
on proportions.

Given 20.40 meq of propionate consumed, the daughter product

concentration is predicted to be 0.23 µmol/L. Based on those numbers, treatment 5-4
(Hydrogen + PCB 132) produced the greatest amount of daughter products per meq of
electron donor consumed.
The LH culture differs from the two known PCB dechlorinators, o-17 and DF-1, in
that hydrogen was the electron donor that produced the most dechlorination.
Dechlorination in the o-17 culture was greatest when acetate was the electron donor (Cutter
et al., 2001). Dechlorination in the DF-1 culture was greatest when fumarate was the
electron donor (Wu et al., 2000). In contrast, all of the isolated Dehalococcoides strains [MB
(Cheng and He, 2009), VS (Cupples et al., 2003), GT (Sung et al., 2006),
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Figure 5.14 Average PCB daughter product concentrations for triplicate bottles in treatments 5-1 (Lactate + PCB 132),
5-2 (Acetate + PCB 132), 5-3 (Propionate + PCB 132), and 5-4 (Hydrogen + PCB 132) as a function of milliequivalents of
electron donor consumed. Error bars represent one standard deviation.
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BAV1 (He et al., 2003), 195 (Maymó-Gatell et al., 1997), CBDB1 (Adrian et al., 2000), and
KB-1/VC (Duhamel et al., 2004)] utilize hydrogen, like the LH culture. Given the results
presented here it seems likely that the LH dechlorinators utilized the hydrogen available in
each of the treatments, while other organisms in the mixed culture utilized the lactate,
propionate, and acetate. Additional research is needed to isolate the LH dechlorinators and
to determine their electron donor specificity.
5.2.2. Methane and Organic Acids Results
The initial protocol called for adding 2.1 meq of electron donor per bottle, or 100
times the amount of electron donor required for complete dechlorination of the PCB 132.
This amount of electron donor was divided into five equal portions and added at t = 0, 52,
100, 128, and 144 d. After 164 days, 2.1 meq of electron donor had been consumed and
very little dechlorination had occurred in any of the treatments. A comparison with the
second enrichment culture showed that at t = 123 d, when significant amounts of PCB 132
daughter products were first measured, treatment 3-1 (LH + PCB 132) had consumed
37.52 meq/bottle (Figure 4.18); therefore, the initial amount of electron donor fed was
insufficient to achieve dechlorination. At this time (t = 164 d) a new feeding strategy was
implemented. The treatments were monitored more frequently and electron donor was
added as soon as all of the previous addition was consumed. In addition, for all treatments
except those supplemented with hydrogen (5-4: Hydrogen + PCB 132 and 5-8: Hydrogen
Control) the amount of electron donor added at each feeding was gradually increased to
approximately 26 meq per bottle. There were physical limitations on the amount of H2 that
could be added at one time. There were either 60 or 73 mL of headspace in each bottle

150

(Section 3.5), depending on whether it was a modified serum bottle or not. The volume of
gas added had to be limited in order to control the internal pressure to that which the bottle
could withstand. The initial amount of H2 added was gradually increased from 0.4 meq (0.1
atm) per bottle to 0.8 meq (0.2 atm) per bottle. This amount was fed to treatments 5-4
(Hydrogen + PCB 132) and 5-8 (Hydrogen Control) for the remainder of the experiment.
The cumulative lactate consumed, transient acetate and propionate concentrations,
and methane produced in treatments 5-1 (Lactate + PCB 132) and 5-5 (Lactate Control) are
shown in Figure 5.15. As seen in the second enrichment culture, lactate was fermented to
acetate and propionate, which were then consumed. While the standard deviations are not
shown as error bars on the figure for clarity, at t = 386 d the amount of lactate consumed,
acetate and propionate concentrations, and methane produced were not significantly
different in the two treatments (Student’s t-test, α = 0.05). The presence of PCB 132 had no
impact on the amount of lactate consumed or the amount of any of the products produced.
Throughout the incubation period, propionate was present in higher concentrations than
acetate. One explanation is that lactate was fermented via the acrylate pathway (Figure 5.12,
pathway L1) which produces two molecules of propionate and one molecule of acetate for
every three molecules of lactate fermented. Alternatively, acetate may be consumed more
rapidly than propionate resulting in more propionate accumulating in the cultures. The first
explanation is more likely because propionate was detected and pathway L1 is the only one
that produces propionate from lactate.
The average electron donor balance, defined as the ratio of the milliequivalents of
products quantified to donor added, was calculated for treatments 5-1 (Lactate + PCB 132)
and 5-5 (Lactate; Tables 5.7 and 5.8). The initial lactate concentrations were calculated from
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Figure 5.15 Average cumulative lactate consumed, transient acetate and propionate concentrations, and methane
produced in triplicate serum bottles for treatments 5-1 (Lactate + PCB 132) and 5-5 (Lactate Control). Error bars not
shown.
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the known amounts added to the bottles. The initial sulfate concentration was calculated
using the known concentration of sulfate in the media. All other initial concentrations were
assumed to be zero. The final concentrations of methane and hydrogen were measured by
headspace analysis.

The final concentrations of lactate, acetate, and propionate were

measured by HPLC. The final concentrations of PCBs 91 and 51 were measured by
GC/ECD.
Table 5.7 Average electron donor balance for treatment 5-1 (Lactate + PCB 132).
Initial
Final
Equivalents
Balance
mmol/bottle meq/bottle mmol/bottle meq/bottle (meq/bottle)a
Donor
Lactate
12.85
154.20
0.00
0.00
154.20
Acetate
0.00
0.00
0.16
1.25
1.25
Propionate
0.00
0.00
0.29
2.90
2.90
2SO4
0.19
1.56
0.00
0.00
1.55
Products
CH4
0.00
0.00
15.89
127.10
127.10
H2
0.00
0.00
0.00
0.00
0.00
PCB 91
0.00
0.00
6.23E-05 1.25E-04
0.00
PCB 51
0.00
0.00
2.89E-05 1.15E-04
0.00
Products/Donors = 0.86
a
Initial meq – Final meq, except for SO42-, which was calculated as Final meq –
Initial meq because it was consumed rather than produced.
Table 5.8 Average electron donor balance for treatment 5-5 (Lactate Control).
Initial
Final
Equivalents
Balance
mmol/bottle meq/bottle mmol/bottle meq/bottle (meq/bottle) a
Donor
Lactate
13.23
158.77
0.00
0.00
158.77
Acetate
0.00
0.00
0.21
1.69
1.69
Propionate
0.00
0.00
1.95
19.47
19.47
SO420.19
1.55
0.00
0.00
1.55
Products
CH4
0.00
0.00
12.61
100.91
100.91
H2
0.00
0.00
0.00
0.00
0.00
Products/Donors = 0.78
a
Initial meq – Final meq, except for SO42-, which was calculated as Final meq – Initial meq
because it was consumed rather than produced.
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The average electron donor balance was 0.86 for treatment 5-1 (Lactate + PCB 132)
and 0.78 for treatment 5-5 (Lactate Control). This is reasonable given the uncertainties in
measuring the known quantities. Less than 0.001% of the meq lactate added was used for
dechlorination of PCBs. The majority of the lactate added was converted to methane. This
indicates that methanogens comprise a major portion of the mixed LH.

This is not

surprising given that dechlorinators were such a low percentage of the overall bacterial
population in the second enrichment culture (Section 4.3.4).
The cumulative amount of acetate consumed and methane produced in treatments
5-2 (Acetate + PCB 132) and 5-6 (Acetate Control) are shown in Figure 5.16. While the
amount of acetate consumed appears to be less in treatment 5-6 (Acetate Control), at
t = 386 d the difference was not statistically significant (Student’s t-test, α = 0.05). Acetate
consumption in one of the three treatment 5-6 (Acetate Control) bottles did not begin until
greater amounts of acetate were added. This phenomena also affected the average amount
of methane produced in treatment 5-6 (Acetate Control), but again at t = 386 d there was
not a statistically significant difference between the two treatments (Student’s t-test,
α = 0.05). Propionate was not detected in either treatment. This indicates that acetate
conversion via pathway A2 (Figure 5.12) did not occur.
The average electron donor balance for treatments 5-2 (Acetate + PCB 132) and 5-6
(Acetate Control; Tables 5.9 and 5.10) was calculated in the same manner as the electron
donor balance for the lactate amended treatments. The average electron donor balance was
0.98 for treatment 5-2 (Acetate + PCB 132) and 0.90 for treatment 5-6 (Acetate Control),
which is reasonable given the uncertainties in measuring the known quantities.
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Figure 5.16 Average cumulative acetate consumed and methane produced in triplicate serum bottles for treatments 5-2
(Acetate + PCB 132) and 5-6 (Acetate Control). Error bars not shown.
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treatment 5-1 (Lactate + PCB 132), less than 0.001% of the meq of acetate added was used
for dechlorination of PCBs, rather the majority of the acetate was converted to methane.
Table 5.9 Average electron donor balance for treatment 5-2 (Acetate + PCB 132).
Initial
Final
Equivalents
Balance
mmol/bottle meq/bottle mmol/bottle meq/bottle (meq/bottle) a
Donor Acetate
17.90
143.21
0.00
0.00
143.21
2SO4
0.10
0.81
0.02
0.16
0.64
CH4
0.00
0.00
17.39
139.14
139.14
Products H
0.00
0.00
0.00
0.00
0.00
2
PCB 91
0.00
0.00
1.08E-05
2.16E-05
2.16E-05
PCB 51
0.00
0.00
3.62E-06
1.45E-05
1.45E-05
Products/Donors = 0.98
a
Initial meq – Final meq, except for SO42-, which was calculated as Final meq – Initial meq
because it was consumed rather than produced.
Table 5.10 Average electron donor balance for treatment 5-6 (Acetate Control).
Initial
Final
Equivalents
Balance
mmol/bottle meq/bottle mmol/bottle meq/bottle (meq/bottle)
Donor Acetate
15.00
120.03
0.00
0.00
120.03
2SO4
0.10
0.81
0.02
0.13
0.68
Products CH4
0.00
0.00
13.40
107.18
107.18
H2
0.00
0.00
0.00
0.00
0.00
Products/Donors = 0.90
a
Initial meq – Final meq, except for SO42-, which was calculated as Final meq – Initial meq
because it was consumed rather than produced.
The cumulative amount of propionate consumed, transient acetate concentration,
and methane produced in treatments 5-3 (Propionate + PCB 132) and 5-7 (Propionate
Control) are shown in Figure 5.17.

A small amount of acetate was present in both

treatments throughout the incubation period. The actual amount of acetate produced may
have been higher, but the acetate was apparently quickly consumed, presumably by
conversion to methane.

The large quantity of methane produced in these treatments

supports this idea. Again there is no statistically significant difference in the amount of
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Figure 5.17 Average cumulative propionate consumed, transient acetate concentration, and methane produced in
triplicate serum bottles for treatments 5-3 (Propionate + PCB 132) and 5-7 (Propionate Control). Error bars not shown.
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propionate consumed, the acetate concentration, or the methane produced at t = 386 d in
the two treatments (Student’s t-test, α = 0.05). Small, transient quantities of acetate were
present in both treatments. This suggests that a combination of pathways P1, A1, and H2
was responsible for conversion of propionate to methane, with pathway A1 occurring at a
high enough rate to prevent an accumulation of acetate.
The average electron donor balance for treatments 5-3 (Propionate + PCB 132) and
5-7 (Propionate Control; Tables 5.11 and 5.12) was calculated in the same manner as the
electron donor balance for the lactate amended treatments. The average electron donor
balance was 0.86 for treatment 5-3 (Propionate + PCB 132) and 0.94 for treatment 5-7
(Propionate Control). This is reasonable given the uncertainties in measuring the known
quantities. Like treatments 5-1 (Lactate + PCB 132) and 5-2 (Acetate + PCB 132), less than
0.001% of the meq of propionate added was used for dechlorination of PCBs, rather the
majority of the acetate was converted to methane.
Table 5.11 Average electron donor balance for treatment 5-3 (Propionate + PCB 132).
Initial
Final
mmol/
meq/
mmol/
meq/ Equivalents Balance
bottle
bottle
bottle
bottle
(meq/bottle) a
Donor Propionate
10.47
125.63
0.68
6.84
118.78
Acetate
0.00
0.00
0.09
0.70
0.70
2SO4
0.10
0.81
0.00
0.01
0.80
Product
CH4
0.00
0.00
12.63
101.03
101.03
s
H2
0.00
0.00
0.00
0.00
0.00
PCB 91
0.00
0.00
4.99E-05
9.98E-05
9.98E-05
PCB 51
0.00
0.00
2.06E-05
8.24E-05
8.24E-05
Products/Donors = 0.86
a
Initial meq – Final meq, except for SO42-, which was calculated as Final meq –
Initial meq because it was consumed rather than produced.
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Table 5.12 Average electron donor balance for treatment 5-7 (Propionate Control).
Initial
Final
mmol/
meq/
mmol/
meq/ Equivalents Balance
bottle
bottle
bottle
bottle
(meq/bottle)
Donor Propionate
10.48
125.73
0.00
0.00
125.73
Acetate
0.00
0.00
0.00
0.00
0.00
2SO4
0.10
0.81
0.00
0.01
0.80
Product
s
CH4
0.00
0.00
14.70
117.63
117.63
H2
0.00
0.00
0.00
0.00
0.00
Products/Donors = 0.94
a
Initial meq – Final meq, except for SO42-, which was calculated as Final meq –
Initial meq because it was consumed rather than produced.
The cumulative amount of hydrogen consumed, transient acetate and propionate
concentrations, and methane produced in treatments 5-4 (Hydrogen + PCB 132) and 5-8
(Hydrogen Control) are shown in Figure 5.18. The amount of hydrogen consumed and
methane produced in the two treatments are virtually identical, indicating that reductive
dechlorination had no impact on electron donor consumption or the metabolic products
produced. An accumulation of acetate was observed at less than 50 d, which was very early
in the incubation period. This suggests the presence of acetogens (pathway H3, Figure 5.12)
in the LH culture. Both an electron donor and a carbon source are required for microbial
growth. Many compounds, such as lactate, can serve as both. When hydrogen is used as the
electron donor an organic compound or carbon dioxide must be available as a carbon
source. No known strains of Dehalococcoides are capable of acetogenesis; the strains that have
been isolated utilize hydrogen as the electron donor and acetate as a carbon source (Cheng
and He, 2009; Sung et al., 2006; Maymó-Gatell et al., 1997). Amending the LH culture with
hydrogen and acetate is a possible strategy for further enriching for Dehalococcoides, as
acetogens would no longer be necessary to provide the needed carbon source. Transient
amounts of propionate were also detected. The only known mechanism for propionate
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Figure 5.18 Average cumulative hydrogen consumed, transient acetate and propionate concentrations, and methane
produced in triplicate serum bottles for treatments 5-4 (Hydrogen + PCB 132) and 5-8 (Hydrogen Control). Error bars
not shown.
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formation given the experimental set-up is pathway A2 (Figure 5.12). This is surprising,
given that propionate was not detected in treatments 5-2 (Acetate + PCB 132) and 5-6
(Acetate Control).

Using the acetate, propionate, and hydrogen concentrations from

treatments 5-2 (Acetate + PCB 132) and 5-4 (Hydrogen + PCB 132) at t = 17 d, the Gibbs
free energy change for the culture conditions was calculated for treatments 5-2 (Acetate +
PCB 132) and 5-4 (Hydrogen + PCB 132).

The higher hydrogen partial pressure of

treatment 5-4 (Hydrogen + PCB 132) shifted the thermodynamics, making pathway A2
feasible in this treatment whereas it was not possible in the acetate fed treatment (treatment
5-2). The hydrogen concentration in the control treatments [5-6 (Acetate Control) and 5-8
(Hydrogen Control)] were similar to those in the PCB-amended treatments, therefore the
Gibbs free energy change would be similar as well.
The average electron donor balance for treatments 5-4 (Hydrogen + PCB 132) and
5-8 (Hydrogen Control; Tables 5.13 and 5.14) was calculated in the same manner as the
electron donor balance for the lactate amended treatments. The average electron donor
balance was 1.13 for treatment 5-4 (Hydrogen + PCB 132) and 1.12 for treatment 5-8
(Hydrogen Control). This is reasonable given the uncertainties in measuring the known
quantities. Like treatments 5-1 (Lactate + PCB 132) and 5-2 (Acetate + PCB 132), less than
0.001% of the meq of hydrogen added was used for dechlorination of PCBs, rather the
majority of the hydrogen was converted to methane.
The fact that methane was produced in all treatments except treatment 5-9 (Live
Control) indicates that methanogens were present and able to grow using all four electron
donors or the products of the electron donor consumption (i.e., the acetate and propionate
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produced in the lactate or hydrogen amended treatments). Methanogens are Archaea and
are strictly anaerobic. Methane accounted for the majority (64–108%) of the electron donor
provided in each of the treatments. This indicates that methanogens are a major component
of the LH culture. It is possible that the methanogens are out-competing the dechlorinators
for electron donor, thus inhibiting dechlorination.
Table 5.13 Average electron donor balance for treatment 5-4 (Hydrogen + PCB 132).
Initial
Final
Equivalents
Balance
mmol/bottle meq/bottle mmol/bottle meq/bottle (meq/bottle) a
Donor
H2
10.20
20.40
0.00
0.00
20.40
Acetate
0.00
0.00
0.00
0.00
0.00
Propionate
0.00
0.00
0.00
0.00
0.00
2SO4
0.12
0.93
0.00
0.03
0.90
Products
CH4
0.00
0.00
2.78
22.21
22.21
PCB 91
0.00
0.00
3.74E-05 7.48E-05
7.48E-05
PCB 51
0.00
0.00
1.23E-05 4.94E-05
4.94E-05
Products/Donors = 1.13
a
Initial meq – Final meq, except for SO42-, which was calculated as Final meq – Initial meq
because it was consumed rather than produced.
Table 5.14 Average electron donor balance for treatment 5-8 (Hydrogen Control).
Initial
Final
Equivalents
Balance
mmol/bottle meq/bottle mmol/bottle meq/bottle (meq/bottle) a
Donor
H2
10.20
20.40
0.00
0.00
20.40
Acetate
0.00
0.00
0.00
0.00
0.00
Propionate
0.00
0.00
0.00
0.00
0.00
Products
2SO4
0.10
0.81
0.00
0.02
0.78
CH4
0.00
0.00
2.76
22.04
22.04
Products/Donors = 1.12
a
Initial meq – Final meq, except for SO42-, which was calculated as Final meq – Initial meq
because it was consumed rather than produced.
Figure 5.19 shows the cumulative amount of electron donor consumed for each of
the PCB-amended treatments. During the early phase of the incubation (t = 0 to t = 200 d),
when all of the treatments were being supplied with equivalent amounts of electron donor,
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Figure 5.19 Average cumulative electron donor consumption in triplicate serum
bottles for treatments 5-1 (Lactate + PCB 132), 5-2 (Acetate + PCB 132), 5-3
(Propionate + PCB 132), and 5-4 (Hydrogen + PCB 132). Error bars represent one
standard deviation.
there was no measurable difference in the cumulative amount of electron donor consumed.
Because of the physical limitations to the amount of hydrogen that could be added at one
time, the cumulative electron donor consumed by treatment 5-4 lagged throughout the
remainder of the experiment.

From t = 200 d to t = 311 d, treatment 5-2 (Acetate +

PCB 132) had the highest cumulative electron donor consumed, followed by treatment 5-1
(Lactate + PCB 132), and 5-3 (Propionate + PCB 132). The amount of electron donor
consumed in treatments 5-1 (Lactate + PCB 132) and 5-3 (Propionate + PCB 132) was
similar until t = 285 d, when the amount of electron donor consumed in treatment 5-1
(Lactate + PCB 132) increased rapidly, matching treatment 5-2 (Acetate + PCB 132) at
t = 311 d.
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Figure 5.20 compares the amount of electron donor consumed by the four control
treatments. The standard deviation among the triplicates for the control treatments was
much greater and obscures any differences there might be among the control treatments,
which explains why there were no statistically significant differences between the amount of
electron donor consumed with and without PCB 132 present.
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Figure 5.20 Average cumulative electron donor consumption in triplicate serum
bottles for treatments 5-5 (Lactate), 5-6 (Acetate), 5-7 (Propionate), and 5-8
(Hydrogen). Error bars represent one standard deviation.
5.2.3. Absorbance Results
Figures 5.21 and 5.22 show the absorbance in the PCB amended treatments
(treatments 5-1 through 5-4) and the controls (treatments 5-5 through 5-9), respectively.
From highest to lowest absorbance the PCB amended treatments are 5-1 (Lactate +
PCB 132), 5-3 (Propionate + PCB 132), 5-2 (Acetate + PCB 132), and 5-4 (Hydrogen +
PCB 132). From highest to lowest absorbance the control treatments are 5-5 (Lactate
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Figure 5.21 Average absorbance in triplicate serum bottles for treatments 5-1 (Lactate
+ PCB 132), 5-2 (Acetate + PCB 132), 5-3 (Propionate + PCB 132), and 5-4
(Hydrogen + PCB 132). Error bars represent one standard deviation.
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Figure 5.22 Average absorbance in triplicate serum bottles for treatments 5-5 (Lactate
Control), 5-6 (Acetate Control), 5-7 (Propionate Control), 5-8 (Hydrogen Control),
and 5-9 (Live Control). Error bars represent one standard deviation.
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Control), 5-6 (Acetate Control), 5-7 (Propionate Control), and 5-8 (Hydrogen Control). This
was expected given that the lactate amended treatments received the greatest amount of
electron donor and the hydrogen amended treatments received the least amount. The
unamended treatment 5-9 (Live Control) showed no significant change in absorbance
between t = 0 and t = 386 d (Student’s t-test, α = 0.05). While the absorbance of treatment
5-3 (Propionate + PCB 132) was greater than that of treatment 5-2 (Acetate + PCB 132), the
reverse was true of the control treatments (treatments 5-6 and 5-7). However, at t = 386 d
there was no statistically significant difference among the four treatments (Single factor
ANOVA, α = 0.05). There were no significant differences between the PCB amended
treatments (5-1 through 5-4) and their respective control treatments (5-5 through 5-8) at
t = 386 d (Student’s t-test, α = 0.05).
5.2.4. Sulfate Results
Sulfate was a component of the media and was monitored because it can serve as an
electron acceptor.

Figures 5.23 and 5.24 show the sulfate concentration in the PCB

amended treatments (treatments 5-1 through 5-4) and the controls (treatments 5-5 through
5-9), respectively. Sulfate was consumed in all nine treatments, indicating that SRBs are
acomponent of the LH culture. SRBs are strictly anaerobic, typically gram negative bacteria
that utilize fatty acids or hydrogen as electron donors and sulfate as an electron acceptor,
reducing it to hydrogen sulfide.

In the absence of chlorinated ethenes, Dehalococcoides

ethenogenes strain 195 did not grow in media amended with sulfate (Maymó-Gatell et al.,
1997), indicating that Dehalococcoides ethenogenes strain 195 cannot use sulfate as an electron
acceptor and is not an SRB. Thus it is likely that the LH Dehalococcoides strains are not SRBs
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Figure 5.23 Average sulfate concentration in triplicate serum bottles for treatments
5-1 (Lactate + PCB 132), 5-2 (Acetate + PCB 132), 5-3 (Propionate + PCB 132), and
5-4 (Hydrogen + PCB 132). Error bars represent standard deviation.
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Figure 5.24 Average sulfate concentration in triplicate serum bottles for treatments
5-5 (Lactate Control), 5-6 (Acetate Control), 5-7 (Propionate Control), 5-8 (Hydrogen
Control), and 5-9 (Live Control). Error bars represent standard deviation.
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and another organism is utilizing sulfate as a terminal electron acceptor. The amount of
electron donor utilized by the SRBs is relatively small (0.4-4% of the electron donor
available; Tables 5-7 through 5-14). This may indicate that the SRBs are a small component
of the LH culture or that the SRBs are also able to grow fermentatively.
The hydrogen amended treatments (5-4: Hydrogen + PCB 132 and 5-8: Hydrogen
Control) consumed sulfate the fastest, followed by the propionate amended treatments (5-3:
Propionate + PCB 132 and 5-7: Propionate Control), then the lactate amended treatments
(5-1: Lactate + PCB 132 and 5-5: Lactate Control), then the acetate amended treatments
(5-2: Acetate + PCB 132 and 5-6: Acetate Control), and finally treatment 5-9 (Live Control).
It is interesting that the hydrogen amended treatments consumed the sulfate most quickly
because those treatments had the lowest amount of electron donor consumed. This suggests
that the hydrogen consuming species preferentially utilizes pathway H4 (Figure 5.12) but is
capable of growing via one of the other pathways, or that the SRB utilizing pathway H4 outcompetes the other hydrogen utilizing species whose growth is limited until the sulfate is
consumed.
Propionate appeared to accumulate in treatments 5-1 (Lactate + PCB 132) and 5-5
(Lactate Control) as sulfate was depleted (Figure 5.15).

Sulfate was added to these

treatments at t = 232 d to test whether it would spur propionate consumption. The second
dose of sulfate was rapidly consumed, accompanied by a decrease in the propionate
concentration. Once the addition of sulfate had been consumed (approximately t = 271 d)
propionate accumulated in treatments 5-1 (Lactate + PCB 132) and 5-5 (Lactate Control).
There was no significant difference between the sulfate consumption for the PCB amended
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treatment versus the control at t = 386 d for any of the electron donors tested (Student’s ttest, α = 0.05).
5.2.5. Electron Donor Summary
At t = 386 d treatment 5-3 (Propionate + PCB 132) contained the highest
concentration of PCB daughter products. However, the four electron donors had been
added at different rates and in different quantities. When dechlorination was normalized by
the amount of electron donor consumed, treatment 5-4 (Hydrogen + PCB 132) had
produced the greatest amount of daughter products. This differs from two of the known
PCB dechlorinators, o-17 and DF-1. It is possible that the LH dechlorinators utilized the
hydrogen available in each of the treatments, while other organisms in the mixed culture
utilized the lactate, propionate, and acetate. Additional research is needed to isolate the LH
dechlorinators and to determine their electron donor specificity.
Based on the organic acid results of treatments 5-1 (Lactate + PCB 132) and 5-5
(Lactate Control), the LH culture appears to ferment lactate to propionate and acetate via
the acrylate pathway (pathway L1, Figure 5.12). In treatments 5-2 (Acetate + PCB 132) and
5-6 (Acetate Control) the majority of the acetate was converted to methane with a very small
portion of the electrons being utilized for dechlorination. Propionate was not detected in
the acetate-fed treatments, indicating that pathway A2 (Figure 5.12) did not occur in these
treatments.

In the propionate-fed treatments (5-3: Propionate + PCB 132 and 5-7:

Propionate Control) acetate was detected at low concentrations suggesting that a
combination of pathways P1, A1, and H2 were active, with acetate consumption by
methanogens occurring at a high enough rate to prevent its accumulation (Figure 5.12).
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Acetate was detected in treatments 5-4 (Hydrogen + PCB 132) and 5-8 (Hydrogen Control),
suggesting the presence of acetogens (pathway H3, Figure 5.12). The acetate produced likely
served as a carbon source for the dechlorinating organisms; carbon dioxide was the only
other carbon source available. In addition, propionate was detected in the hydrogen-fed
treatments, indicating that under these conditions pathway A2 (Figure 5.12) was feasible. In
all eight electron donor amended treatments the majority of the electron donor was
converted to methane, indicating that methanogens predominated in all eight treatments. It
seems likely that the methanogens are out-competing the dechlorinators for electron donor,
thus inhibiting dechlorination.
5.3. Effect of Microbial Inhibitors
Three microbial inhibitors were tested to determine their effects on the LH culture.
By selecting compounds that specifically inhibit certain types of microorganisms their role in
the mixed culture can be inferred. As seen in Figures 4.5, 4.11, and 4.17, the LH culture
remained methanogenic throughout the enrichment process. The culture also contains
SRBs, as evidenced by the consumption of sulfate in all nine of the electron donor
treatments (Figures 5.22 and 5.23). BES and molybdate were used to inhibit each of these
populations, respectively. In addition, vancomycin was used to inhibit the gram positive
bacteria.

Methanogens are Archaea, while SRBs are typically gram negative, thus

vancomycin should inhibit a different population of prokaryotes in the LH culture.
The potential metabolic pathways for the LH culture are shown in Figure 5.12. BES
should inhibit methanogens and thus pathways A1 and H2. Molybdate should inhibit SRBs
and pathways L3, P2, A3, and H4. In addition, molybdate has been shown to inhibit
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methanogens in a variety of microbial cultures including PCB dechlorinating cultures
(Pulliam Holoman et al., 1998), anaerobic digestors (Isa and Anderson, 2005), and
freshwater sediments (Jones et al, 1982). In particular, pathway H3 is known to be carried
out by Clostridia and Acetobacterium woodii (White, 2000), both SRBs. Pathways L1 [Clostridia
(White, 2000)] and H3 [Clostridia and Acetobacterium woodii (White, 2000)] are known to be
carried out by gram positive bacteria which would be inhibited by vancomycin.
5.3.1. PCB Results
The average concentration of daughter products (PCB 91 and 51) in treatments 6-1
(BES + PCB 132), 6-2 (Molybdate + PCB 132), 6-3 (Vancomycin + PCB 132), and 6-4 (No
Inhibitor Control) are presented in Figure 5.25.

At t = 386 d treatments 6-1 (BES +

PCB 132) and 6-2 (Molybdate + PCB 132) showed no dechlorinating activity, while
treatments 6-3 (Vancomycin + PCB 132) and 6-4 (No Inhibitor Control) both showed
activity. While the concentration of daughter products (PCB 91 and 51) was greater in
treatment 6-4 (No Inhibitor Control) the difference was not statistically significant (Two-way
ANOVA with replication, α = 0.05). The concentrations of daughter products in treatments
6-3 (Vancomycin + PCB 132) and 6-4 (No Inhibitor Control) were similar to those seen in
treatments 5-1 (Lactate + PCB 132) and 5-3 (Propionate + PCB 132) in the electron donor
experiment (Figure 5.13).
It was surprising that dechlorination was not seen in treatment 6-1 (BES +
PCB 132), given that dechlorination occurred in both the o-17 (Cutter et al., 2001) and DF-1
(Wu et al., 2000) cultures in the presence of BES. In the o-17 culture, which was also
methanogenic, the addition of BES (3 mM) resulted in only slight inhibition of
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Figure 5.25 Average daughter product concentrations in triplicate serum bottles for treatments 6-1 (BES + PCB 132), 6-2
(Molybdate + PCB 132), 6-3 (Vancomycin + PCB 132), and 6-4 (No Inhibitor Control + PCB 132). Error bars represent
one standard deviation.
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dechlorination when acetate was provided at a concentration of 20 mM, but completely
inhibited dechlorination when the acetate concentration was 5 mM (Cutter et al., 2001). In
the DF-1 culture, which was not methanogenic, the addition of BES (2 mM) resulted in only
slight inhibition of dechlorination (Wu et al., 2000).
It was not surprising that dechlorination was not seen in treatment 6-2 (Molybdate +
PCB 132), given that molybdate inhibited dechlorination in both the o-17 (Pulliam Holoman
et al., 1998) and DF-1 (Wu et al., 2000) cultures. The addition of sodium molybdate at
concentrations of 2 and 20 mM completely inhibited dechlorination and methanogenesis,
and inhibited growth in the o-17 culture (Pulliam Holoman et al., 1998). While Pulliam
Holoman et al. (1998) did not give an explanation for the inhibition of methanogenesis by
molybdate in the o-17 culture, this phenomena has been reported as early as 1982 (Jones et
al., 1982). Molybdate ions can form molybdosulfide complexes (e.g., MoO2S22-; MoS42-),
binding up available free sulfide (Tonsager and Averill, 1980). This may impact microbes
that require sulfide, such as methanogens, and may explain the inhibition of methanogenesis
seen in treatment 6-2 (Molybdate + PCB 132) of this work and in the o-17 culture (Pulliam
Holoman et al., 1998). The addition of sodium molybdate at concentrations of 2 and 20
mM inhibited dechlorination and growth in the DF-1 culture (Wu et al., 2000).
The PCB results for treatments 6-1 through 6-4 indicate that methanogens and SRBs
were necessary for dechlorination given the experimental conditions, while gram positive
bacteria were not. The dechlorinating organisms were identified as two Dehalococcoides species
(Section 4.3.4). Thus it is unlikely that methanogens or SRBs are directly involved in
dechlorinating PCBs, instead they most likely provide a growth factor needed by the
Dehaloccoides species. Given the results of the electron donor experiments (Section 5.2), it is
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likely that the Dehaloccoides species are not capable of utilizing lactate as an electron donor
and instead used the hydrogen and acetate produced when other microorganisms consumed
the lactate.
5.3.2. Methane and Organic Acids Results
The initial protocol for adding electron donor to the inhibitor treatments was the
same as for treatments 5-1 (Lactate + PCB 132) and 5-5 (Lactate Control) of the electron
donor treatments, with 2.1 meq/bottle of lactate being added in five equal portions. The
same slow dechlorination rates were seen in the inhibitor treatments and the feeding
protocol was amended in the same manner as for treatments 5-1 (Lactate + PCB 132) and
5-5 (Lactate Control).
Figure 5.26 shows the cumulative lactate consumed, the transient acetate and
propionate concentrations, and the methane produced in treatment 6-1 (BES + PCB 132).
This treatment consumed the largest quantity of lactate, 146 mmol/L at t = 386 d. This
treatment behaved far differently than the previous LH cultures. The lactate was still
fermented to a mixture of acetate and propionate.

As expected the acetate was not

consumed, as the methanogens that would normally utilize it and produce methane (pathway
A1, Figure 5.12) were inhibited by the BES. Propionate also was not consumed. This is
consistent with the organic acid results of the propionate-fed treatments (5-3: Propionate +
PCB 132 and 5-7: Propionate Control) which suggested that the LH culture contains
methanogens that syntrophically convert propionate to methane and carbon dioxide via
acetate and hydrogen (pathways P1, A1 and H1, Figure 5.12) (Stams et al., 1998). The low
hydrogen partial pressure due to the consumption of hydrogen by the methanogens makes
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Figure 5.26 Average cumulative lactate consumption, transient acetate and propionate concentrations, and methane
produced in triplicate serum bottles for treatment 6-1 (BES + PCB 132). Error bars represent one standard deviation.
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the oxidation of propionate to acetate, carbon dioxide, and hydrogen thermodynamically
feasible.

Thus, the inhibition of the methanogens by BES may have disrupted the

syntrophic conversion of propionate to acetate, or it may have favored acetogenesis, i.e.,
pathway H3.
The average electron donor balance, defined as the ratio of the milliequivalents of
products quantified to donor added, was calculated for treatment 6-1 (BES + PCB 132;
Table 5.15). The initial lactate concentration was calculated from the known amount added
to the bottles.

The initial sulfate concentration was calculated using the known

concentration of sulfate in the media. All other initial concentrations were assumed to be
zero. The final concentration of methane was measured by headspace analysis. The final
concentrations of lactate, acetate, and propionate were measured by HPLC. The final
concentration of sulfate was measure by IC. The final concentrations of PCBs 91 and 51
were measured by GC/ECD.
Table 5.15 Average electron donor balance for treatment 6-1 (BES + PCB 132).
Equivalents
Balance
Initial
Final
(meq/bottle)a
mmol/bottle meq/bottle mmol/bottle meq/bottle
Donor
Lactate
13.77
165.28
0.01
0.17
165.11
Acetate
0.00
0.00
5.37
42.93
42.93
Propionate
0.00
0.00
8.45
101.37
101.37
2SO4
0.21
1.69
0.00
0.00
1.69
Products
CH4
0.00
0.00
0.00
0.00
0.00
PCB 91
0.00
0.00
1.05E-06 2.10E-06
2.10E-06
PCB 51
0.00
0.00
0.00E+00 0.00E+00
0.00E+00
Products/Donors = 0.88
a
2Initial meq – Final meq, except for SO4 , which was calculated as Final meq – Initial meq
because it was consumed rather than produced.
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The average electron donor balance was 0.88 for treatment 6-1 (BES + PCB 132).
This is reasonable given the uncertainties in measuring the known quantities. Less than
0.001% of the meq lactate added was used for dechlorination of PCBs. In contrast to
treatment 3-1, (LH + PCB 132, Table 4.6) and treatment 5-1 (Lactate + PCB 132, Table 5.3)
the majority of the electrons were present as propionate (61%) and acetate (26%) at
t = 386 d.
Figure 5.27 shows the cumulative lactate consumed, the transient acetate and
propionate concentrations, and the methane produced in treatment 6-2 (Molybdate +
PCB 132). This treatment consumed the least amount of lactate, 0.12 mmol/L at t = 386 d.
The addition of molybdate almost completely inhibited the consumption of lactate
(pathways L1, L2, and L3; Figure 5.12). A small amount of acetate was produced. Methane
production was also completely inhibited, most likely because acetate and hydrogen were not
available as substrates (pathways H1 and A1, Figure 5.12).
The complete lack of activity was surprising given that pathway L3 is the only
pathway known to be utilized by SRBs. The ratio of lactate equivalents to sulfate equivalents
was 1:1.2, indicating that there was enough sulfate present to allow conversion of all of the
lactate to acetate via pathway L3. Pathway L1 is utilized by Clostridium species (White, 2000)
and pathway L2 is utilized by Clostridium formicoaceticum (Tang et al, 1988). However, similar
results were seen in the o-17 culture where molybdate completely inhibited dechlorination
and methanogenesis (Pulliam Holoman et al., 1998).

In the DF-1 culture molybdate

inhibited dechlorination and growth (Wu et al., 2000). In addition, non-specific inhibition of
methanogenesis by sodium molybdate has been reported (Oremland and Capone, 1988).
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Figure 5.27 Average cumulative lactate consumption, transient acetate and propionate concentrations, and methane
produced in triplicate serum bottles for treatment 6-2 (Molybdate + PCB 132). Error bars represent one standard
deviation.
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The average electron donor balance for treatment 6-2 (Molybdate + PCB 132;
Table 5.16) was calculated in the same manner as the electron donor balance for the BES
amended treatment.

The average electron donor balance was 0.03 for treatment 6-2

(Molybdate + PCB 132). This is close to the zero balance that was expected, given the lack
of activity in the treatment. The concentration of lactate at t = 386 d, measured by HPLC,
was significantly less (Student’s t-test, α = 0.05) than the concentration of lactate added,
which was calculated based on the weight of a lactate stock solution added to the serum
bottles. However, no other parameters (i.e., production of acetate, propionate, or methane)
indicate that lactate was consumed in treatment 6-2 (Molybdate + PCB 132). The lactate
concentration immediately after the lactate was added was not measured via HPLC. It is
unclear what the fate of the lactate was in this treatment.
Table 5.16 Average electron donor balance for treatment 6-2 (Molybdate + PCB 132).
Initial
Final
Equivalents Balance
mmol/bottle meq/bottle mmol/bottle meq/bottle
(meq/bottle) a
Donor Lactate
0.07
0.80
0.05
0.65
0.14
Acetate
0.00
0.00
0.01
0.04
0.04
Propionate
0.00
0.00
0.00
0.00
0.00
2SO4
0.12
0.93
0.12
0.97
-0.04
Products
CH4
0.00
0.00
0.00
0.00
0.00
PCB 91
0.00
0.00
0.00E+00 0.00E+00
0.00E+00
PCB 51
0.00
0.00
0.00E+00 0.00E+00
0.00E+00
Products/Donors = 0.03
a
Initial meq – Final meq, except for SO42-, which was calculated as Final meq – Initial meq
because it was consumed rather than produced.
Figure 5.28 shows the cumulative lactate consumed, the transient acetate and
propionate concentrations, and the methane produced in treatment 6-3 (Vancomycin +
PCB 132).

This treatment showed the second highest amount of lactate consumed,

109.57 mmol/L at t = 386 d. The addition of vancomycin inhibited the production of
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Figure 5.28 Average cumulative lactate consumption, transient acetate and propionate concentrations, and methane
produced in triplicate serum bottles for treatment 6-3 (Vancomycin + PCB 132). Error bars represent one standard
deviation.
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propionate. This is markedly different from the behavior of treatment 5-1 (Lactate +
PCB 132, Figure 5.15), where the propionate concentration was greater than acetate
concentration. This indicates that at least two different species in the LH culture are capable
of fermenting lactate, one of which is gram positive and ferments lactate to propionate or
more likely, a mix of acetate and propionate (pathway L1, Figure 5.12) and another which is
gram negative and oxidizes lactate to acetate (pathway L3, Figure 5.12). This was expected
as pathway L1 is known to be utilized by Clostridium species (White, 2000) that are not
capable of utilizing sulfate as a terminal electron acceptor, while pathway L3 is utilized by
SRBs (White, 2000). Pathway L2 (Figure 5.12) is utilized by the gram positive bacterium,
Clostridium formicoaceticum (Tang et al., 1988) and would also be inhibited in treatment 6-3
(Vancomycin + PCB 132).
The average electron donor balance for treatment 6-3 (Vancomycen + PCB 132;
Table 5.17) was calculated in the same manner as the electron donor balance for the BES
amended treatment.

The average electron donor balance was 0.88 for treatment 6-3

(Vancomycin + PCB 132). This is reasonable given the uncertainties in measuring the
known quantities. Less than 0.001% of the meq lactate added was used for dechlorination
of PCBs.
Figure 5.29 shows the cumulative lactate consumed, the transient acetate and
propionate concentrations, and the methane produced in treatment 6-4 (No Inhibitor
Control). This treatment showed the third highest amount of lactate consumed at t = 386 d,
96.86 mmol/L. This treatment behaved in a manner similar to treatment 3-3 (LH +
PCB 132, Figure 4.18) of the second enrichment culture and treatment 5-1 (Lactate +
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PCB 132, Figure 5.15) of the electron donor experiment. Lactate was fermented to a
mixture of acetate and propionate, which were then consumed, resulting in the production
of methane.
Table 5.17 Average electron donor balance for treatment 6-3 (Vancomycin +
PCB 132).
Equivalents
Balance
Initial
Final
(meq/bottle)
mmol/bottle meq/bottle mmol/bottle meq/bottle
Donor
Lactate
10.22
122.61
0.00
0.00
122.61
Acetate
0.00
0.00
0.03
0.22
0.22
Propionate
0.00
0.00
0.14
1.72
1.72
2SO4
0.21
1.68
0.00
0.00
1.68
Products
CH4
0.00
0.00
13.07
104.59
104.59
PCB 91
0.00
0.00
1.00E-04
2.01E-04
2.01E-04
PCB 51
0.00
0.00
2.09E-05
8.34E-05
8.34E-05
Products/Donors = 0.88
a
Initial meq – Final meq, except for SO42-, which was calculated as Final meq – Initial meq
because it was consumed rather than produced.
The average electron donor balance for treatment 6-4 (No Inhibitor Control;
Table 5.18) was calculated in the same manner as the electron donor balance for the BES
amended treatment. The average electron donor balance was 0.94 for treatment 6-4 (No
Inhibitor Control). This is reasonable given the uncertainties in measuring the known
quantities. It is similar to the electron donor balance for treatment 5-1 (Lactate + PCB 132,
0.86) of the electron donor experiment. Less than 0.001% of the meq lactate added was
used for dechlorination of PCBs.
Figure 5.30 shows the cumulative amount of electron donor consumed (the amount
of lactate consumed minus the amount of organic acids remaining) for each of the inhibitor
treatments. While treatment 6-1 (BES + PCB 132) consumed the most lactate from t = 0 to
t = 386 d, it had the second lowest cumulative electron donor consumed because the
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Figure 5.29 Average cumulative lactate consumption, transient acetate and propionate concentrations, and methane
produced in triplicate serum bottles for treatment 6-4 (No Inhibitor Control). Error bars represent one standard
deviation.
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majority of the lactate was fermented to acetate and propionate, which persisted. The
percentage of the lactate that was utilized (i.e., that was not fermented to acetate or
propionate) ranged from 44-77% over the time of incubation with the average being 66%.
As a result treatment 6-3 (Vancomycin + PCB 132) had the most cumulative electron donor
consumed, followed by treatment 6-4 (No Inhibitor Control). Treatment 6-2 (Molybdate +
PCB 132) had the least cumulative electron donor consumed, which was expected given that
very little lactate was consumed in that treatment. The cumulative electron donor consumed
by each treatment was statistically different (Single factor ANOVA, α = 0.05).
Table 5.18 Average electron donor balance for treatment 6-4 (No Inhibitor Control).
Initial
Final
Equivalents
Balance
(meq/bottle)
a
mmol/bottle meq/bottle mmol/bottle meq/bottle
Donor Lactate
9.31
111.70
0.00
0.00
111.70
Acetate
0.00
0.00
0.03
0.20
0.20
Propionate
0.00
0.00
1.46
17.46
17.46
SO420.21
1.70
0.00
0.00
1.70
Products
CH4
0.00
0.00
10.64
85.11
85.11
PCB 91
0.00
0.00
1.36E-04
2.71E-04
2.71E-04
PCB 51
0.00
0.00
1.24E-04
4.96E-04
4.96E-04
Products/Donors = 0.94
a
2Initial meq – Final meq, except for SO4 , which was calculated as Final meq – Initial meq
because it was consumed rather than produced.

5.3.3. Sulfate Results
Figure 5.31 shows the sulfate concentration in the four inhibitor treatments. There
was no significant change (Student’s t-test, α = 0.05) in the sulfate concentration in treatment
6-2 (Molybdate + PCB 132) over the course of the incubation, indicating that the molybdate
was effective in inhibiting sulfate reduction. This is not surprising given that almost all
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Figure 5.30 Average cumulative electron donor consumed in the inhibitor experiment. Error bars represent one standard
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Figure 5.31 Average sulfate concentration in triplicate serum bottles for treatments 6-1 (BES + PCB 132), 6-2 (Molybdate
+ PCB 132), 6-3 (Vancomycin + PCB 132), and 6-4 (PCB 132). Error bars represent one standard deviation.
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activity in this treatment, including lactate consumption and methane production was
inhibited. Treatments 6-1 (BES + PCB 132) and 6-4 (No Inhibitor Control) consumed
sulfate the fastest, initially. Sulfate consumption, in treatment 6-3 (Vancomycin + PCB 132),
lagged during the first 150 days of incubation, and then increased rapidly. The sulfate in all
three treatments was depleted around t = 210 d. In treatments 5-1 (Lactate + PCB 132) and
5-5 (Lactate Control) lactate consumption and methane production appeared to lag (Figure
5.15) once the sulfate was depleted. To avoid a possible, similar lag in lactate consumption
and methane production, on day 233, sulfate was added to treatments 6-1 (BES + PCB 132),
6-3 (Vancomycin + PCB 132), and 6-4 (Inhibitor Control).

The sulfate was rapidly

consumed in all three treatments. Lactate consumption and methane production remained
high even after the sulfate addition was consumed.
5.3.4. Inhibitor Experiment Summary
BES and molybdate completely inhibited dechlorination in treatments 6-1 (BES +
PCB 132) and 6-2 (Molybdate + PCB 132), respectively. As the dechlorinating organisms in
the LH culture have been identified as Dehalococcoides strains (Section 4.3.4), this indicates that
methanogens and SRBs provide growth factors necessary for the dechlorinating organisms
under these experimental conditions. In addition, it appears that SRBs are necessary for the
conversion of lactate and propionate to acetate and hydrogen. The results of the electron
donor experiments (Section 5.2) indicated that the Dehalococcoides strains in the LH culture
utilize hydrogen as the electron donor, suggesting that hydrogen is the substrate not available
in treatments 6-1 (BES + PCB 132) and 6-2 (Molybdate + PCB 132).
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While the concentration of daughter products was smaller in treatment 6-3
(Vancomycin + PCB 132) than in the control (treatment 6-4), the difference was not
statistically significant.

This implies that the gram positive bacteria inhibited by the

vancomycin were not the only species capable of providing the necessary substrates (most
likely hydrogen) and growth factors to the Dehalococcoides strains. The pathways known to be
utilized by gram positive bacteria are L1 (White, 2000), L2 (Tang et al. 1988), and H3 (White,
2000) (Figure 5.12).
The addition of BES completely inhibited methane production and dechlorination in
the LH culture.

As a result acetate and propionate accumulated, providing additional

evidence that acetate and propionate are not used as the electron donor for dechlorination.
The addition of molybdate completely inhibited the consumption of lactate. Of the three
pathways for lactate conversion (Figure 5.12) only one is mediated by SRBs. Therefore it is
likely that non-specific inhibition of the other lactate-consuming microorganisms occurred in
treatment 6-2 (Molybdate + PCB 132).

The addition of vancomycin inhibited the

production of propionate in treatment 6-3 (Vancomycin + PCB 132), which was expected
given that pathway L1 is utilized by gram positive bacteria (White, 2000).
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CHAPTER SIX
THE EFFECTS OF BIOAUGMENTATION ON THE
LH PCB-DECHLORINATING CULTURE

6.1. Bioaugmented Microcosms
The bioaugmented microcosms were set up concomitantly with the microcosms
(Chapter 4). The purpose of the bioaugmented microcosms was to determine if the addition
of a culture known to contain Dehalococcoides that chlororespire chlorinated ethenes could
enhance PCB dechlorination in Lake Hartwell sediments. Figures 4.1 and 6.1 show the PCB
concentrations over time for treatments 1-1 (LH + PCB 132) and 7-1 (LH + CCEBC +
PCB 132), respectively. Dechlorination in treatment 7-1 (LH + CCEBC + PCB 132) closely
resembled that seen in treatment 1-1 (LH + PCB 132) in terms of daughter products
produced, and the rate and extent of dechlorination. PCB 132 was dechlorinated to PCB 91,
then PCB 51, and finally PCB 19. Increases in other congeners were not detected. The final
concentration of PCB 132 (t = 567 d) was 77±62 µmol/kg sed in treatment 1-1 (LH +
PCB 132) and 148±43 µmol/kg sed in treatment 7-1 (LH + CCEBC + PCB 132). The
PCB 132 concentration was significantly less is treatment 1-1 (Two-way ANOVA with
replication, α = 0.05). There are two possible explanations of this, first that chlorinated
ethenes present in the commercial culture inhibited the LH culture, and second, that the
commercial culture inhibited the LH culture in some way. The commercial culture was
sparged with a mixture of 70% N2 and 30% CO2 for 30 min to remove the chlorinated
ethenes prior to the culture being added to the microcosms. Therefore it appears that the
commercial culture inhibited the LH culture in treatment 7-1 (LH + CCEBC + PCB 132).
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Figure 6.1 Average PCB dechlorination results for triplicate microcosms in treatment 7-1 (LH + CCEBC+ PCB 132).
Error bars represent one standard deviation.
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Chiral analysis of the PCBs was performed to determine if the addition of the
commercial culture affected the enantioselectivity of the dechlorination. Figures 6.2 and 6.3
show the EF of PCB 132 and PCB 91, respectively.

The EF of PCB 132 remained

unchanged throughout the experiment. The EF of PCB 91 decreased over time. There
were no significant differences between the two treatments at any of the sampling time
points (Student’s t-test, α = 0.05).
Figure 6.4 shows the cumulative methane produced in treatments 1-1 (LH +
PCB 132), 7-1 (LH + CCEBC + PCB 132), and 7-2 (Bioaugmented Electron Donor
Control). At t = 0, 2.0 meq (15mg) of lactate, enough electron equivalents to completely
dechlorinate the PCB 132 and satisfy the sulfate demand, was added to each bottle in
treatments 1-1 (LH + PCB 132), 7-1 (LH + CCEBC + PCB 132), and 7-2 (Bioaugmented
Electron Donor Control). In addition, 34.3 meq of acetone was added to each bottle in the
three treatments. The acetone added to treatments 1-1 (LH + PCB 132) and 7-1 (LH +
CCEBC + PCB 132) was the solvent used to deliver the PCB 132. This provided a total of
36.3 meq of electron donor. An equivalent amount of acetone was added to treatment 7-2
(Bioaugmented Electron Donor Control) because it may also serve as an electron donor.
Prior to the second addition of lactate at t = 357 d, treatment 7-2 (Bioaugmented Electron
Donor Control) had produced the most methane per bottle (21.92 meq or 2.74 mmol),
followed by treatment 1-1 (LH + PCB 132) with 21.6 meq per bottle (2.70 mmol/bottle),
and treatment 7-1 (LH + CCEBC + PCB 132) having produced the least methane
(17.76 meq/bottle; 2.22 mmol/bottle). The methane produced in treatments 1-1 (LH +
PCB 132), 7-1 (LH + CCEBC + PCB 132), and 7-2 (Bioaugmented Electron Donor
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Figure 6.2 Average enantiomeric fraction of PCB 132 for triplicate microcosms in treatments 1-1 (LH + PCB 132) and 7-1
(LH + CCEBC + PCB 132). Error bars represent one standard deviation.
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Figure 6.3 Average enantiomeric fraction of PCB 91 for triplicate microcosms in treatments 1-1 (LH + PCB 132) and 7-1
(LH + CCEBC + PCB 132). * PCB 91 detected; EF equals zero. Error bars represent one standard deviation.
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Figure 6.4 Average cumulative methane produced for triplicate microcosms in treatments 1-1 (LH + PCB 132), 7-1 (LH +
CCEBC + PCB 132), and 7-2 (Bioaugmented Electron Donor Control). Error bars represent one standard deviation.
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Control) represents 58%, 49%, and 59% of the total electron donor available, respectively.
At t = 357 d the amount of methane produced treatments 1-1 (LH + PCB 132), 7-1 (LH +
CCEBC + PCB 132), and 7-2 (Bioaugmented Electron Donor Control) was significantly
different (One-way ANOVA, α = 0.05).
A second addition of lactate (11.9 meq of 88.4 mg) was made at t = 357 d, resulting
in a second period of rapid methane production.

Following the addition, cumulative

methane produced increased in all three treatments until approximately t = 385 d and then
decreased. Decreases were not seen in other treatments analyzed during that time period,
indicating that the response factor remained unchanged. Diffusion through the septa is the
most likely explanation for the decreases.
Methane production in treatment 1-1 (LH + PCB 132) increased 7.76 meq
(0.97 mmol) per bottle, accounting for 65% of the second lactate addition. Treatment 7-1
(LH + CCEBC + PCB 132) had a smaller increase, 5.12 meq (0.64 mmol) per bottle,
accounting for 43% of the lactate added. Treatment 7-2 (Bioaugmented Electron Donor
Control) had the smallest increase in methane, 4.4 meq (0.55 mmol) per bottle, accounting
for 37% of the lactate added. From t = 357 d to t = 567 d, the variability within each
treatment increased for all three treatments. By t = 567 d the three treatments were no
longer significantly different (Single factor ANOVA, α = 0.05).
The average electron balance, defined as the ratio of the milliequivalents of products
quantified to donors added, was calculated for treatments 1-1 (LH + PCB 132) and 7-1 (LH
+ CCEBC + PCB 132); Tables 4.1 and 6.1). The initial lactate and acetone concentrations
were calculated from the known amounts added to the microcosms. The initial sulfate
concentration was calculated using the known concentration of sulfate in the media. All
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other initial concentrations were assumed to be zero. The final concentration of methane
was measured by headspace analysis. The final concentrations of PCBs 91, 51, and 19 were
measure by analysis of the medium/sediment slurry. All other final concentrations were
assumed to be zero.
Table 6.1 Average electron balance for triplicate microcosms in treatment 7-1 (LH +
CCEBC + PCB 132).
Treatment 7-1 (LH + CCEBC + PCB 132)
Added
Final
Electron
Balancea
mmol/bottle meq/bottle mmol/bottle meq/bottle (meq/bottle)
Lactate
1.18
14.20
0.00
0.00
14.20
Donor
Acetone
2.24
35.88
0.00
0.00
35.88
Products SO420.12
0.93
0.00
0.00
0.93
CH4
0.00
0.00
3.52
28.18
28.18
PCB 91
0.00
0.00
3.82E-03
7.65E-03
0.01
PCB 51
0.00
0.00
4.37E-02
1.75E-01
0.17
PCB 19
0.00
0.00
5.68E-02
2.27E-01
0.23
Products/Donors =
0.60
a
2Initial meq – Final meq, except for SO4 , which was calculated as Final meq – Initial meq
because it was consumed rather than produced.
The average electron balance was 0.60 for both treatments 1-1 (LH + PCB 132) and
7-1 (LH + CCEBC + PCB 132). This is low, even given the uncertainties in measuring the
known quantities. As discussed in Section 4.1.2, the most likely explanations are that one or
more of the products assumed to be zero were not zero (i.e., acetone, sulfate, or hydrogen)
or additional metabolic products were present that were not measured. Possible metabolic
products not included in the electron balance are fatty acids such as acetate and propionate,
hydrogen, and biomass.

196

6.2. Bioaugmented Enrichment Culture
The bioaugmented enrichment culture was prepared concomitantly with the first
enrichment culture. The purpose of this enrichment culture was to further test the activity
of the chloroethene-dechlorinating commercial culture, given the negative results of the
bioaugmented microcosms. Transfers were made from treatments 1-1 (LH + PCB 132) and
7-1 (LH + CCEBC + PCB 132), creating treatments 2-1 (LH + PCB 132) and 8-1 (LH +
CCEBC + PCB 132), respectively. In addition, treatments 8-2 (CCEBC + PCB 132), 8-3
(Live Control), and 8-4 (Killed Control) were set up. Adding treatment 8-2 (CCEBC +
PCB 132) tested whether the commercial culture would dechlorinate PCB 132 in the absence
of the LH culture, in other words was the LH culture inhibiting or out-competing the
commercial culture.
Achiral PCB results for the four PCB 132 amended treatments are shown in
Figure 6.5. As with the first enrichment culture, the PCB 132 was plated on the inner
surface of the serum bottles; therefore, the PCB concentration in suspension is not constant.
Rather, the concentration changes as the PCB 132 desorbs from the glass, enters the media,
sorbs to the sediment and biomass and is dechlorinated. Due to the increase in biomass
with time, the amount of PCBs present in suspension also increased. Therefore, the achiral
PCB results are presented in the same manner as the LH enrichment culture, i.e., as the sum
of the PCB 91 and PCB 51 concentrations, expressed as µmol/L. Of the four treatments,
only treatments 2-1 (LH + PCB 132) and 8-1 (LH + CCEBC + PCB 132) showed any
evidence of reductive dechlorination of the PCB 132. Treatment 8-2 (CCEBC + PCB 132),
which was inoculated with only the commercial culture, showed no evidence of reductive
dechlorination of PCB 132 at t = 134 d. There was no statistical difference between the
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Figure 6.5 Average PCB daughter product concentrations for triplicate bottles in treatments 2-1 (LH + PCB 132), 8-1
(LH + CCEBC + PCB 132), 8-2 (CCEBC + PCB 132), and 8-4 (Killed Control). Error bars represent one standard
deviation.
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amount of daughter products produced by treatments 2-2 (LH + PCB 132) and 8-1 (LH +
CCEBC + PCB 132) at t = 45 d and t = 105 d (Two-way ANOVA with replication,
α = 0.05). The amount of daughter products in treratment 2-2 (LH + PCB 132) was greater
than that in treatment 8-1 (LH + CCEBC + PCB 132) at t = 134 d (Two-way ANOVA with
replication, α = 0.05).
The results of chiral analysis of PCB 132 and 91 are shown in Figures 6.6 and 6.7,
respectively. The chiral signature of PCB 132 remains racemic for all four treatments
throughout the 134 day incubation period. The small amount of PCB 91 present at t = 0 in
treatments 2-1 (LH + PCB 132) and 8-1 (LH + CCEBC + PCB 132), 0.2 µmol/L and
0.1 µmol/L, respectively, was due to carryover in the inocula. Thus the t = 0 EF values of
0.37 ± 0.01 and 0.36 ± 0.01 (treatments 2-1 and 8-1, respectively) should be used for all
subsequent comparisons. From t = 0 to t = 134 d the EF of PCB 91 decreased in treatment
2-1 (LH + PCB 132) from 0.37 ± 0.01 to 0.09 ± 0.03 and from 0.36 ± 0.01 to 0.08 ± 0.04 in
treatment 8-1 (LH + CCEBC + PCB 132). This represents a statistically significant change
(Two-way ANOVA with replication, α = 0.05). There was not a statistically significant
difference between the EF of PCB 91 in the two treatments at t = 134 d (Two-way ANOVA
with replication, α = 0.05).
Figure 6.8 shows the cumulative methane produced in treatment 2-1 (LH + PCB
132) and the bioaugmentation enrichment culture. At t = 0, 19.9 meq (147.92 mg) of lactate
was added to each bottle in treatments 2-1 (LH + PCB 132), 8-1 (LH + CCEBC + PCB
132), and 8-2 (CCEBC + PCB 132). Methane production was observed in treatment 8-1
(LH + CCEBC + PCB 132) first, followed by treatment 2-1 (LH + PCB 132), then
treatment 8-2 (CCEBC + PCB 132), at t = 8 d, 21 d, and 39 d, respectively. The amount of
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Figure 6.6 Average enantiomeric fraction of PCB 132 for triplicate bottles in treatments 2-1 (LH + PCB 132), 8-1 (LH +
CCEBC + PCB 132), 8-2 (CCEBC + PCB 132), and 8-4 (Killed Control). Error bars represent one standard deviation.
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Figure 6.8 Average cumulative methane produced for triplicate bottles in treatments 2-1 (LH + PCB 132), 8-1 (LH +
CCEBC + PCB 132), 8-2 (CCEBC + PCB 132), 8-3 (Live Control), and 8-4 (Killed Control). Error bars represent one
standard deviation.
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methane produced at t = 134 d follows the same trend, with treatment 8-1 (LH + CCEBC +
PCB 132) having the greatest amount (15.68 meq/bottle; 1.96 mmol/bottle) over the course
of the incubation, then treatment 2-1 (LH + PCB 132) with 12.4 meq/bottle
(1.55 mmol/bottle), and then treatment 8-2 (CCEBC + PCB 132) with 1.78 meq/bottle
(0.222 mmol/bottle). The methane produced in treatments 2-1 (LH + PCB 132), 8-1 (LH +
CCEBC + PCB 132), and 8-2 (CCEBC + PCB 132) represents 79%, 62%, and 9% of the
total electron donor available, respectively. A statistically insignificant (Student’s t-test,
α = 0.05) amount of methane was produced in treatments 8-3 (Live Control) and 8-4 (Killed
Control).
Comparisons of the amount of methane produced were made between treatments
2-1 (LH + PCB 132), 8-1 (LH + CCEBC + PCB 132), and 8-2 (CCEBC + PCB 132) on the
days that PCB samples were collected, i.e., t = 64 d, 78 d, 105 d, 113 d, and 134 d. There
were no statistically significant differences (Student’s t-test, α = 0.05) between treatments 8-1
(LH + CCEBC + PCB 132) and 2-1 (LH + PCB 132). Beginning at t = 85 days, both of
those treatments were significantly different (Student’s t-test, α = 0.05) from treatment 8-3
(Commercial Culture + PCB 132). The commercial culture is not methanogenic, therefore it
was expected that it would produce less methane than the treatments containing the
methanogenic LH culture.
The average electron balance, defined as the ratio of the milliequivalents of products
to donors was calculated for treatments 2-1 (LH + PCB 132), 8-1 (LH + CCEBC + PCB
132), and 8-2 (CCEBC + PCB 132; Tables 4.4, 6.2, and 6.3, respectively). The initial lactate
concentration was calculated from the known amount added to the first enrichment
cultureand bioaugmentation culture. The initial sulfate concentration was calculated using
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the known concentration of sulfate in the media. All other initial concentrations were
assumed to be zero. The final concentration of methane was measured using headspace
analysis. The final concentrations of PCBs 91 and 51 were measured by analysis of the
medium/sediment slurry. All other final concentrations were assumed to be zero.
Table 6.2 Average electron balance for triplicate bottles in treatment 8-1 (LH +
CCEBC + PCB 132).
Treatment 8-1 (LH + CCEBC + PCB 132)
Added
Final
Electron
Balancea
mmol/bottle meq/bottle mmol/bottle meq/bottle (meq/bottle)
Donor Lactate
1.67
19.98
0.00
0.00
19.98
2Products SO4
0.12
0.93
0.00
0.00
0.93
CH4
0.00
0.00
1.96
15.70
15.70
PCB 91
0.00
0.00
1.22E-03
2.45E-03
0.00
PCB 51
0.00
0.00
1.26E-03
5.04E-03
0.01
Products/Donor =
0.83
a
2Initial meq – Final meq, except for SO4 , which was calculated as Final meq – Initial meq
because it was consumed rather than produced.
Table 6.3 Average electron balance for triplicate bottles in treatment 8-2 (CCEBC +
PCB 132).
Treatment 8-2 (CCEBC + PCB 132)
Added
Final
Electron
mmol/bottl meq/bottl
Balancea
e
e
mmol/bottle meq/bottle (meq/bottle)
Donor
Lactate
0.17
2.06
0.00
0.00
2.06
2Products
SO4
0.12
0.93
0.00
0.00
0.93
CH4
0.00
0.00
0.22
1.78
1.78
PCB 91
0.00
0.00
0.00
1.36E-06
0.00
PCB 51
0.00
0.00
0.00
7.73E-10
0.00
Products/Donor =
1.32
a
2Initial meq – Final meq, except for SO4 , which was calculated as Final meq – Initial meq
because it was consumed rather than produced.
The average electron balance was 0.53 for treatment 2-1 (LH + PCB 132), 0.83 for
treatment 8-1 (LH + CCEBC + PCB 132), and 1.32 for treatment 8-2 (CCEBC + PCB 132).
As discussed in Section 4.2.2, the electron balance for treatment 2-1 (LH + PCB 132) is low,
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either because some of the products assumed to be zero were not zero (i.e., acetone, lactate,
and sulfate) or one or more metabolic products present were not quantified. Possible
metabolic products that were not included in the electron balance are fatty acids such as
acetate and propionate, hydrogen, and biomass. The electron balance for treatment 8-1 (LH
+ CCEBC + PCB 132) is higher than that of treatment 2-1 (LH + PCB 132). However it is
still low, even given the uncertainties in measuring the known quantities.

The same

reasoning given for treatment 2-1 (LH + PCB 132) applies to the electron balance for
treatment 8-1 (LH + CCEBC + PCB 132). The electron balance for treatment 8-2 (CCEBC
+ PCB 132) was greater than one, which would indicate that more products were present at
the end of the experiment than were added to the bottles initially. This is physically
impossible. It is possible that electron donor present in the innocula was not accounted for.
If this occurred, it would have also been true of treatment 8-1 (LH + CCEBC + PCB 132),
which had a low electron balance. The difference in the amount of methane produced in
treatments 8-1 (LH + CCEBC + PCB 132) and 8-2 (CCEBC + PCB 132) may account for
the differences in the electron donor balance.
The absence of daughter products in the commercial culture treatment after 134 days
of incubation, combined with the lack of differences between treatments 2-1 (LH + PCB
132) and 8-1 (LH + CCEBC + PCB 132) indicate that under these experimental conditions
the commercial culture is unable to dechlorinate PCB 132. Both achiral and chiral analyses
of PCBs support this observation. It has been shown that chiral analysis of PCBs can
provide evidence for enantioselective dechlorination (Hall, 2004) even when achiral analysis
of the same samples yielded weak evidence that reductive dechlorination occurred (Müller et
al., 2004). It has been shown that in different environments the preferred enantiomer may

205

differ. For example in a study of the degradation of metalaxyl the R-enantiomer was
degraded much faster than the S-enantiomer in a German soil, whereas the S-enantiomer
was degraded faster in a typical Cameroonian soil (Monkiedje et al., 2003). Differences in
enantioselectivity can be seen on an even smaller scale. In a study of sediment cores from
the same reservoir (Lake Hartwell), the EF of PCB 149 was 0.41 for one sediment core
(G27) and 0.70 for another sediment core (G46) (Wong et al., 2001). Thus it is reasonable
to expect that two different cultures might show differences in their enantioselectivity even
though the differences in the overall congener concentrations were similar.

As no

differences were seen between treatments 2-1 (LH + PCB 132) and 8-1 (LH + CCEBC +
PCB 132), the lack of differences in EF supports the conclusion that there were no
differences between the two treatments.
There is a great deal of diversity in the specificity of the various Dehalococcoides strains
for chlorinated ethenes, as shown in Table 2.1. Thus it is likely that different Dehalococcoides
strains will also have different activities against PCBs. It has been shown that D. ethenogenes
strain 195 can dechlorinate PCB 116, although it is not known whether or not this activity is
linked to growth of the microorganism (Fennell et al., 2004). RFLP analysis of a sedimentfree culture (JN) that dechlorinates Aroclor 1260 revealed the presence of Dehalococcoides
strains CBDB1 and FL2 (Bedard et al., 2006). While there is no definitive evidence given
that the Dehalococcoides strains are responsible for the dechlorinating activity in the JN culture,
the fact that none of the other identified strains in the culture have been associated with
reductive dechlorination makes them the most likely candidates. The commercial culture
used in these experiments contains Dehalococcoides strains BAV1, FL2, and CBDB1 (Duhamel
et al., 2004).

Considering that the commercial culture used contains three strains of
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Dehalococcoides, two of which have been shown to be present in a PCB dechlorinating culture,
it is surprising that activity was not seen in these experiments.
A number of factors play a role in determining whether a particular congener is
dechlorinated. Dechlorination patterns characterized by removal of chlorines at positions
adjacent to the biphenyl bridge have been identified (see section 2.2.1.2). It is postulated
that these dechlorination patterns are due to the action of different microbial populations.
Therefore it is possible that the Dehalococcoides-containing commercial culture is capable of
dechlorinating PCB congeners other than PCB 132. Further studies are needed to evaluate
the ability of the commercial culture to dechlorinate other congeners.
While it has been shown that Dehalococcoides strain 195 is capable of dechlorinating at
least one PCB congener (Fennell et al., 2004) and there is initial evidence that strains FL2
and CBDB1 (Bedard et al., 2006) are capable of dechlorinating several other PCB congeners,
there was no evidence of activity against PCB 132 by the three strains in the commercial
culture used in these experiments. This is interesting given that the PCB dechlorinating
organisms in the LH culture were identified as Dehalococcoides strains. Additional research is
needed to elucidate the role of Dehalococcoides strains in the reductive dechlorination of PCBs.
In addition, research is needed to determine how to cultivate a PCB-dechlorinating
culture for use in the field. Bioaugmentation cultures have been developed from a number
of chlorinated ethene contaminated sites.

Successful field demonstrations have been

conducted using commercially available cultures (Ellis et al., 2000; Major et al., 2002) as well
as cultures developed from the site being remediated (Lendvay et al., 2003). A potential
advantage of bioaugmentation with a culture developed from the site being remediated is
that the culture may be better suited to grow and compete under those geochemical
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conditions. In a similar laboratory experiment testing two bioaugmentation cultures for their
ability to dechlorinate chlorinated ethenes, the bioaugmentation culture developed from the
site (the Department of Energy’s Savannah River Site) was more effective than the
commercial culture used (Wood, 2006). Given the results of the LH bioaugmentation
experiments, developing a culture from the LH enrichment cultures may be a better strategy
for bioaugmentation of PCB-dechlorination in Lake Hartwell than utilizing a commercial
culture.
Finally, research is needed to adapt current bioaugmentation methods for sediment
environments, such as Lake Hartwell. Because of their chemical properties, when released
into the environment PCBs tend to accumulate in sediments.

Bioaugmentation with

Dehalococcoides has been shown to be a successful strategy for remediation of chlorinated
ethenes through field studies (Lendvay et al., 2003; Major et al., 2002; Ellis et al., 2000). All
of these studies were conducted in the subsurface. The techniques used need to be adapted
to the saturated, underwater environment in which PCB contamination is common. Some
of the key issues that need to be resolved are how to add add bioaugmentation cultures and
electron donor in sediment environments, ways to prevent excessive diffusive losses of
electron donor into the water column, and improved, possibly in situ, monitoring
technologies to document remedial activity.
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CHAPTER SEVEN
CONCLUSIONS AND RECOMMENDATIONS

7.1. Conclusions
This study is the first to identify and characterize the PCB dechlorinating
microorganisms in Lake Hartwell, SC. Dehalococcoides rDNA was detected in the actively
dechlorinating LH cultures using targeted PCR primers. qPCR indicated the number of
copies of Dehalococcoides 16S rRNA per mL culture increased as PCB 132 was dechlorinated,
while the number of copies remained constant in the non-PCB amended control. qPCR
using reductive dehalogenase specific primers indicated that ardA gene copies were present
at approximately half the number of Dehalococcoides 16S rRNA copies, indicating that two
strains of Dehalococcoides were present in the LH cultures. Nearly complete Dehalococcoides 16S
rRNA genes from the second enrichment culture were sequenced.

Alignment of the

sequences showed that one sequence was present, which most closely matched the known
Dehalococcoides strains. A principal outcome of this dissertation was the development of a
sediment-free culture from Lake Hartwell sediments that dechlorinated PCB 132 to PCBs 91
and 51.
The specific conclusions of this research are:
1) PCB 132 was dechlorinated to PCB 91, then PCB 51, and finally PCB 19 in
microcosms containing Lake Hartwell sediments with lactate as the electron
donor, as seen previously (Pakdeesusuk et al., 2003a). The dechlorination of
PCB 132 was non-enantioselective, while the dechlorination of PCB 91 was
enantioselective.
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2) The LH dechlorinating microorganisms could be slowly “weaned” off of
sediment by decreasing the amount of dry, autoclaved sediments added during
each transfer of the culture. The dechlorination of PCB 51 to PCB 19 was lost,
however.

It appears likely that the microbial population that dechlorinated

PCB 51 to PCB 19 was lost during the transfer.
3) Based on the results of PCR using Dehalococcoides specific primers Dehalococcoides
were present in actively dechlorinating LH culture but not in cultures without
PCBs present. qPCR using Dehalococcoides specific primers demonstrated that the
number of copies of Dehalococcoides 16S rRNA per mL culture increased as
PCB 132 was dechlorinated, linking PCB dechlorination to the growth of
Dehalococcoides in the LH culture. Based on the qPCR results the yield was
estimated to be 1.1 x 109 Dehalococcoides cells per µmol of chlorine removed.
4) Based on qPCR using reductive dehalogenase specific primers, two distinct
strains of Dehalococcoides were present in the LH cultures, one which carried the
ardA gene and one that did not. The reductive dehalogenase genes tceA, bvcA,
and vcrA were not detected in the LH culture.

Dehalococcoides strains 195

(Magnuson et al., 2000), BAV1 (Krajmalnik-Brown et al., 2004), GT (Sung et al.,
2006), VS (Müller et al., 2004), FL2 (He et al., 2005), and KB-1/PCE (Waller et
al., 2005) are all known to carry one or more of the reductive dehalogenase genes
tceA, bvcA, or vcrA.

Therefore it is unlikely that any of these strains are

responsible for the PCB dechlorinating activity seen in the LH cultures.
5) Dehalococcoides specific primers were used to amplify nearly complete 16S rRNA
sequences from genomic DNA extracted from treatment 3-1 (LH + PCB 132).
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The amplified sequences were cloned and sequenced. All of the sequences
represented the same organism. The LH 16S rRNA sequence most closely
matched the sequences of all known Dehalococcoides strains (>98%), including the
JN culture and D. ethenogenes strain 195.
6) Based on the alternate electron acceptor experiments (Section 5.1) the two
Dehalococcoides strains in the LH culture are novel strains. All of the previously
identified Dehalococcoides strains dechlorinate one or more of the chlorinated
compounds tested.
a) The LH culture did not dechlorinate 1,2,4-triCB, 1,2-diCB, 1,3-diCB, and
1,4-diCB.

Dehalococcoides strain CBDB1 (Adrian et al., 2000) and

Dehalococcoides ethenogenes strain 195 are known to dechlorinate 1,2,4-triCB
(Fennell et al., 2004).
b) The LH culture did not dechlorinate PCE, TCE, cis-DCE, or VC.
Dehalococcoides ethenogenes strain 195 (Maymó-Gatell et al., 1999), and
Dehalococcoides strains BAV1 (He et al., 2003), GT (Sung et al., 2006), VS
(Müller et al., 2004), FL2 (He et al., 2005), KB-1/VC (Duhamel et al., 2004),
and MB (Cheng and He, 2009) utilize one of more the chlorinated ethenes
tested.
7) Based on the electron donor experiments (Section 5.2) dechlorination was
greatest when hydrogen was provided as the electron donor. Acetogens present
in the LH culture provided acetate which was used as a carbon source. It is likely
that the LH dechlorinators utilized the hydrogen produced by fermentation in
the treatments supplied with lactate, propionate, and acetate.
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8) Based on the results of the inhibitor experiments, BES and molybdate
completely inhibit dechlorination in the LH culture.

Vancomycin does not

inhibit dechlorination in the LH culture. The results of the inhibitor experiment
in combination with the results of the electron donor experiment suggest that
BES and molybdate may inhibit the production of growth factors by
methanogens and sulfidogens that are necessary for PCB 132 dechlorination in
the LH culture.
9) The results of the bioaugmentation experiments indicate that the commercial
culture that was evaluated is unable to dechlorinate PCB 132. The commercial
culture contains several types of Dehalococcoides and is widely used for
bioaugmentation at sites contaminated with chlorinated ethenes; however the
strains of Dehalococcoides present in the commercial culture are unable to
dechlorinate PCB 132.
7.2. Recommendations for Future Work
This research identified two novel strains of Dehalococcoides as the microorganisms
responsible for dechlorinating PCBs 132 and 91 in Lake Hartwell sediments.

qPCR

indicated that both Dehalococcoides strains grew as a consequence of reductive dechlorination
of PCB 132, suggesting that the microorganisms utilize PCB 132 and 91 as a terminal
electron acceptor in a respiratory process (i.e., organohalide respiration). The Dehalococcoides
strains were a minor component of the mixed culture, representing approximately 2% of the
total bacterial DNA present. Additional research is needed to develop methods of further
enriching or isolating the Dehalococcoides strains in the LH culture.
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Initial microcosm experiments in this research demonstrated the reduction of
PCB 132, to PCB 91, to PCB 51, to PCB 19. These initial results agreed with previous
research (Pakdeesusuk et al., 2003a) which showed the same dechlorination pattern in Lake
Hartwell sediments. During the enrichment process reported in this research, the PCB 51
dechlorinating activity was lost. Further research is needed to determine why the PCB 51
dechlorinating population was lost and if it can be enriched for under different conditions.
PCB 19 (the product of PCB 51 dechlorination) is a more preferable endpoint for reductive
dechlorinations since, having only three chlorine atoms rather than four, its susceptibility to
aerobic oxidation is greater. In addition, the enrichment culture should be evaluated to
determine its ability to dechlorinate other PCB congeners.
The microbial community reported in this research was capable of utilizing lactate,
acetate, propionate, and hydrogen as an electron donor. Hydrogen was demonstrated to be
the most effective electron donor for reductive dechlorination. It is possible that the LH
dechlorinators utilized the hydrogen available in each of the treatments, while other
organisms in the mixed culture utilized the lactate, propionate, and acetate. Additional
research is needed to isolate the LH dechlorinators and to determine their electron donor
specificity.
The identification of the dechlorinating organisms reported here, along with the
identification of the other PCB-dechlorinating cultures, o-17 (Cutter et al., 2001), DF-1 (Wu
et al., 2002a), and JN (Bedard et al., 2007), is an important step in developing practical
remediation strategies for PCB contaminated sites.

Bioaugmentation is one such

remediation strategy. Several successful bioaugmentation field demonstrations have been
conducted at chlorinated ethene contaminated sites (Ellis et al., 2000; Major et al., 2002;
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Lendvay et al., 2003).

Research is needed to determine how to cultivate a PCB-

dechlorinating culture for use in the field. In addition, research is needed to adapt current
bioaugmentation methods for sediment environments, such as Lake Hartwell.
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